data_2e45_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e45 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD21 ' N ' ' A' ' 15' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.45 -170.78 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.951 1.501 . . . . 0.0 110.121 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.06 121.32 30.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 110.56 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.13 6.02 49.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.4 m95 -120.05 136.53 54.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.875 -1.367 . . . . 0.0 109.858 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.482 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 2.0 mmt -116.35 166.23 12.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.804 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -120.19 106.37 11.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.529 -0.732 . . . . 0.0 109.423 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.7 t -109.41 162.38 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 0.0 110.733 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.63 80.54 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.826 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.88 169.57 17.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.44 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -59.68 -22.5 62.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -81.3 -32.05 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.14 175.95 28.64 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 51.0 m -81.15 113.19 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 49.8 p90 -114.39 -156.21 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.511 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 84.2 m-85 -131.77 135.25 46.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.484 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 4.9 t90 -107.04 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.863 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.68 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -80.06 109.63 14.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.477 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 47.3 mt -67.83 -36.91 10.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 112.616 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.28 -62.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 122.997 0.999 . . . . 0.0 111.833 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.551 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 2.9 t -86.39 -18.16 32.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.918 -1.114 . . . . 0.0 110.536 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 84.41 -13.99 48.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 8.9 m -59.18 160.99 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -1.17 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 154.15 36.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 41.9 mt-30 -142.04 -175.57 4.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -136.8 1.89 2.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 23.1 mt-10 -120.04 160.22 43.9 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 110.088 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.56 110.68 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.944 1.497 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 123.929 1.489 . . . . 0.0 110.323 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.542 HD12 ' CE2' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -71.17 -162.93 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.947 1.498 . . . . 0.0 110.404 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.2 120.23 36.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.477 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.26 -0.08 26.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.571 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 56.8 m95 -117.43 141.81 47.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.543 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.456 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 34.2 mmm -120.71 165.7 14.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 110.73 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -120.64 105.81 11.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.533 -0.73 . . . . 0.0 109.498 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.6 t -107.91 163.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 110.752 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.4 tt0 -121.19 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.737 -0.602 . . . . 0.0 109.767 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.82 174.46 5.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.376 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 p -67.8 -6.71 22.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -26.18 12.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.48 -176.23 38.84 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -94.07 118.42 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -1.13 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.2 p90 -114.48 -154.06 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 15' ' ' LEU . 64.5 m-85 -135.52 135.54 40.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.4 t90 -107.31 132.51 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.805 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.7 t60 -93.22 108.07 19.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.111 . . . . 0.0 110.388 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.592 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 12.4 mt -63.17 -39.23 49.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.468 -0.77 . . . . 0.0 112.542 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 46.2 Cg_endo -73.01 -62.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.125 1.066 . . . . 0.0 111.951 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.579 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.6 -30.78 21.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.134 . . . . 0.0 110.933 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.61 6.86 60.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -74.39 152.58 39.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 110.192 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.12 38.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.532 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 56.2 mt-30 -141.97 -143.57 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.131 -0.981 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.425 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 67.6 t-105 -136.83 -54.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.1 mt-10 -92.04 164.95 21.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.448 -0.782 . . . . 0.0 110.239 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -72.5 129.49 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.991 1.522 . . . . 0.0 110.338 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.1 Cg_endo . . . . . 0 C--N 1.306 -1.66 0 O-C-N 123.868 1.457 . . . . 0.0 110.493 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD13 ' CD ' ' A' ' 16' ' ' PRO . 4.5 mm? . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.05 -159.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.949 1.499 . . . . 0.0 110.203 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.46 123.59 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.689 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 8.83 55.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.3 m95 -120.5 138.82 53.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.944 -1.327 . . . . 0.0 109.899 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 82.1 mmm -120.87 170.29 9.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 110.696 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -120.42 110.26 16.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.495 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -112.39 163.8 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 110.87 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 21.9 tt0 -120.91 91.78 3.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 110.02 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -92.02 -172.67 3.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 110.635 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.8 p -67.12 -33.72 76.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.184 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.568 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -73.3 -18.63 61.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.316 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.21 -172.42 22.95 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 54.7 m -85.51 113.85 22.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.124 . . . . 0.0 110.081 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.3 p90 -114.31 -156.26 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' MET . 58.3 m-85 -128.89 142.3 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 3.9 t90 -112.26 126.99 55.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.062 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.545 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.7 t60 -84.69 109.25 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 110.122 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.596 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 56.0 mt -65.12 -38.25 27.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 112.404 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.7 Cg_endo -74.0 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.115 1.061 . . . . 0.0 111.891 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.545 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.53 -26.94 24.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.84 -1.163 . . . . 0.0 111.096 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.72 0.22 75.76 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -67.91 154.75 40.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -1.171 . . . . 0.0 110.353 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.53 152.84 37.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 109.877 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 49.8 mt-30 -142.15 -168.86 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.568 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 99.6 m95 -137.51 1.12 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.127 -0.983 . . . . 0.0 110.596 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 4.0 mt-10 -120.3 162.11 35.59 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -74.69 116.02 4.48 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.117 1.588 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.763 0 O-C-N 123.949 1.5 . . . . 0.0 110.452 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.0 mm? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.5 Cg_endo -70.07 177.86 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.892 1.469 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.79 122.85 27.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.679 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 4.93 30.5 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.528 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 50.4 m95 -120.49 135.79 54.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.977 -1.308 . . . . 0.0 109.985 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.507 ' SD ' ' CD1' ' A' ' 33' ' ' ILE . 78.9 mmm -120.6 165.83 14.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.895 . . . . 0.0 110.815 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -120.76 114.31 21.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.698 . . . . 0.0 109.659 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 5.4 t -116.87 162.16 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.931 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 pt20 -120.7 99.77 6.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 109.872 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -176.93 3.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 26' ' ' SER . 14.2 p -52.45 -66.34 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -42.09 -51.37 4.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.92 -171.21 42.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 6.7 m -85.1 118.84 24.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.0 p90 -114.34 -158.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 42' ' ' PRO . 24.2 m-85 -129.78 129.47 44.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.986 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.85 120.89 40.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.412 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.578 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.0 t-160 -82.85 110.28 17.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.998 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 30.6 mt -67.66 -40.5 25.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.499 -0.751 . . . . 0.0 112.34 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.2 Cg_endo -73.71 -56.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.286 1.15 . . . . 0.0 111.737 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.565 HG23 ' CE1' ' A' ' 32' ' ' HIS . 15.5 p -86.66 -31.48 21.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.937 -1.102 . . . . 0.0 110.557 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.26 -11.84 69.88 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.5 m -61.16 158.48 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.06 . . . . 0.0 110.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.71 157.5 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 mt-30 -141.73 -144.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.005 . . . . 0.0 110.477 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.439 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 71.1 t-105 -144.57 -55.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.6 mt-10 -90.63 164.81 25.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.56 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 46.2 Cg_endo -73.82 120.59 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.445 ' HD2' HD12 ' A' ' 15' ' ' LEU . 49.1 Cg_endo . . . . . 0 C--N 1.307 -1.632 0 O-C-N 123.821 1.432 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 30' ' ' TYR . 4.3 mm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.8 Cg_endo -68.38 -160.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.974 1.513 . . . . 0.0 110.033 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.76 39.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.0 110.703 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.4 -15.05 56.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.679 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 54.1 m95 -95.02 139.42 31.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.508 ' SD ' ' CD1' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -114.72 163.57 15.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 110.586 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.55 102.81 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.463 -0.773 . . . . 0.0 109.352 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 6.6 t -106.36 162.04 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 110.564 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.87 82.16 1.88 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.52 -0.738 . . . . 0.0 109.953 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.36 161.0 29.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 0.0 110.389 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -54.27 -20.94 7.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -83.99 -32.53 24.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.65 167.28 20.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.3 m -79.52 116.3 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 110.233 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 51.4 p90 -114.97 -160.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.698 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE1' HD12 ' A' ' 15' ' ' LEU . 70.7 m-85 -128.95 125.89 38.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.914 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.505 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.4 t90 -99.52 116.08 30.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.577 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.679 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.2 t-160 -78.98 108.94 12.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.777 . . . . 0.0 109.889 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 61.7 mt -68.66 -35.69 7.07 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.603 -0.686 . . . . 0.0 112.827 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.6 Cg_endo -72.21 -60.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 122.972 0.985 . . . . 0.0 111.573 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.585 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 3.1 t -86.59 -23.69 25.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.982 -1.074 . . . . 0.0 110.442 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.61 -14.71 62.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 2.8 m -58.6 157.2 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.179 . . . . 0.0 110.199 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -120.73 162.86 19.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.925 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 30.4 mt-30 -149.4 -156.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -143.56 -35.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.449 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 45.4 mt-10 -91.84 162.97 29.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.6 Cg_endo -73.39 111.38 3.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.02 1.537 . . . . 0.0 110.579 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 0.0 110.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' CD1' ' HD2' ' A' ' 43' ' ' PRO . 3.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.1 Cg_endo -70.17 -179.2 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.427 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 98.05 2.1 58.24 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.3 m95 -119.6 132.12 55.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.254 . . . . 0.0 109.938 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 33.9 mmm -120.4 164.81 15.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 0.0 110.646 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -120.84 113.45 20.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.5 t -113.98 161.39 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.82 94.36 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.605 -0.685 . . . . 0.0 109.964 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.27 173.1 7.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.41 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -57.75 -45.32 86.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -32.52 70.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.12 20.86 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 45.9 m -80.13 116.57 20.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -1.189 . . . . 0.0 110.186 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 54.6 p90 -114.52 -159.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 110.401 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' MET . 92.5 m-85 -132.7 143.73 49.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.8 t90 -112.25 124.38 52.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.436 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.562 ' CE1' HG23 ' A' ' 35' ' ' THR . 4.8 t-160 -86.23 97.42 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.617 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.2 mt -58.46 -41.63 90.25 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 112.76 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.7 Cg_endo -69.35 -56.01 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.078 1.041 . . . . 0.0 111.717 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.562 HG23 ' CE1' ' A' ' 32' ' ' HIS . 34.4 p -86.84 -49.67 7.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.887 -1.133 . . . . 0.0 110.457 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -4.41 19.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.1 m -73.62 158.28 35.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.38 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.66 160.46 23.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.987 . . . . 0.0 110.019 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 70.9 mt-30 -141.98 -171.68 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.568 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 93.5 m95 -136.64 2.73 2.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.023 -1.048 . . . . 0.0 110.351 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -133.13 163.78 48.64 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.5 Cg_endo -71.84 125.03 10.65 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.288 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 52.8 Cg_endo . . . . . 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.0 110.75 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.1 Cg_endo -67.44 -160.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.869 1.458 . . . . 0.0 110.095 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.02 128.97 36.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.988 . . . . 0.0 111.02 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 34' ' ' PRO . . . 91.49 -19.97 44.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.608 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 48.6 m95 -88.77 136.31 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.919 -1.342 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.575 ' CG ' ' CD1' ' A' ' 33' ' ' ILE . 7.2 mmt -119.12 165.11 14.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -120.74 106.63 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.647 -0.658 . . . . 0.0 109.31 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.1 t -105.95 159.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.547 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.9 pt20 -121.15 82.46 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 0.0 110.213 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.17 162.03 27.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.0 110.294 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -55.07 -20.53 9.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.173 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.48 -31.95 26.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.298 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.91 172.53 28.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 4.9 m -87.98 114.37 24.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.216 -1.167 . . . . 0.0 110.117 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.581 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 42.2 p90 -115.0 -156.34 0.6 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.0 110.622 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CE1' HD12 ' A' ' 15' ' ' LEU . 65.3 m-85 -131.37 145.84 52.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.359 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.3 t90 -117.74 122.31 43.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.608 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 2.8 t-160 -84.36 98.21 9.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.781 . . . . 0.0 109.903 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 20' ' ' MET . 19.2 mt -68.8 -51.88 19.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 0.0 111.732 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.0 Cg_endo -65.85 -8.67 20.41 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.152 1.08 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 23.7 m -120.12 -69.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 110.433 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.44 -10.23 5.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -86.61 165.97 15.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -1.081 . . . . 0.0 110.151 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.04 159.5 25.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.567 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 34.1 mt-30 -142.49 -161.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 52.7 m95 -140.02 -37.82 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 31.2 mt-10 -94.92 164.33 19.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.219 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.3 Cg_endo -72.7 118.71 5.7 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.322 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 123.939 1.494 . . . . 0.0 110.553 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' CD1' ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 42.6 Cg_endo -69.77 -165.34 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.0 110.169 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.88 116.88 29.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.47 2.06 40.75 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.495 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 65.2 m95 -120.45 138.06 54.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.987 -1.302 . . . . 0.0 110.476 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 42.6 mmm -121.09 167.2 12.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -120.7 110.28 16.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.738 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 3.4 t -113.8 159.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.614 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.94 79.37 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.959 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.21 162.33 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 0.0 110.32 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -53.88 -22.67 10.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.984 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -80.61 -34.1 35.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.28 -171.21 38.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 23' ' ' GLN . 22.4 m -96.9 114.15 25.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -1.11 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.0 p90 -114.55 -161.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.522 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 54.5 m-85 -131.18 122.37 26.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.0 t90 -91.89 130.77 37.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.13 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.0 t60 -89.65 105.81 18.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.047 -1.033 . . . . 0.0 109.904 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.595 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 34.0 mt -59.37 -41.21 85.93 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 0.0 112.61 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.1 Cg_endo -72.08 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.184 1.097 . . . . 0.0 111.935 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.46 -34.67 20.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 111.004 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 101.08 0.11 54.71 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.87 152.67 42.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.173 . . . . 0.0 109.876 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.71 152.89 36.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.894 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 14.5 mt-30 -141.79 -139.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -151.85 -48.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.893 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 54.2 mt-10 -86.14 163.64 42.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.141 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -73.15 126.45 11.15 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.984 1.518 . . . . 0.0 110.468 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.5 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.951 1.501 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -70.43 -162.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.001 1.527 . . . . 0.0 110.122 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.83 118.43 34.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 105.88 7.13 36.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.545 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 47.7 m95 -119.08 123.46 44.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.018 -1.283 . . . . 0.0 109.668 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.512 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.4 tpp -106.96 170.17 8.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 111.214 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.512 ' N ' ' HG3' ' A' ' 20' ' ' MET . 3.1 ttt180 -121.43 110.3 15.9 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.704 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.1 t -110.04 159.65 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.068 -1.02 . . . . 0.0 110.399 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 6.5 tt0 -120.8 93.84 4.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.8 167.02 11.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -49.86 -49.51 49.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' OG ' ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -54.03 -35.6 62.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.26 -0.9 . . . . 0.0 110.08 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.53 179.52 30.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 55.7 m -86.75 115.1 23.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -1.17 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.581 ' HB3' ' CE3' ' A' ' 40' ' ' TRP . 46.6 p90 -114.44 -155.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' MET . 52.2 m-85 -136.13 152.47 50.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.559 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.3 t90 -118.68 120.1 36.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.555 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.3 t-160 -79.03 93.28 5.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 110.098 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.4 mt -62.86 -39.05 49.43 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.566 -0.709 . . . . 0.0 112.406 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.95 -45.33 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.077 1.041 . . . . 0.0 111.7 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.555 ' OG1' ' CG ' ' A' ' 32' ' ' HIS . 44.1 p -86.17 -55.06 4.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.184 . . . . 0.0 110.398 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.3 -11.19 8.6 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 38' ' ' THR . 96.0 m -86.4 170.71 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.02 170.96 9.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 38' ' ' THR . 54.3 mt-30 -158.71 -177.48 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 79.5 m95 -136.47 3.11 2.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.243 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 24.4 mt-10 -119.66 160.18 43.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.93 110.26 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.997 1.524 . . . . 0.0 110.357 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.0 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 O-C-N 123.961 1.506 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD1' ' HD2' ' A' ' 43' ' ' PRO . 3.8 mm? . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -70.0 -161.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.932 1.49 . . . . 0.0 110.457 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.93 124.35 38.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.92 8.25 57.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.572 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.6 m95 -120.57 136.64 54.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.251 . . . . 0.0 110.051 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 6.8 mmm -120.61 168.29 11.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.432 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -120.78 112.11 18.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.835 . . . . 0.0 109.848 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 7.5 t -113.16 162.43 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -121.09 93.35 4.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.2 171.14 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.969 . . . . 0.0 110.315 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -60.89 -30.79 70.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.392 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -22.67 56.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.7 172.86 18.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.8 m -83.55 117.63 23.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.5 p90 -114.17 -159.12 0.68 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.35 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 95.1 m-85 -132.2 125.77 31.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.4 t90 -92.3 127.92 37.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.268 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.58 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.1 t60 -89.15 110.21 20.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.847 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 13.2 mt -68.27 -37.0 9.81 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -71.96 -36.22 6.28 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 122.936 0.967 . . . . 0.0 111.685 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -116.84 -42.93 2.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 110.376 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' HIS . . . 112.34 -2.74 26.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -66.6 151.89 46.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -1.211 . . . . 0.0 110.369 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -116.7 171.21 8.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 40.4 mt-30 -149.89 -148.59 0.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.01 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -147.4 -37.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.062 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 2.4 mt-10 -101.19 166.08 13.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.7 Cg_endo -72.46 119.42 6.11 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.914 1.481 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.7 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 O-C-N 123.996 1.524 . . . . 0.0 110.437 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.33 -163.07 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.851 1.448 . . . . 0.0 110.478 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.26 126.23 37.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.664 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.75 9.29 60.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.674 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 51.1 m95 -120.33 138.96 53.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.921 -1.341 . . . . 0.0 109.842 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 37.1 mmm -120.06 168.59 11.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.856 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -120.23 110.89 17.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 109.543 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 17.1 t -112.51 166.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.938 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 2.5 tt0 -120.6 82.88 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 109.685 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.72 176.16 6.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.6 p -63.51 -22.62 66.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.235 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -29.82 27.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.77 -164.88 33.86 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 19.8 m -94.79 113.48 25.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.198 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 47.6 p90 -114.06 -155.55 0.57 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.561 ' CE1' HD13 ' A' ' 15' ' ' LEU . 75.6 m-85 -129.9 139.81 51.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.866 . . . . 0.0 110.418 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.9 t90 -110.85 118.1 35.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.674 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -79.19 110.57 14.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 110.536 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.602 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 54.7 mt -68.36 -39.86 17.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 112.054 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 47.0 Cg_endo -75.09 -55.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.282 1.149 . . . . 0.0 111.844 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.528 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 30.1 p -86.29 -14.3 44.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.098 . . . . 0.0 110.565 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 69.85 5.06 50.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 9.2 m -80.93 160.85 24.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -1.173 . . . . 0.0 109.926 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 152.18 38.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.988 . . . . 0.0 110.078 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 22.8 mt-30 -141.9 -171.21 3.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -137.04 2.01 2.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.4 mt-10 -115.95 155.06 48.32 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.08 110.99 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.009 1.531 . . . . 0.0 110.43 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.6 Cg_endo . . . . . 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.7 Cg_endo -69.63 -165.98 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.872 1.459 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.18 121.73 30.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.46 4.18 57.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.673 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.7 m95 -119.05 131.31 55.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.898 -1.354 . . . . 0.0 110.027 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.518 ' HE2' ' CD1' ' A' ' 33' ' ' ILE . 13.8 mmt -118.59 168.0 11.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 110.768 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' CZ ' HG21 ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.19 105.54 11.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.472 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.4 t -107.47 153.76 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -122.53 83.95 2.19 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 26' ' ' SER . 1.2 p-10 -73.93 -166.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.012 -1.055 . . . . 0.0 110.477 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.4 p -83.59 43.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.325 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.466 ' HB2' ' OD2' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -155.37 -36.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 110.32 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 165.19 29.5 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 13.2 m -86.78 112.86 22.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -1.179 . . . . 0.0 110.151 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.7 p90 -113.33 -156.58 0.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 110.407 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE1' HD11 ' A' ' 15' ' ' LEU . 78.9 m-85 -127.27 138.72 53.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.5 t90 -111.44 113.57 26.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.673 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -77.47 107.74 10.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 6.1 mt -68.66 -40.42 18.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 112.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 45.9 Cg_endo -74.86 -48.93 0.17 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.266 1.14 . . . . 0.0 112.181 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.576 HG23 ' CE1' ' A' ' 32' ' ' HIS . 32.4 p -86.17 -27.97 24.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.71 49.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 38' ' ' THR . 98.2 m -70.63 169.75 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -1.188 . . . . 0.0 110.257 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -121.36 179.44 4.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 110.012 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 57.7 mt-30 -157.69 -162.02 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.943 . . . . 0.0 110.444 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -136.69 -36.51 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 10.7 mt-10 -103.14 164.49 15.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 48.2 Cg_endo -74.38 117.72 5.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.022 1.538 . . . . 0.0 110.447 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 123.845 1.444 . . . . 0.0 110.297 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.497 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.5 Cg_endo -70.25 -161.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.499 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.07 122.73 33.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.696 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 94.8 6.56 60.56 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.577 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.1 m95 -120.26 136.13 54.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.26 . . . . 0.0 109.638 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.516 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 38.4 ttm -120.46 171.41 8.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 111.264 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' CG ' ' A' ' 20' ' ' MET . 57.2 ttt-85 -121.45 108.7 13.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.742 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 19.6 t -113.48 163.0 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.738 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.0 mt-30 -121.33 112.32 18.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.663 -0.648 . . . . 0.0 109.783 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.7 -178.02 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.149 -0.97 . . . . 0.0 110.476 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 26' ' ' SER . 12.4 t -65.54 -24.52 67.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -84.81 -17.96 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.957 . . . . 0.0 110.119 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.23 175.18 13.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 25.9 m -80.01 117.53 20.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.131 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.3 p90 -114.2 -152.78 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.7 m-85 -133.2 139.09 46.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.072 -1.018 . . . . 0.0 110.593 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.9 t90 -110.48 122.53 47.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 109.71 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.581 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.8 t60 -80.41 103.76 10.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.216 -0.928 . . . . 0.0 110.218 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.1 mt -63.52 -37.69 32.25 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.545 -0.722 . . . . 0.0 112.484 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.3 Cg_endo -72.32 -62.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.024 1.013 . . . . 0.0 111.51 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.65 -35.77 19.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 103.91 -8.35 50.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.7 OUTLIER -58.95 152.19 20.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -1.185 . . . . 0.0 110.105 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.44 153.24 36.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.109 -0.994 . . . . 0.0 109.838 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 19.4 mt-30 -142.24 -142.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.405 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 97.4 m95 -149.54 -38.84 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 35.9 mt-10 -99.24 163.56 18.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -74.08 131.63 15.7 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.494 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 47.5 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 O-C-N 123.903 1.475 . . . . 0.0 110.461 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD21 ' N ' ' A' ' 15' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 42.0 Cg_endo -69.11 -168.34 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.889 1.468 . . . . 0.0 110.329 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.97 123.55 34.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.129 -0.982 . . . . 0.0 110.72 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 106.02 -3.34 38.29 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.625 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 55.4 m95 -112.81 110.72 21.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.305 . . . . 0.0 109.477 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 25.4 ttt -91.22 171.33 9.31 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.054 0.93 . . . . 0.0 111.302 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' CG ' ' A' ' 20' ' ' MET . 67.4 ttt180 -121.05 107.06 12.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.8 t -108.53 160.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 110.533 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 4.2 mt-30 -121.02 80.04 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 0.0 110.068 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 154.63 40.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -45.67 -27.91 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -42.7 52.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.04 -176.49 45.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 94.0 m -93.56 114.18 26.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.577 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.59 -156.33 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.44 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 98.2 m-85 -131.73 147.09 52.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.272 -0.892 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.499 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.4 t90 -115.43 119.93 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.479 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.625 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 3.0 t-160 -76.37 83.37 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 109.706 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.515 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.1 mt -52.89 -50.41 81.72 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 41.4 Cg_endo -68.71 -11.7 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.199 1.105 . . . . 0.0 111.606 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.596 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 85.6 m -120.56 -73.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.06 -17.21 2.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -74.62 161.59 29.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 110.099 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 170.38 9.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.542 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 50.3 mt-30 -147.75 -151.21 0.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.186 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -148.19 -42.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.3 mm-40 -98.45 167.53 11.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -73.16 113.46 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 123.909 1.479 . . . . 0.0 110.312 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.4 mm? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.2 Cg_endo -70.22 -166.73 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.817 1.43 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.13 121.64 34.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 110.535 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.47 1.83 23.09 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.503 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 77.6 m95 -120.8 136.46 54.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.842 -1.387 . . . . 0.0 110.064 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 2.2 tpt -120.62 174.15 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' N ' ' HG3' ' A' ' 20' ' ' MET . 0.1 OUTLIER -121.0 104.66 9.97 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 48.0 t -106.76 168.96 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.966 . . . . 0.0 110.529 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.458 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -120.76 86.12 2.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.107 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 152.18 39.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t -49.19 -22.3 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.53 -35.81 19.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.97 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.23 40.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' OG1' ' HG3' ' A' ' 23' ' ' GLN . 72.8 m -84.05 117.21 23.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 43.9 p90 -114.62 -154.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 89.7 m-85 -132.3 142.75 49.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 2.9 t90 -112.13 130.23 55.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.038 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.59 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.5 t60 -86.64 100.22 12.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.193 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 59.0 mt -56.52 -42.16 94.86 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 112.556 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.1 Cg_endo -69.11 -66.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.026 1.014 . . . . 0.0 111.882 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.43 -38.02 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.843 -1.161 . . . . 0.0 110.654 -179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 106.66 -0.56 36.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -61.5 150.17 36.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.247 . . . . 0.0 109.9 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.72 151.9 38.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 38' ' ' THR . 4.7 mt-30 -142.0 -139.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.981 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -150.71 -40.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.116 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -103.73 168.29 8.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.088 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.1 Cg_endo -71.7 128.68 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.987 1.52 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.6 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 O-C-N 123.91 1.479 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.21 -160.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.979 1.515 . . . . 0.0 110.362 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.84 135.05 35.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.628 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 91.04 8.48 64.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 59.7 m95 -120.37 139.49 52.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.263 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 5.4 ttt -120.42 170.51 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 111.349 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 20' ' ' MET . 6.3 ttt-85 -121.96 112.48 18.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.681 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 42.4 t -114.96 168.77 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -120.78 92.27 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -86.53 162.91 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -56.59 -28.44 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.903 . . . . 0.0 110.341 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -79.73 -26.05 40.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.311 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.43 173.62 25.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 22' ' ' VAL . 29.8 m -79.05 116.31 19.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 39.5 p90 -114.42 -154.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.281 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.466 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 80.6 m-85 -136.28 151.35 49.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.521 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.522 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 6.0 t90 -120.04 123.59 43.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.586 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 2.2 t60 -79.05 101.79 8.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 16.3 mt -62.16 -38.14 44.86 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.1 Cg_endo -70.57 -58.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.881 0.938 . . . . 0.0 111.419 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.586 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -92.39 -41.58 10.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 110.56 -3.25 29.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.26 150.97 44.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.132 -1.216 . . . . 0.0 110.121 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.18 149.87 41.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.048 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 24.7 mt-30 -141.78 -167.88 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.466 ' CZ3' ' OG ' ' A' ' 26' ' ' SER . 94.3 m95 -136.79 2.59 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -124.0 164.44 29.41 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.9 Cg_endo -72.16 112.46 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.972 1.511 . . . . 0.0 110.337 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.431 -179.906 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -70.6 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.094 1.576 . . . . 0.0 110.439 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.37 39.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.5 2.68 35.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.681 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 40.2 m95 -114.97 122.37 46.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.94 -1.33 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 64.6 mmm -106.36 164.15 12.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.46 117.58 28.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.514 -0.741 . . . . 0.0 109.503 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.1 t -118.5 163.59 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.921 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.496 ' NE2' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.72 96.85 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.933 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.3 175.56 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.503 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.8 p -53.19 -57.16 11.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.361 -0.837 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.9 m -48.79 -43.04 37.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.9 -176.52 39.17 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' NE2' ' A' ' 23' ' ' GLN . 1.7 m -84.75 116.18 23.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.11 -158.15 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 110.199 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 92.3 m-85 -132.01 130.31 41.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 110.031 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.2 t90 -98.95 110.72 23.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.681 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.5 t-160 -76.58 111.92 12.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 9.8 mt -67.76 -40.17 22.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 112.117 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.4 Cg_endo -74.16 -55.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.243 1.128 . . . . 0.0 111.622 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.579 HG22 ' CE1' ' A' ' 32' ' ' HIS . 19.9 p -86.64 -8.61 57.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.476 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 60.96 12.92 31.49 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 159.69 18.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -1.233 . . . . 0.0 110.078 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.48 156.43 31.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.996 . . . . 0.0 109.675 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 12.9 mt-30 -142.72 -141.43 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 39' ' ' GLN . 93.4 m95 -150.98 -38.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.178 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.512 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 32.2 mt-10 -100.31 163.89 17.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.9 Cg_endo -73.07 127.2 11.86 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.939 1.494 . . . . 0.0 110.399 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 44.8 Cg_endo . . . . . 0 C--N 1.305 -1.714 0 O-C-N 124.043 1.549 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.476 HD13 ' CE1' ' A' ' 30' ' ' TYR . 3.6 mm? . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -69.8 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 131.97 38.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.03 7.99 73.03 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.687 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.3 m95 -118.09 122.17 42.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.885 -1.362 . . . . 0.0 109.969 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 33' ' ' ILE . 29.6 mmt -106.38 168.35 9.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.793 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -120.66 107.1 12.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.4 t -106.75 166.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.096 -1.003 . . . . 0.0 110.6 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.2 tt0 -120.39 87.84 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.847 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.62 169.11 17.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -58.16 -27.83 64.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.347 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -25.12 41.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.29 179.47 27.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 92.8 m -83.29 116.89 22.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 53.0 p90 -114.15 -154.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 77.4 m-85 -129.85 141.37 50.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 110.416 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.5 t90 -114.65 111.16 20.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.687 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.9 t-160 -76.74 107.18 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.484 -0.76 . . . . 0.0 110.304 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.599 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 7.6 mt -65.8 -40.33 38.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.575 -0.703 . . . . 0.0 111.954 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.45 -53.58 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.299 1.157 . . . . 0.0 111.874 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.521 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 20.4 p -86.46 -7.76 58.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.929 -1.107 . . . . 0.0 110.639 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.17 11.66 27.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -87.14 156.99 19.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 0.0 109.962 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.22 153.68 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.114 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' O ' ' CG ' ' A' ' 40' ' ' TRP . 35.3 mt-30 -146.84 -138.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.175 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 95.7 m95 -157.04 -37.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 38.4 mt-10 -89.51 161.95 38.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 115.63 4.42 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.972 1.511 . . . . 0.0 110.304 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.762 0 O-C-N 124.02 1.537 . . . . 0.0 110.469 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.2 mm? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.5 Cg_endo -67.81 -160.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.374 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.74 128.33 36.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 111.068 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.92 75.07 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.685 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 55.2 m95 -98.33 129.93 45.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.663 -1.493 . . . . 0.0 110.054 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 57.0 mmm -114.72 165.27 12.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.396 -0.815 . . . . 0.0 110.816 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -120.7 106.49 11.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 109.64 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -106.4 164.31 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.087 -1.008 . . . . 0.0 110.845 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.8 86.87 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.732 . . . . 0.0 109.988 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 172.96 8.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.424 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.7 p -52.26 -50.46 62.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -52.96 -31.83 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.98 -179.59 22.9 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 58.3 m -79.01 114.67 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 110.056 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.38 -159.51 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 110.535 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 50.8 m-85 -126.84 125.81 42.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.095 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 11.7 t90 -99.93 116.19 31.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.521 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.685 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.3 t-160 -82.73 109.02 16.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.6 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 18.4 mt -68.22 -39.77 18.18 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 112.138 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.58 -55.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.257 1.135 . . . . 0.0 111.602 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 32' ' ' HIS . 11.2 p -86.64 -10.7 53.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.085 . . . . 0.0 110.315 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 66.26 7.66 39.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -82.25 154.67 25.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.162 -1.199 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.74 151.18 39.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.866 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 13.3 mt-30 -141.91 -141.46 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.562 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 66.2 m95 -153.36 -40.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 1.7 mt-10 -93.63 169.19 10.51 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.198 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.4 Cg_endo -72.24 125.91 11.24 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.445 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.8 Cg_endo . . . . . 0 C--N 1.306 -1.682 0 O-C-N 123.971 1.511 . . . . 0.0 110.596 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.544 HD12 ' CE2' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 44.3 Cg_endo -70.41 -162.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.969 1.51 . . . . 0.0 110.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 118.74 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.368 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.18 5.35 37.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.527 ' CH2' ' CD ' ' A' ' 39' ' ' GLN . 53.4 m95 -119.88 140.5 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -1.232 . . . . 0.0 109.959 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -120.67 165.52 14.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.645 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -120.16 106.8 12.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.335 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.7 t -111.75 161.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 111.108 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.82 84.88 2.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.798 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 -175.39 4.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.944 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.1 p -66.86 -28.91 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -27.56 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.45 -166.3 30.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 23.5 m -92.5 114.24 26.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.1 p90 -114.33 -157.74 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.028 . . . . 0.0 110.255 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.544 ' CE2' HD12 ' A' ' 15' ' ' LEU . 73.6 m-85 -135.85 130.23 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 6.8 t90 -98.04 130.36 44.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.563 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 5.4 t-160 -90.84 104.12 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.5 mt -62.14 -41.35 74.9 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 112.637 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.2 Cg_endo -71.89 -56.18 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.278 1.146 . . . . 0.0 111.728 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.497 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 16.1 p -86.53 -44.37 11.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 0.0 110.409 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.88 -6.83 33.05 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 m -69.11 161.07 29.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 110.375 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.38 165.89 14.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 0.0 110.076 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 46.7 mt-30 -147.95 -141.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -146.63 -54.19 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' C ' ' CE1' ' A' ' 30' ' ' TYR . 35.5 mt-10 -90.73 163.11 31.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 0.0 110.308 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.466 ' HB3' ' OH ' ' A' ' 30' ' ' TYR . 45.4 Cg_endo -73.51 116.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.039 1.547 . . . . 0.0 110.421 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.2 Cg_endo . . . . . 0 C--N 1.305 -1.745 0 O-C-N 123.91 1.479 . . . . 0.0 110.364 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.904 0.383 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 45.5 Cg_endo -71.78 -161.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.033 1.543 . . . . 0.0 110.36 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.74 118.12 34.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.12 7.08 23.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.566 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 45.2 m95 -120.29 133.4 55.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.231 . . . . 0.0 109.56 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 9.5 mmm -114.72 167.55 10.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.159 -0.963 . . . . 0.0 110.916 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -120.9 108.93 14.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 10.9 t -109.0 165.22 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.809 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.2 mt-30 -120.63 85.04 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.574 -0.704 . . . . 0.0 109.791 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.2 179.5 7.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -62.05 -34.44 76.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -25.32 63.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.126 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.53 -166.05 28.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 24.8 m -93.08 114.02 26.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.168 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.5 p90 -114.02 -156.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.292 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.511 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 43.5 m-85 -130.61 135.13 47.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 110.337 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.504 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -104.98 115.55 30.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.577 ' CE1' HG23 ' A' ' 35' ' ' THR . 2.8 t-160 -76.93 111.24 12.27 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.603 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 mt -68.79 -40.13 16.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.513 -0.742 . . . . 0.0 112.198 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.0 Cg_endo -73.25 -56.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.253 1.133 . . . . 0.0 111.785 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 32' ' ' HIS . 23.5 p -86.33 -22.86 26.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.96 -1.087 . . . . 0.0 110.423 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 83.82 -12.46 52.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -61.91 159.92 13.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -1.208 . . . . 0.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.494 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -121.17 163.0 19.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.386 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 38' ' ' THR . 36.6 mt-30 -147.32 -145.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.065 -1.022 . . . . 0.0 110.385 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.564 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 33.7 m95 -145.95 -39.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 110.069 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 39.3 mt-10 -103.84 165.25 13.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.89 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.7 Cg_endo -71.96 123.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.885 1.466 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.307 -1.64 0 O-C-N 123.887 1.467 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.0 Cg_endo -68.42 -160.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.875 1.46 . . . . 0.0 110.066 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 126.48 36.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 110.643 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 33' ' ' ILE . . . 96.59 -20.19 51.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.552 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 45.8 m95 -89.98 129.07 36.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.909 -1.348 . . . . 0.0 109.957 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 23.2 mmt -106.56 166.47 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 110.704 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -120.18 110.83 17.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 24.2 t -112.17 165.8 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 0.0 110.732 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -120.66 111.09 17.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.755 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.84 179.21 4.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.622 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -60.07 -45.62 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.357 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -27.95 69.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.324 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.42 177.56 22.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 22' ' ' VAL . 6.9 m -78.81 118.52 20.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -1.152 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.5 p90 -114.28 -155.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 110.283 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.456 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 36.4 m-85 -135.36 149.98 49.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.511 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 t90 -118.62 115.87 25.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 2.7 t-160 -76.84 111.47 12.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.155 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 mm -69.37 -40.74 15.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.507 -0.745 . . . . 0.0 112.324 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.9 Cg_endo -73.6 -50.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.293 1.154 . . . . 0.0 112.022 -178.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.554 HG23 ' CE1' ' A' ' 32' ' ' HIS . 38.1 p -86.27 -23.71 26.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 0.0 110.344 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.47 -12.42 51.56 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.3 m -71.88 166.74 21.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -1.209 . . . . 0.0 110.379 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.49 158.35 28.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 110.045 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 64.6 mt-30 -150.22 -173.47 4.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.136 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -136.63 2.21 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.0 110.503 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 17.5 mt-10 -114.48 163.44 19.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.1 Cg_endo -73.12 111.66 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.036 1.545 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HG2' ' CD ' ' A' ' 16' ' ' PRO . 46.2 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.488 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.73 0.3 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.0 Cg_endo -70.05 172.96 11.94 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.975 1.513 . . . . 0.0 110.088 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.32 22.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.637 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.17 1.11 22.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.476 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 57.6 m95 -120.48 142.42 49.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.278 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.474 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 1.4 mmt -120.64 167.49 12.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.873 . . . . 0.0 110.392 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -120.23 104.32 9.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.79 . . . . 0.0 109.607 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 29' ' ' TYR . 11.9 t -108.34 164.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.443 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.66 96.64 5.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.17 170.92 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -49.61 -59.21 3.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -31.83 5.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.41 -178.28 25.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 4.8 m -78.97 121.67 25.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -1.163 . . . . 0.0 110.121 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.586 ' CE2' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.63 -160.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.194 -0.941 . . . . 0.0 110.353 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 61.2 m-85 -130.05 119.12 22.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.445 -0.784 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 32' ' ' HIS . 8.7 t90 -88.7 141.2 28.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.578 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.9 t60 -100.42 105.43 16.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.976 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 mt -60.05 -40.05 74.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.627 . . . . 0.0 112.648 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.8 Cg_endo -71.88 -63.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.103 1.054 . . . . 0.0 111.66 -178.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.574 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.1 -38.83 17.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.131 . . . . 0.0 110.744 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 104.98 3.44 42.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.2 m -73.08 156.27 38.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -1.136 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 1.8 p -120.59 160.15 23.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.766 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 27.7 mt-30 -145.16 -141.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 72.0 t-105 -140.09 -58.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 17.8 mt-10 -89.62 165.24 26.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 43.8 Cg_endo -71.43 118.11 5.5 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.92 1.484 . . . . 0.0 110.36 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.307 -1.649 0 O-C-N 123.972 1.512 . . . . 0.0 110.544 -179.895 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 41.3 Cg_endo -68.62 -161.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.97 1.511 . . . . 0.0 109.803 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.35 117.62 34.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 110.699 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.13 28.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 43.2 m95 -98.68 139.93 33.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.32 . . . . 0.0 109.928 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 47.2 mmm -116.65 165.7 12.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 110.884 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -120.6 111.84 18.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.591 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 5.9 t -112.54 163.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 35.9 tt0 -120.47 89.57 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 179.13 6.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -63.1 -33.43 75.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 110.356 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.429 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -72.9 -21.84 60.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.211 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.45 -176.88 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 9.0 m -85.75 113.72 22.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.591 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 40.9 p90 -114.14 -154.9 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 46.6 m-85 -133.99 145.78 49.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.943 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.505 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.4 t90 -115.12 118.89 34.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.116 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.595 ' CD2' ' CE2' ' A' ' 19' ' ' TRP . 2.4 t-160 -79.85 110.12 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.593 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 38.8 mt -69.41 -39.48 12.43 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.715 -0.616 . . . . 0.0 112.408 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.5 Cg_endo -73.59 -53.32 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.162 1.085 . . . . 0.0 111.92 -178.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.53 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 53.4 p -86.39 -21.39 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 110.322 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -8.83 57.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.4 m -70.56 163.28 27.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.27 148.15 44.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 110.218 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 59.2 mt-30 -142.53 -170.97 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.542 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 83.1 m95 -136.5 1.8 2.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.437 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.59 160.27 42.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.91 112.26 3.47 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.084 1.571 . . . . 0.0 110.477 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.577 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 O-C-N 124.012 1.533 . . . . 0.0 110.436 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.1 mm? . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.6 Cg_endo -69.67 -160.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.905 1.476 . . . . 0.0 110.472 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 120.1 37.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 110.429 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.68 7.41 45.09 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.558 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 52.3 m95 -119.85 133.53 55.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.226 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 59.6 mmm -120.44 166.6 13.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -121.08 111.34 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.4 t -110.43 161.56 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -121.04 83.94 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 168.32 18.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -54.18 -35.5 62.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.85 -166.28 34.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 24.0 m -101.44 113.4 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 110.073 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 45.7 p90 -114.32 -157.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.604 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 27.6 m-85 -130.02 135.18 47.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -105.4 121.84 44.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.43 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.2 t-160 -83.33 107.35 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.901 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 52.7 mt -67.42 -38.3 15.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.82 . . . . 0.0 112.372 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.6 Cg_endo -73.5 -57.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.067 1.035 . . . . 0.0 111.529 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.508 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 13.9 p -86.89 -34.48 19.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.922 -1.111 . . . . 0.0 110.419 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 98.68 -9.41 62.22 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.6 m -62.89 156.68 23.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.061 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 159.57 24.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 109.554 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 37.5 mt-30 -144.33 -137.4 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 110.496 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -159.0 -48.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 42.1 mt-10 -92.45 165.54 19.22 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.647 -0.658 . . . . 0.0 110.002 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.4 Cg_endo -71.56 122.17 8.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.004 1.529 . . . . 0.0 110.292 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' HD11 ' A' ' 15' ' ' LEU . 44.7 Cg_endo . . . . . 0 C--N 1.307 -1.624 0 O-C-N 123.913 1.48 . . . . 0.0 110.346 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.332 0.587 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -112.94 81.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 60.29 21.02 10.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.4 m95 57.07 55.67 5.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 2' ' ' SER . 3.1 m120 -48.94 165.48 0.26 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 -26.54 15.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.042 1.548 . . . . 0.0 110.475 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -84.12 -71.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 7' ' ' ASN . . . 42.38 -160.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.02 47.52 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.246 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.84 -159.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 12' ' ' ASP . 1.1 m -79.43 -162.5 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 110.286 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 2.8 p30 -58.3 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -104.33 -53.42 2.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' SER . 7.6 t70 -177.98 54.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD21 ' N ' ' A' ' 15' ' ' LEU . 4.1 mm? -67.71 171.33 5.42 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.056 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.45 -170.78 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.951 1.501 . . . . 0.0 110.121 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.06 121.32 30.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 110.56 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.13 6.02 49.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.4 m95 -120.05 136.53 54.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.875 -1.367 . . . . 0.0 109.858 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.482 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 2.0 mmt -116.35 166.23 12.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.804 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 3.9 ttt180 -120.19 106.37 11.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.529 -0.732 . . . . 0.0 109.423 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.7 t -109.41 162.38 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 0.0 110.733 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.63 80.54 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.826 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.88 169.57 17.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.44 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -59.68 -22.5 62.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -81.3 -32.05 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.14 175.95 28.64 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 51.0 m -81.15 113.19 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 49.8 p90 -114.39 -156.21 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.511 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 84.2 m-85 -131.77 135.25 46.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.484 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 4.9 t90 -107.04 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.863 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.68 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -80.06 109.63 14.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.477 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 47.3 mt -67.83 -36.91 10.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 112.616 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.28 -62.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 122.997 0.999 . . . . 0.0 111.833 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.551 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 2.9 t -86.39 -18.16 32.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.918 -1.114 . . . . 0.0 110.536 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 84.41 -13.99 48.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 8.9 m -59.18 160.99 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -1.17 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 154.15 36.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 41.9 mt-30 -142.04 -175.57 4.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -136.8 1.89 2.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 23.1 mt-10 -120.04 160.22 43.9 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 110.088 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.56 110.68 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.944 1.497 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 47.1 Cg_endo -74.17 110.95 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.929 1.489 . . . . 0.0 110.323 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.94 62.77 0.4 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 105.79 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -1.16 . . . . 0.0 110.003 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.47 99.25 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.32 87.91 9.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.112 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.43 -2.52 11.87 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.012 1.533 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.3 m -89.69 -28.81 19.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.872 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.171 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' OD2' ' O ' ' A' ' 1' ' ' ASP . 4.5 p-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.241 0.543 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.562 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 2.2 t -132.31 104.11 6.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 2' ' ' SER . 15.3 m-85 -162.45 47.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -45.97 156.57 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.44 143.12 25.84 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 -24.01 18.14 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.471 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -85.33 -25.94 26.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ASN . . . -60.26 -147.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.57 112.66 21.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -48.02 136.16 11.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -92.66 -163.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.339 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' HB2' HD22 ' A' ' 15' ' ' LEU . 9.4 p-10 -42.47 126.82 3.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 20.0 p -75.42 -27.31 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.346 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' SER . 5.7 t0 -179.83 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.494 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.542 HD12 ' CE2' ' A' ' 30' ' ' TYR . 4.1 mm? -90.53 167.18 17.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.018 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -71.17 -162.93 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.947 1.498 . . . . 0.0 110.404 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.2 120.23 36.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.477 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.26 -0.08 26.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.571 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 56.8 m95 -117.43 141.81 47.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.543 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.456 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 34.2 mmm -120.71 165.7 14.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 110.73 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -120.64 105.81 11.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.533 -0.73 . . . . 0.0 109.498 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.6 t -107.91 163.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 110.752 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.4 tt0 -121.19 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.737 -0.602 . . . . 0.0 109.767 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.82 174.46 5.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.376 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 p -67.8 -6.71 22.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -26.18 12.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.48 -176.23 38.84 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -94.07 118.42 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -1.13 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.2 p90 -114.48 -154.06 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.542 ' CE2' HD12 ' A' ' 15' ' ' LEU . 64.5 m-85 -135.52 135.54 40.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.4 t90 -107.31 132.51 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.805 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.7 t60 -93.22 108.07 19.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.111 . . . . 0.0 110.388 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.592 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 12.4 mt -63.17 -39.23 49.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.468 -0.77 . . . . 0.0 112.542 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 46.2 Cg_endo -73.01 -62.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.125 1.066 . . . . 0.0 111.951 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.579 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.6 -30.78 21.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.134 . . . . 0.0 110.933 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.61 6.86 60.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -74.39 152.58 39.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 110.192 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.12 38.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.532 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 56.2 mt-30 -141.97 -143.57 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.131 -0.981 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.425 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 67.6 t-105 -136.83 -54.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.1 mt-10 -92.04 164.95 21.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.448 -0.782 . . . . 0.0 110.239 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -72.5 129.49 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.991 1.522 . . . . 0.0 110.338 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.1 Cg_endo -72.95 121.84 7.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.868 1.457 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.02 113.22 1.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.67 -17.38 14.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -1.16 . . . . 0.0 110.121 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.74 143.79 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.177 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t 177.5 138.89 0.23 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 -90.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.052 1.554 . . . . 0.0 110.45 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 m -90.98 158.86 16.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.175 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 2' ' ' SER . 81.0 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 1' ' ' ASP . 0.3 OUTLIER 63.99 86.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 110.229 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.65 -44.5 8.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -51.81 112.44 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.249 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -126.64 138.59 32.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.176 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -27.61 14.33 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.047 1.551 . . . . 0.0 110.477 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -90.51 40.26 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.273 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.85 17.46 15.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.21 84.36 5.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -76.33 170.53 16.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.278 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.35 -168.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.7 -162.6 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 110.245 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -105.59 53.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 110.184 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 13' ' ' SER . 19.2 m-20 56.13 53.32 9.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD13 ' CD ' ' A' ' 16' ' ' PRO . 4.5 mm? -85.21 168.79 18.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.885 . . . . 0.0 110.071 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.05 -159.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.949 1.499 . . . . 0.0 110.203 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.46 123.59 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.689 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 8.83 55.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.3 m95 -120.5 138.82 53.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.944 -1.327 . . . . 0.0 109.899 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 82.1 mmm -120.87 170.29 9.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 110.696 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -120.42 110.26 16.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.495 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -112.39 163.8 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 110.87 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 21.9 tt0 -120.91 91.78 3.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 110.02 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -92.02 -172.67 3.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 110.635 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.8 p -67.12 -33.72 76.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.184 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.568 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -73.3 -18.63 61.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.316 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.21 -172.42 22.95 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 54.7 m -85.51 113.85 22.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.124 . . . . 0.0 110.081 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.3 p90 -114.31 -156.26 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' MET . 58.3 m-85 -128.89 142.3 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 3.9 t90 -112.26 126.99 55.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.062 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.545 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.7 t60 -84.69 109.25 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 110.122 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.596 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 56.0 mt -65.12 -38.25 27.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 112.404 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.7 Cg_endo -74.0 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.115 1.061 . . . . 0.0 111.891 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.545 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.53 -26.94 24.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.84 -1.163 . . . . 0.0 111.096 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.72 0.22 75.76 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -67.91 154.75 40.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -1.171 . . . . 0.0 110.353 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.53 152.84 37.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 109.877 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 49.8 mt-30 -142.15 -168.86 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.568 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 99.6 m95 -137.51 1.12 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.127 -0.983 . . . . 0.0 110.596 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 4.0 mt-10 -120.3 162.11 35.59 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -74.69 116.02 4.48 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.117 1.588 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.29 99.21 1.09 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.949 1.5 . . . . 0.0 110.452 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.71 100.09 1.37 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -113.48 133.25 55.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -1.143 . . . . 0.0 110.265 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.89 -37.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.354 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -73.97 -52.51 4.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.319 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 47' ' ' SER . 47.4 Cg_endo -75.14 130.01 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.785 1.413 . . . . 0.0 110.426 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.59 36.18 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.38 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.168 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.28 0.562 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -113.49 -21.93 10.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.67 88.88 5.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.198 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 4' ' ' TRP . 11.4 t-105 -50.02 141.14 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.51 109.29 0.91 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.945 . . . . 0.0 110.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.81 -90.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.962 1.506 . . . . 0.0 110.513 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' ALA . 3.1 m-80 -82.25 -71.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.226 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 7' ' ' ASN . . . 44.71 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -76.93 99.85 5.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -53.91 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.25 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.86 -168.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' HB3' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -60.13 -167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.304 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 4.8 p -69.06 -47.61 64.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 170.77 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.346 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' A' ' 12' ' ' ASP . 4.0 mm? -66.9 168.11 11.78 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.973 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.5 Cg_endo -70.07 177.86 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.892 1.469 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.79 122.85 27.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.679 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 4.93 30.5 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.528 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 50.4 m95 -120.49 135.79 54.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.977 -1.308 . . . . 0.0 109.985 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.507 ' SD ' ' CD1' ' A' ' 33' ' ' ILE . 78.9 mmm -120.6 165.83 14.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.895 . . . . 0.0 110.815 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -120.76 114.31 21.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.698 . . . . 0.0 109.659 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 5.4 t -116.87 162.16 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.931 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 pt20 -120.7 99.77 6.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 109.872 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -176.93 3.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 26' ' ' SER . 14.2 p -52.45 -66.34 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -42.09 -51.37 4.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.92 -171.21 42.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 6.7 m -85.1 118.84 24.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.0 p90 -114.34 -158.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 42' ' ' PRO . 24.2 m-85 -129.78 129.47 44.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.986 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.85 120.89 40.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.412 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.578 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.0 t-160 -82.85 110.28 17.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.998 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 30.6 mt -67.66 -40.5 25.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.499 -0.751 . . . . 0.0 112.34 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.2 Cg_endo -73.71 -56.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.286 1.15 . . . . 0.0 111.737 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.565 HG23 ' CE1' ' A' ' 32' ' ' HIS . 15.5 p -86.66 -31.48 21.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.937 -1.102 . . . . 0.0 110.557 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.26 -11.84 69.88 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.5 m -61.16 158.48 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.06 . . . . 0.0 110.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.71 157.5 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 mt-30 -141.73 -144.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.005 . . . . 0.0 110.477 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.439 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 71.1 t-105 -144.57 -55.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.6 mt-10 -90.63 164.81 25.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.56 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 46.2 Cg_endo -73.82 120.59 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.445 ' HD2' HD12 ' A' ' 15' ' ' LEU . 49.1 Cg_endo -75.31 150.88 37.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.821 1.432 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.82 23.98 77.27 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 -37.32 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -1.133 . . . . 0.0 110.342 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.62 8.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.307 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -162.35 130.36 2.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.105 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.68 -168.32 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.877 1.462 . . . . 0.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.75 -179.02 2.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.233 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.157 0.503 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.94 172.46 7.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -156.82 -64.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -56.09 -179.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -58.06 156.31 20.73 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.42 -36.08 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.088 1.573 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -146.33 37.6 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.0 -155.66 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD2' ' N ' ' A' ' 10' ' ' GLU . 40.5 p90 -74.59 -159.57 0.09 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 110.129 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.557 ' N ' ' CD2' ' A' ' 9' ' ' PHE . 2.4 tt0 -158.51 147.72 19.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.135 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -58.48 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 50.1 p-10 -47.77 149.38 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.285 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 p -80.01 -61.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.21 48.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 30' ' ' TYR . 4.3 mm? -70.97 167.82 25.77 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.8 Cg_endo -68.38 -160.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.974 1.513 . . . . 0.0 110.033 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.76 39.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.0 110.703 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.4 -15.05 56.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.679 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 54.1 m95 -95.02 139.42 31.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.508 ' SD ' ' CD1' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -114.72 163.57 15.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 110.586 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.55 102.81 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.463 -0.773 . . . . 0.0 109.352 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 6.6 t -106.36 162.04 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 110.564 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.87 82.16 1.88 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.52 -0.738 . . . . 0.0 109.953 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.36 161.0 29.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 0.0 110.389 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -54.27 -20.94 7.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -83.99 -32.53 24.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.65 167.28 20.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.3 m -79.52 116.3 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 110.233 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 51.4 p90 -114.97 -160.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.698 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE1' HD12 ' A' ' 15' ' ' LEU . 70.7 m-85 -128.95 125.89 38.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.914 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.505 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.4 t90 -99.52 116.08 30.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.577 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.679 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.2 t-160 -78.98 108.94 12.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.777 . . . . 0.0 109.889 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 61.7 mt -68.66 -35.69 7.07 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.603 -0.686 . . . . 0.0 112.827 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.6 Cg_endo -72.21 -60.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 122.972 0.985 . . . . 0.0 111.573 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.585 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 3.1 t -86.59 -23.69 25.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.982 -1.074 . . . . 0.0 110.442 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.61 -14.71 62.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 2.8 m -58.6 157.2 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.179 . . . . 0.0 110.199 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -120.73 162.86 19.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.925 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 30.4 mt-30 -149.4 -156.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -143.56 -35.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.449 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 45.4 mt-10 -91.84 162.97 29.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.6 Cg_endo -73.39 111.38 3.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.02 1.537 . . . . 0.0 110.579 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.8 Cg_endo -73.63 79.06 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 0.0 110.436 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.95 39.73 1.67 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -101.51 24.91 9.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -1.16 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.93 22.45 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.49 65.51 1.46 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 110.323 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.61 -6.92 19.94 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 110.539 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 23.2 t -87.14 -23.98 24.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 49' ' ' SER . 1.7 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.277 0.56 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.99 45.94 20.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.468 ' O ' ' HB3' ' A' ' 4' ' ' TRP . 17.4 m-85 -101.71 -6.28 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 4' ' ' TRP . 13.7 p-90 -177.45 125.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 110.237 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.16 132.56 45.02 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 110.341 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.24 -90.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.936 1.493 . . . . 0.0 110.355 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -108.02 -33.02 7.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.94 . . . . 0.0 109.884 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 56.14 85.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.818 . . . . 0.0 110.229 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -152.33 101.23 2.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.11 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -65.15 170.01 4.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 110.208 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -64.87 -166.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -54.63 -172.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.122 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 2.5 p -69.58 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 13' ' ' SER . 48.5 m-20 -149.49 50.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' CD1' ' HD2' ' A' ' 43' ' ' PRO . 3.6 mm? -93.38 167.12 14.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.041 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.1 Cg_endo -70.17 -179.2 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.427 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 98.05 2.1 58.24 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.3 m95 -119.6 132.12 55.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.254 . . . . 0.0 109.938 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 33.9 mmm -120.4 164.81 15.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 0.0 110.646 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -120.84 113.45 20.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.5 t -113.98 161.39 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.82 94.36 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.605 -0.685 . . . . 0.0 109.964 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.27 173.1 7.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.41 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -57.75 -45.32 86.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -32.52 70.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.12 20.86 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 45.9 m -80.13 116.57 20.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -1.189 . . . . 0.0 110.186 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 54.6 p90 -114.52 -159.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 110.401 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' MET . 92.5 m-85 -132.7 143.73 49.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.8 t90 -112.25 124.38 52.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.436 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.562 ' CE1' HG23 ' A' ' 35' ' ' THR . 4.8 t-160 -86.23 97.42 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.617 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.2 mt -58.46 -41.63 90.25 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 112.76 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.7 Cg_endo -69.35 -56.01 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.078 1.041 . . . . 0.0 111.717 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.562 HG23 ' CE1' ' A' ' 32' ' ' HIS . 34.4 p -86.84 -49.67 7.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.887 -1.133 . . . . 0.0 110.457 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -4.41 19.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.1 m -73.62 158.28 35.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.38 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.66 160.46 23.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.987 . . . . 0.0 110.019 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 70.9 mt-30 -141.98 -171.68 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.568 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 93.5 m95 -136.64 2.73 2.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.023 -1.048 . . . . 0.0 110.351 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -133.13 163.78 48.64 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.5 Cg_endo -71.84 125.03 10.65 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.288 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 52.8 Cg_endo -81.05 64.07 8.83 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.0 110.75 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 43' ' ' PRO . . . 55.77 109.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -60.5 156.36 16.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -1.191 . . . . 0.0 110.149 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.17 -166.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.2 p -167.05 135.53 2.16 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.873 . . . . 0.0 110.103 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 -177.44 2.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.958 1.504 . . . . 0.0 110.519 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -128.47 51.21 2.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.096 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.438 ' OXT' ' CG ' ' A' ' 50' ' ' GLN . 4.7 pt20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.217 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.222 0.534 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.7 74.46 1.66 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -78.83 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.443 ' CE3' ' HB2' ' A' ' 17' ' ' ALA . 68.5 t-105 -62.38 105.3 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 110.321 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.74 113.16 24.24 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 4' ' ' TRP . 45.8 Cg_endo -72.33 -24.54 19.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.885 1.466 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 55.45 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.03 -155.37 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -52.94 123.12 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.18 158.28 33.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.04 -165.09 1.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.283 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 0.2 OUTLIER -61.44 -162.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.916 . . . . 0.0 110.26 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.54 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.76 45.86 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.326 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? -100.16 168.7 9.02 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.1 Cg_endo -67.44 -160.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.869 1.458 . . . . 0.0 110.095 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.443 ' HB2' ' CE3' ' A' ' 4' ' ' TRP . . . -90.02 128.97 36.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.988 . . . . 0.0 111.02 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA3' ' HG3' ' A' ' 34' ' ' PRO . . . 91.49 -19.97 44.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.608 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 48.6 m95 -88.77 136.31 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.919 -1.342 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.575 ' CG ' ' CD1' ' A' ' 33' ' ' ILE . 7.2 mmt -119.12 165.11 14.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -120.74 106.63 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.647 -0.658 . . . . 0.0 109.31 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.1 t -105.95 159.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.547 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.9 pt20 -121.15 82.46 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 0.0 110.213 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.17 162.03 27.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.0 110.294 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -55.07 -20.53 9.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.173 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.48 -31.95 26.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.298 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.91 172.53 28.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 4.9 m -87.98 114.37 24.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.216 -1.167 . . . . 0.0 110.117 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.581 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 42.2 p90 -115.0 -156.34 0.6 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.0 110.622 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CE1' HD12 ' A' ' 15' ' ' LEU . 65.3 m-85 -131.37 145.84 52.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.359 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.3 t90 -117.74 122.31 43.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.608 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 2.8 t-160 -84.36 98.21 9.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.781 . . . . 0.0 109.903 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 20' ' ' MET . 19.2 mt -68.8 -51.88 19.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 0.0 111.732 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.0 Cg_endo -65.85 -8.67 20.41 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.152 1.08 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 23.7 m -120.12 -69.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 110.433 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.44 -10.23 5.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -86.61 165.97 15.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -1.081 . . . . 0.0 110.151 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.04 159.5 25.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.567 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 34.1 mt-30 -142.49 -161.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.507 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 52.7 m95 -140.02 -37.82 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 31.2 mt-10 -94.92 164.33 19.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.219 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.3 Cg_endo -72.7 118.71 5.7 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.322 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.59 -38.1 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.939 1.494 . . . . 0.0 110.553 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.3 136.22 14.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -60.05 141.26 56.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -1.089 . . . . 0.0 110.177 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -158.82 -179.25 7.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER 59.24 150.69 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' SER . 46.1 Cg_endo -73.16 161.38 43.29 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.023 1.538 . . . . 0.0 110.377 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' PRO . 23.4 m 43.13 55.63 4.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.136 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.211 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.227 0.537 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.92 139.35 5.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -79.44 -2.01 39.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -51.12 -68.61 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.91 165.35 13.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 110.32 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 7' ' ' ASN . 45.8 Cg_endo -72.71 -26.65 15.9 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.973 1.512 . . . . 0.0 110.38 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 15.3 t-20 -179.07 -50.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 10' ' ' GLU . . . 51.53 50.9 17.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -57.04 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.358 -0.839 . . . . 0.0 110.903 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' ALA . 3.5 pt-20 -94.38 -159.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.956 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -93.62 -163.43 1.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.372 -0.83 . . . . 0.0 110.22 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -60.28 171.07 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.278 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 89.5 p -84.52 45.35 1.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 13' ' ' SER . 7.7 t0 56.86 66.24 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.329 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' CD1' ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? -70.58 172.1 6.8 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 42.6 Cg_endo -69.77 -165.34 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.0 110.169 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.88 116.88 29.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.47 2.06 40.75 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.495 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 65.2 m95 -120.45 138.06 54.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.987 -1.302 . . . . 0.0 110.476 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 42.6 mmm -121.09 167.2 12.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -120.7 110.28 16.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.738 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 3.4 t -113.8 159.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.614 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.94 79.37 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.959 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.21 162.33 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 0.0 110.32 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -53.88 -22.67 10.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.984 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -80.61 -34.1 35.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.28 -171.21 38.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 23' ' ' GLN . 22.4 m -96.9 114.15 25.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -1.11 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.0 p90 -114.55 -161.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.522 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 54.5 m-85 -131.18 122.37 26.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.0 t90 -91.89 130.77 37.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.13 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.0 t60 -89.65 105.81 18.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.047 -1.033 . . . . 0.0 109.904 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.595 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 34.0 mt -59.37 -41.21 85.93 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 0.0 112.61 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.1 Cg_endo -72.08 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.184 1.097 . . . . 0.0 111.935 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.46 -34.67 20.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 111.004 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 101.08 0.11 54.71 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.87 152.67 42.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.173 . . . . 0.0 109.876 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.71 152.89 36.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.894 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 14.5 mt-30 -141.79 -139.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -151.85 -48.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.893 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 54.2 mt-10 -86.14 163.64 42.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.141 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -73.15 126.45 11.15 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.984 1.518 . . . . 0.0 110.468 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.5 Cg_endo -74.06 86.58 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.951 1.501 . . . . 0.0 110.326 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.83 85.18 0.29 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -110.28 140.88 43.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.153 . . . . 0.0 110.143 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.9 104.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 p -81.31 145.19 55.2 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.68 -25.67 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.984 1.518 . . . . 0.0 110.541 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -163.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.235 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.275 0.56 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -152.3 84.82 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.127 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -153.39 -49.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.888 . . . . 0.0 110.292 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -48.28 116.02 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.12 81.87 6.65 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.58 -28.08 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.957 1.504 . . . . 0.0 110.357 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -65.53 -23.94 67.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.044 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.61 111.88 22.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 110.074 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.45 46.52 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 110.309 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -106.63 -174.19 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.95 -160.96 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 12' ' ' ASP . 13.5 t0 52.79 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.5 -78.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.341 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.83 48.22 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? -88.43 167.79 18.13 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.141 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -70.43 -162.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.001 1.527 . . . . 0.0 110.122 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.83 118.43 34.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 105.88 7.13 36.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.545 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 47.7 m95 -119.08 123.46 44.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.018 -1.283 . . . . 0.0 109.668 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.512 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.4 tpp -106.96 170.17 8.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 111.214 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.512 ' N ' ' HG3' ' A' ' 20' ' ' MET . 3.1 ttt180 -121.43 110.3 15.9 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.704 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.1 t -110.04 159.65 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.068 -1.02 . . . . 0.0 110.399 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 6.5 tt0 -120.8 93.84 4.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.8 167.02 11.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -49.86 -49.51 49.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' OG ' ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -54.03 -35.6 62.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.26 -0.9 . . . . 0.0 110.08 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.53 179.52 30.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 55.7 m -86.75 115.1 23.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -1.17 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.581 ' HB3' ' CE3' ' A' ' 40' ' ' TRP . 46.6 p90 -114.44 -155.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' MET . 52.2 m-85 -136.13 152.47 50.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.559 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.3 t90 -118.68 120.1 36.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.555 ' CG ' ' OG1' ' A' ' 35' ' ' THR . 2.3 t-160 -79.03 93.28 5.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 110.098 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.4 mt -62.86 -39.05 49.43 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.566 -0.709 . . . . 0.0 112.406 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.95 -45.33 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.077 1.041 . . . . 0.0 111.7 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.555 ' OG1' ' CG ' ' A' ' 32' ' ' HIS . 44.1 p -86.17 -55.06 4.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.184 . . . . 0.0 110.398 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.3 -11.19 8.6 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 38' ' ' THR . 96.0 m -86.4 170.71 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.02 170.96 9.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 38' ' ' THR . 54.3 mt-30 -158.71 -177.48 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 79.5 m95 -136.47 3.11 2.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.243 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 24.4 mt-10 -119.66 160.18 43.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.93 110.26 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.997 1.524 . . . . 0.0 110.357 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.0 Cg_endo -71.73 -172.9 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.961 1.506 . . . . 0.0 110.503 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.2 -130.86 1.26 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 175.71 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.34 109.29 6.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.213 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -105.6 110.65 64.46 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.285 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.22 116.89 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.048 1.551 . . . . 0.0 110.393 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 p -171.33 173.96 4.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.217 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.232 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.185 0.516 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' ASP . 0.2 OUTLIER 174.65 -170.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 21.8 m-85 -102.94 53.92 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.407 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 62.56 88.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -45.4 161.86 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.63 -25.56 17.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 14.8 t-20 -161.63 -39.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 7' ' ' ASN . . . 173.51 -163.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.433 ' O ' ' C ' ' A' ' 10' ' ' GLU . 25.3 m-85 -67.01 139.23 57.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.002 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' PHE . 4.1 mp0 -40.86 146.72 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.755 . . . . 0.0 110.317 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.482 ' O ' ' C ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -94.29 -162.33 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.872 . . . . 0.0 110.348 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 11' ' ' THR . 1.8 m-20 32.93 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.726 -0.609 . . . . 0.0 111.224 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.53 -54.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -164.58 46.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.267 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD1' ' HD2' ' A' ' 43' ' ' PRO . 3.8 mm? -72.72 167.74 30.69 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -70.0 -161.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.932 1.49 . . . . 0.0 110.457 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.93 124.35 38.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.92 8.25 57.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.572 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.6 m95 -120.57 136.64 54.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.251 . . . . 0.0 110.051 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 6.8 mmm -120.61 168.29 11.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.432 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 35.4 ttt180 -120.78 112.11 18.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.835 . . . . 0.0 109.848 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 7.5 t -113.16 162.43 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -121.09 93.35 4.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.2 171.14 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.969 . . . . 0.0 110.315 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -60.89 -30.79 70.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.392 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -22.67 56.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.7 172.86 18.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.8 m -83.55 117.63 23.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.5 p90 -114.17 -159.12 0.68 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.35 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 95.1 m-85 -132.2 125.77 31.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.4 t90 -92.3 127.92 37.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.268 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.58 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.1 t60 -89.15 110.21 20.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.847 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 13.2 mt -68.27 -37.0 9.81 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -71.96 -36.22 6.28 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 122.936 0.967 . . . . 0.0 111.685 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -116.84 -42.93 2.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 110.376 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' HIS . . . 112.34 -2.74 26.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -66.6 151.89 46.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -1.211 . . . . 0.0 110.369 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -116.7 171.21 8.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 40.4 mt-30 -149.89 -148.59 0.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.01 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -147.4 -37.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.062 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 2.4 mt-10 -101.19 166.08 13.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.7 Cg_endo -72.46 119.42 6.11 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.914 1.481 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.7 Cg_endo -73.62 145.44 37.25 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.996 1.524 . . . . 0.0 110.437 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.82 132.8 5.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.58 80.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.94 172.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -0.865 . . . . 0.0 110.233 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.72 74.3 0.84 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' SER . 46.6 Cg_endo -73.14 104.67 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.034 1.544 . . . . 0.0 110.445 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 15.1 m 59.09 27.18 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.319 0.58 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.91 27.1 6.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -48.29 -41.15 27.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 175.49 -48.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 36.8 t-20 -120.75 112.46 33.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 110.193 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.47 -24.48 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.85 1.447 . . . . 0.0 110.552 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -102.35 42.7 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 5' ' ' ASN . . . -143.43 47.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -102.7 47.58 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.322 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.3 154.43 22.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.128 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 -171.2 2.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.496 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . 23.2 m-20 -67.25 111.23 3.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.251 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.04 -6.58 23.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 110.257 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 14' ' ' ASP . 18.2 p-10 -173.01 97.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 30' ' ' TYR . 4.1 mm? -66.69 169.76 7.21 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.33 -163.07 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.851 1.448 . . . . 0.0 110.478 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.26 126.23 37.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.664 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.75 9.29 60.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.674 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 51.1 m95 -120.33 138.96 53.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.921 -1.341 . . . . 0.0 109.842 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 37.1 mmm -120.06 168.59 11.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.856 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -120.23 110.89 17.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 109.543 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 17.1 t -112.51 166.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.938 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 2.5 tt0 -120.6 82.88 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 109.685 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.72 176.16 6.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.6 p -63.51 -22.62 66.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.235 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -29.82 27.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.77 -164.88 33.86 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 19.8 m -94.79 113.48 25.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.198 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 47.6 p90 -114.06 -155.55 0.57 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.561 ' CE1' HD13 ' A' ' 15' ' ' LEU . 75.6 m-85 -129.9 139.81 51.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.866 . . . . 0.0 110.418 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.9 t90 -110.85 118.1 35.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.674 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -79.19 110.57 14.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 110.536 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.602 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 54.7 mt -68.36 -39.86 17.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 112.054 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 47.0 Cg_endo -75.09 -55.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.282 1.149 . . . . 0.0 111.844 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 30.1 p -86.29 -14.3 44.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.098 . . . . 0.0 110.565 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 69.85 5.06 50.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 9.2 m -80.93 160.85 24.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -1.173 . . . . 0.0 109.926 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 152.18 38.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.988 . . . . 0.0 110.078 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 22.8 mt-30 -141.9 -171.21 3.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -137.04 2.01 2.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.4 mt-10 -115.95 155.06 48.32 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 46.1 Cg_endo -74.08 110.99 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.009 1.531 . . . . 0.0 110.43 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.6 Cg_endo -73.24 -46.78 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.347 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.2 -158.8 0.73 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.6 -87.8 0.56 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.14 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.37 -160.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.09 146.93 36.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 131.47 17.18 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.064 1.56 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.12 161.85 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.3 t0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.2 0.524 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.98 165.91 10.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.203 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -112.07 -146.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.897 . . . . 0.0 110.257 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -45.61 137.49 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.286 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.72 129.51 76.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.62 -30.91 9.24 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.874 1.46 . . . . 0.0 110.427 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 9' ' ' PHE . 47.7 p-10 -85.78 18.23 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 110.313 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.91 -26.11 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' ASN . 3.0 t80 -124.26 81.54 1.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.63 -161.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -83.18 -159.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.333 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 11' ' ' THR . 11.1 p-10 -41.08 161.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.498 -0.751 . . . . 0.0 110.432 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -101.44 -60.07 1.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -170.32 74.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? -98.53 170.25 7.25 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.99 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.7 Cg_endo -69.63 -165.98 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.872 1.459 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.18 121.73 30.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.46 4.18 57.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.673 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.7 m95 -119.05 131.31 55.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.898 -1.354 . . . . 0.0 110.027 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.518 ' HE2' ' CD1' ' A' ' 33' ' ' ILE . 13.8 mmt -118.59 168.0 11.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 110.768 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' CZ ' HG21 ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.19 105.54 11.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.472 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.4 t -107.47 153.76 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -122.53 83.95 2.19 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 26' ' ' SER . 1.2 p-10 -73.93 -166.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.012 -1.055 . . . . 0.0 110.477 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.4 p -83.59 43.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.325 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.466 ' HB2' ' OD2' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -155.37 -36.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 110.32 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 165.19 29.5 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 13.2 m -86.78 112.86 22.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -1.179 . . . . 0.0 110.151 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.7 p90 -113.33 -156.58 0.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 110.407 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE1' HD11 ' A' ' 15' ' ' LEU . 78.9 m-85 -127.27 138.72 53.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.5 t90 -111.44 113.57 26.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.673 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -77.47 107.74 10.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 6.1 mt -68.66 -40.42 18.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 112.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 45.9 Cg_endo -74.86 -48.93 0.17 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.266 1.14 . . . . 0.0 112.181 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.576 HG23 ' CE1' ' A' ' 32' ' ' HIS . 32.4 p -86.17 -27.97 24.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.71 49.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 38' ' ' THR . 98.2 m -70.63 169.75 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -1.188 . . . . 0.0 110.257 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -121.36 179.44 4.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 110.012 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.517 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 57.7 mt-30 -157.69 -162.02 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.943 . . . . 0.0 110.444 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -136.69 -36.51 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 10.7 mt-10 -103.14 164.49 15.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 48.2 Cg_endo -74.38 117.72 5.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.022 1.538 . . . . 0.0 110.447 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo -72.52 -3.31 13.2 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.845 1.444 . . . . 0.0 110.297 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.46 -59.92 1.41 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.19 96.6 10.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -1.128 . . . . 0.0 110.218 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 47' ' ' SER . . . -98.61 62.44 1.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER 41.78 72.57 1.07 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.873 . . . . 0.0 110.123 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.8 95.68 0.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.115 1.587 . . . . 0.0 110.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.59 161.72 26.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.64 154.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -126.97 127.63 45.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -51.64 128.56 23.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.915 . . . . 0.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -157.7 80.36 3.24 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.285 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.46 -25.49 15.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.039 1.547 . . . . 0.0 110.365 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.431 ' O ' ' HB1' ' A' ' 8' ' ' ALA . 2.2 m-80 -76.91 -53.8 7.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 7' ' ' ASN . . . 55.17 177.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.47 126.51 27.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 166.48 15.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -102.17 -161.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 11' ' ' THR . 2.6 t0 56.27 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.418 -0.801 . . . . 0.0 110.386 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -77.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.59 45.53 2.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.497 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? -91.59 169.73 10.77 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.182 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.5 Cg_endo -70.25 -161.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.499 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.07 122.73 33.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.696 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 94.8 6.56 60.56 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.577 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.1 m95 -120.26 136.13 54.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.26 . . . . 0.0 109.638 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.516 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 38.4 ttm -120.46 171.41 8.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 111.264 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' CG ' ' A' ' 20' ' ' MET . 57.2 ttt-85 -121.45 108.7 13.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.742 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 19.6 t -113.48 163.0 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.738 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.0 mt-30 -121.33 112.32 18.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.663 -0.648 . . . . 0.0 109.783 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.7 -178.02 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.149 -0.97 . . . . 0.0 110.476 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 26' ' ' SER . 12.4 t -65.54 -24.52 67.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -84.81 -17.96 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.957 . . . . 0.0 110.119 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.23 175.18 13.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 25.9 m -80.01 117.53 20.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.131 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.3 p90 -114.2 -152.78 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.497 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.7 m-85 -133.2 139.09 46.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.072 -1.018 . . . . 0.0 110.593 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.9 t90 -110.48 122.53 47.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 109.71 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.581 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.8 t60 -80.41 103.76 10.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.216 -0.928 . . . . 0.0 110.218 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.1 mt -63.52 -37.69 32.25 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.545 -0.722 . . . . 0.0 112.484 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.3 Cg_endo -72.32 -62.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.024 1.013 . . . . 0.0 111.51 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.65 -35.77 19.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 103.91 -8.35 50.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.7 OUTLIER -58.95 152.19 20.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -1.185 . . . . 0.0 110.105 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.44 153.24 36.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.109 -0.994 . . . . 0.0 109.838 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 19.4 mt-30 -142.24 -142.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.405 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 97.4 m95 -149.54 -38.84 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 35.9 mt-10 -99.24 163.56 18.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -74.08 131.63 15.7 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.494 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 47.5 Cg_endo -74.69 176.1 10.24 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.903 1.475 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.5 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -64.58 152.34 42.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.17 111.6 6.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.185 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.512 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -59.05 -56.97 30.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.198 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 47' ' ' SER . 45.3 Cg_endo -72.74 158.05 51.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.008 1.531 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.36 170.95 7.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.125 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.315 0.579 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.65 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.33 -33.69 2.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 42.1 t-105 -49.18 144.73 4.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -128.3 114.97 19.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 110.012 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.3 -158.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.874 1.46 . . . . 0.0 110.358 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -53.66 -34.88 60.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 60.72 -155.2 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD2' ' N ' ' A' ' 10' ' ' GLU . 22.4 p90 -64.28 -158.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' CD2' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -62.07 -173.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -113.61 -169.39 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 15' ' ' LEU . 5.6 t0 55.36 92.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -54.08 -79.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.89 64.45 1.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD21 ' N ' ' A' ' 15' ' ' LEU . 4.0 mm? -94.45 168.66 11.02 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 109.977 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 42.0 Cg_endo -69.11 -168.34 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.889 1.468 . . . . 0.0 110.329 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.97 123.55 34.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.129 -0.982 . . . . 0.0 110.72 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 106.02 -3.34 38.29 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.625 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 55.4 m95 -112.81 110.72 21.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.305 . . . . 0.0 109.477 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.496 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 25.4 ttt -91.22 171.33 9.31 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.054 0.93 . . . . 0.0 111.302 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' CG ' ' A' ' 20' ' ' MET . 67.4 ttt180 -121.05 107.06 12.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.8 t -108.53 160.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 110.533 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 4.2 mt-30 -121.02 80.04 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 0.0 110.068 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 154.63 40.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -45.67 -27.91 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -42.7 52.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.04 -176.49 45.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 94.0 m -93.56 114.18 26.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.577 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.59 -156.33 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.44 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 98.2 m-85 -131.73 147.09 52.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.272 -0.892 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.499 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.4 t90 -115.43 119.93 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.479 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.625 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 3.0 t-160 -76.37 83.37 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 109.706 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.515 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.1 mt -52.89 -50.41 81.72 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 41.4 Cg_endo -68.71 -11.7 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.199 1.105 . . . . 0.0 111.606 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.596 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 85.6 m -120.56 -73.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.06 -17.21 2.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -74.62 161.59 29.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 110.099 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 170.38 9.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.542 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 50.3 mt-30 -147.75 -151.21 0.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.186 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -148.19 -42.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.3 mm-40 -98.45 167.53 11.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -73.16 113.46 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.6 Cg_endo -72.9 -91.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.909 1.479 . . . . 0.0 110.312 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' PRO . . . 43.54 65.83 1.42 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -86.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -173.25 -170.56 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.52 82.91 7.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.6 178.72 6.37 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.055 1.555 . . . . 0.0 110.413 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.99 49.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.219 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.22 0.533 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -153.25 -175.09 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 4' ' ' TRP . 26.6 p90 -121.56 -23.05 5.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.084 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.409 ' C ' ' O ' ' A' ' 3' ' ' PHE . 23.7 m95 -43.35 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.43 99.33 0.78 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 7' ' ' ASN . 48.5 Cg_endo -76.04 -158.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.955 1.503 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 27.8 t-20 57.44 36.78 27.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 176.47 36.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.16 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -122.34 74.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' PHE . 68.5 tt0 53.53 174.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -66.85 -166.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.198 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -75.82 -170.86 1.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.295 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -87.2 38.62 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.08 84.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.4 mm? -66.9 168.73 9.82 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.958 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.2 Cg_endo -70.22 -166.73 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.817 1.43 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.13 121.64 34.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 110.535 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.47 1.83 23.09 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.503 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 77.6 m95 -120.8 136.46 54.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.842 -1.387 . . . . 0.0 110.064 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 2.2 tpt -120.62 174.15 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' N ' ' HG3' ' A' ' 20' ' ' MET . 0.1 OUTLIER -121.0 104.66 9.97 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 48.0 t -106.76 168.96 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.966 . . . . 0.0 110.529 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.458 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -120.76 86.12 2.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.107 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 152.18 39.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t -49.19 -22.3 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.53 -35.81 19.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.97 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.23 40.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' OG1' ' HG3' ' A' ' 23' ' ' GLN . 72.8 m -84.05 117.21 23.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 43.9 p90 -114.62 -154.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 89.7 m-85 -132.3 142.75 49.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 2.9 t90 -112.13 130.23 55.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.038 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.59 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.5 t60 -86.64 100.22 12.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.193 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 59.0 mt -56.52 -42.16 94.86 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 112.556 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.1 Cg_endo -69.11 -66.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.026 1.014 . . . . 0.0 111.882 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.43 -38.02 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.843 -1.161 . . . . 0.0 110.654 -179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 106.66 -0.56 36.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -61.5 150.17 36.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.247 . . . . 0.0 109.9 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.462 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.72 151.9 38.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 38' ' ' THR . 4.7 mt-30 -142.0 -139.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.981 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -150.71 -40.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.116 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -103.73 168.29 8.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.088 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.1 Cg_endo -71.7 128.68 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.987 1.52 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.503 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.6 Cg_endo -73.44 155.1 50.81 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.91 1.479 . . . . 0.0 110.348 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 45' ' ' ARG . . . 125.15 165.42 12.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 15.0 ttt180 -176.35 66.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -1.194 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.8 117.84 11.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.257 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.3 t -168.54 105.93 0.52 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.883 . . . . 0.0 110.23 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.21 90.29 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.028 1.541 . . . . 0.0 110.268 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.3 OUTLIER -90.95 -175.08 4.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.294 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 49' ' ' SER . 19.7 mt-30 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.304 0.573 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -156.57 -38.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CG ' ' N ' ' A' ' 4' ' ' TRP . 28.8 p90 -66.95 -43.78 82.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 110.339 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.595 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 15.2 p-90 -61.04 -22.35 64.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.945 . . . . 0.0 110.244 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -129.44 74.22 81.06 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 46.6 Cg_endo -75.07 -89.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.05 1.553 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -66.29 -26.93 67.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 59.1 76.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.349 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.32 49.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -105.71 151.58 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.211 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -112.78 -168.26 1.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 110.282 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' SER . 10.5 p-10 -53.37 141.96 22.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -43.38 -84.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.203 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -153.44 58.37 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? -89.37 165.52 25.55 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.21 -160.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.979 1.515 . . . . 0.0 110.362 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.84 135.05 35.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.628 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 91.04 8.48 64.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 59.7 m95 -120.37 139.49 52.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.263 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 5.4 ttt -120.42 170.51 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 111.349 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 20' ' ' MET . 6.3 ttt-85 -121.96 112.48 18.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.681 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 42.4 t -114.96 168.77 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -120.78 92.27 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -86.53 162.91 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.2 p -56.59 -28.44 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.903 . . . . 0.0 110.341 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -79.73 -26.05 40.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.311 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.43 173.62 25.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 22' ' ' VAL . 29.8 m -79.05 116.31 19.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 39.5 p90 -114.42 -154.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.281 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.466 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 80.6 m-85 -136.28 151.35 49.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.521 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.522 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 6.0 t90 -120.04 123.59 43.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.586 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 2.2 t60 -79.05 101.79 8.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 16.3 mt -62.16 -38.14 44.86 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.1 Cg_endo -70.57 -58.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.881 0.938 . . . . 0.0 111.419 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.586 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -92.39 -41.58 10.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 110.56 -3.25 29.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.26 150.97 44.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.132 -1.216 . . . . 0.0 110.121 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.18 149.87 41.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.048 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 24.7 mt-30 -141.78 -167.88 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.466 ' CZ3' ' OG ' ' A' ' 26' ' ' SER . 94.3 m95 -136.79 2.59 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -124.0 164.44 29.41 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.9 Cg_endo -72.16 112.46 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.972 1.511 . . . . 0.0 110.337 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.9 151.92 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.431 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.19 -155.95 26.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 22.7 ttt-85 -134.85 163.46 29.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.25 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 61.45 144.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 110.272 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.585 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -172.39 -61.55 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 47' ' ' SER . 45.8 Cg_endo -71.7 173.96 11.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.951 1.5 . . . . 0.0 110.418 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 p -163.49 123.99 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.209 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.325 0.583 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.7 t -152.5 -82.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 4' ' ' TRP . 1.1 m-85 -81.31 -158.91 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.513 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER 174.76 -31.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -116.69 89.34 27.96 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.32 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.975 1.513 . . . . 0.0 110.388 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -126.27 65.27 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.933 . . . . 0.0 110.042 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.54 -156.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.94 127.26 25.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -125.96 16.47 7.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 12' ' ' ASP . 1.1 m -66.53 -162.35 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.297 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 11' ' ' THR . 13.1 p30 -43.07 151.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.872 . . . . 0.0 110.227 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -103.15 -64.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 11.8 p-10 -164.31 51.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.5 mm? -71.73 165.76 46.43 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -70.6 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.094 1.576 . . . . 0.0 110.439 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.37 39.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.5 2.68 35.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.681 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 40.2 m95 -114.97 122.37 46.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.94 -1.33 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 64.6 mmm -106.36 164.15 12.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.46 117.58 28.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.514 -0.741 . . . . 0.0 109.503 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.1 t -118.5 163.59 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.921 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.496 ' NE2' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.72 96.85 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.933 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.3 175.56 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.503 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.8 p -53.19 -57.16 11.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.361 -0.837 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.9 m -48.79 -43.04 37.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.9 -176.52 39.17 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' NE2' ' A' ' 23' ' ' GLN . 1.7 m -84.75 116.18 23.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.11 -158.15 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 110.199 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 92.3 m-85 -132.01 130.31 41.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 110.031 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.2 t90 -98.95 110.72 23.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.681 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.5 t-160 -76.58 111.92 12.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 9.8 mt -67.76 -40.17 22.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 112.117 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.4 Cg_endo -74.16 -55.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.243 1.128 . . . . 0.0 111.622 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.579 HG22 ' CE1' ' A' ' 32' ' ' HIS . 19.9 p -86.64 -8.61 57.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.476 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 60.96 12.92 31.49 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 159.69 18.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -1.233 . . . . 0.0 110.078 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.48 156.43 31.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.996 . . . . 0.0 109.675 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 12.9 mt-30 -142.72 -141.43 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 39' ' ' GLN . 93.4 m95 -150.98 -38.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.178 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 32.2 mt-10 -100.31 163.89 17.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.9 Cg_endo -73.07 127.2 11.86 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.939 1.494 . . . . 0.0 110.399 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 44.8 Cg_endo -72.67 79.66 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.043 1.549 . . . . 0.0 110.314 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.74 -176.63 18.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -73.4 144.21 46.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -1.129 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 45.17 -98.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER 61.17 135.09 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.022 -1.049 . . . . 0.0 110.13 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.74 173.1 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.926 1.487 . . . . 0.0 110.487 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.63 144.21 22.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.286 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.245 0.545 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 1' ' ' ASP . 0.2 OUTLIER 43.55 79.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -107.4 53.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.169 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 171.3 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 110.207 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -145.5 135.55 11.81 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.134 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.21 -92.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.934 1.491 . . . . 0.0 110.443 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -102.07 48.52 0.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 110.274 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.29 159.72 17.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.21 120.03 5.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.257 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.18 -175.93 3.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -72.16 -160.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p30 -42.31 138.71 1.64 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -75.57 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 110.395 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -131.36 47.89 2.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.294 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.476 HD13 ' CE1' ' A' ' 30' ' ' TYR . 3.6 mm? -99.61 167.95 10.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -69.8 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 131.97 38.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.03 7.99 73.03 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.687 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.3 m95 -118.09 122.17 42.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.885 -1.362 . . . . 0.0 109.969 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 33' ' ' ILE . 29.6 mmt -106.38 168.35 9.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.793 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -120.66 107.1 12.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.4 t -106.75 166.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.096 -1.003 . . . . 0.0 110.6 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.2 tt0 -120.39 87.84 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.847 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.62 169.11 17.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.9 p -58.16 -27.83 64.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.347 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -25.12 41.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.29 179.47 27.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 92.8 m -83.29 116.89 22.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 53.0 p90 -114.15 -154.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 77.4 m-85 -129.85 141.37 50.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 110.416 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.5 t90 -114.65 111.16 20.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.687 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.9 t-160 -76.74 107.18 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.484 -0.76 . . . . 0.0 110.304 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 7.6 mt -65.8 -40.33 38.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.575 -0.703 . . . . 0.0 111.954 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.45 -53.58 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.299 1.157 . . . . 0.0 111.874 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.521 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 20.4 p -86.46 -7.76 58.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.929 -1.107 . . . . 0.0 110.639 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.17 11.66 27.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -87.14 156.99 19.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 0.0 109.962 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.22 153.68 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.114 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' O ' ' CG ' ' A' ' 40' ' ' TRP . 35.3 mt-30 -146.84 -138.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.175 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 95.7 m95 -157.04 -37.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 38.4 mt-10 -89.51 161.95 38.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 115.63 4.42 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.972 1.511 . . . . 0.0 110.304 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 45.0 Cg_endo -72.04 127.99 13.47 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.02 1.537 . . . . 0.0 110.469 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.66 -94.25 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -116.0 120.17 38.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -1.188 . . . . 0.0 110.204 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.62 72.9 1.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.549 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -54.17 -58.78 12.15 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.375 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' CD ' ' CB ' ' A' ' 47' ' ' SER . 46.5 Cg_endo -73.27 83.0 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.531 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.69 -25.56 13.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.25 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.186 0.517 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 p -59.16 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.275 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.55 -77.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -53.42 169.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.284 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.38 148.41 40.44 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.258 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.02 -31.6 7.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.975 1.513 . . . . 0.0 110.384 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.27 47.91 0.87 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.89 -90.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.366 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -173.44 86.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.27 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.88 -170.86 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 110.253 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -173.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.047 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 38.9 p-10 -64.26 -173.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 2.2 p -86.57 49.63 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 13' ' ' SER . 66.7 m-20 56.36 50.25 13.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.2 mm? -68.74 171.43 6.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.011 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.5 Cg_endo -67.81 -160.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.374 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.74 128.33 36.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 111.068 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.92 75.07 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.685 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 55.2 m95 -98.33 129.93 45.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.663 -1.493 . . . . 0.0 110.054 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 57.0 mmm -114.72 165.27 12.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.396 -0.815 . . . . 0.0 110.816 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 12.7 ttt180 -120.7 106.49 11.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 109.64 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -106.4 164.31 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.087 -1.008 . . . . 0.0 110.845 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.8 86.87 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.732 . . . . 0.0 109.988 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 172.96 8.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.424 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.7 p -52.26 -50.46 62.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -52.96 -31.83 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.98 -179.59 22.9 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 58.3 m -79.01 114.67 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 110.056 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.38 -159.51 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 110.535 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 50.8 m-85 -126.84 125.81 42.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.095 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 11.7 t90 -99.93 116.19 31.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.521 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.685 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.3 t-160 -82.73 109.02 16.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.6 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 18.4 mt -68.22 -39.77 18.18 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 112.138 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.58 -55.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.257 1.135 . . . . 0.0 111.602 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 32' ' ' HIS . 11.2 p -86.64 -10.7 53.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.085 . . . . 0.0 110.315 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 66.26 7.66 39.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -82.25 154.67 25.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.162 -1.199 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.74 151.18 39.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.866 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 13.3 mt-30 -141.91 -141.46 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.562 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 66.2 m95 -153.36 -40.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 1.7 mt-10 -93.63 169.19 10.51 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.198 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.4 Cg_endo -72.24 125.91 11.24 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.445 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.8 Cg_endo -72.99 107.6 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.971 1.511 . . . . 0.0 110.596 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.06 153.89 5.73 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.43 142.4 45.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.19 -170.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 110.165 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.19 107.43 53.9 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.88 -160.81 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.02 1.537 . . . . 0.0 110.408 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.6 m -139.55 178.02 7.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.167 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p -66.08 -22.73 66.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -0.96 . . . . 0.0 110.284 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.19 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.252 -0.905 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 8.8 m95 50.05 -162.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.63 118.7 62.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.237 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.3 -32.25 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 1.5 t30 -74.13 -27.55 60.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.206 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 7' ' ' ASN . . . 66.09 -164.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -78.57 139.18 38.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.34 148.28 3.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -83.96 -161.52 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' THR . 4.7 p-10 -54.22 -167.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.41 -86.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -128.95 61.5 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.323 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.544 HD12 ' CE2' ' A' ' 30' ' ' TYR . 4.1 mm? -85.9 168.24 20.4 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.073 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 44.3 Cg_endo -70.41 -162.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.969 1.51 . . . . 0.0 110.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 118.74 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.368 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.18 5.35 37.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.527 ' CH2' ' CD ' ' A' ' 39' ' ' GLN . 53.4 m95 -119.88 140.5 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -1.232 . . . . 0.0 109.959 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -120.67 165.52 14.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.645 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 29.9 ttt180 -120.16 106.8 12.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.335 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.7 t -111.75 161.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 111.108 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.82 84.88 2.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.798 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 -175.39 4.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.944 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.1 p -66.86 -28.91 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -27.56 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.45 -166.3 30.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 23.5 m -92.5 114.24 26.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.1 p90 -114.33 -157.74 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.028 . . . . 0.0 110.255 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.544 ' CE2' HD12 ' A' ' 15' ' ' LEU . 73.6 m-85 -135.85 130.23 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 6.8 t90 -98.04 130.36 44.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.563 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 5.4 t-160 -90.84 104.12 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.5 mt -62.14 -41.35 74.9 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 112.637 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.2 Cg_endo -71.89 -56.18 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.278 1.146 . . . . 0.0 111.728 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.497 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 16.1 p -86.53 -44.37 11.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 0.0 110.409 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.88 -6.83 33.05 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 m -69.11 161.07 29.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 110.375 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.38 165.89 14.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 0.0 110.076 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 46.7 mt-30 -147.95 -141.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -146.63 -54.19 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' C ' ' CE1' ' A' ' 30' ' ' TYR . 35.5 mt-10 -90.73 163.11 31.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 0.0 110.308 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.466 ' HB3' ' OH ' ' A' ' 30' ' ' TYR . 45.4 Cg_endo -73.51 116.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.039 1.547 . . . . 0.0 110.421 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.2 Cg_endo -73.29 130.83 15.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.91 1.479 . . . . 0.0 110.364 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.06 126.23 5.59 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -49.24 107.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -1.144 . . . . 0.0 110.243 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.69 126.13 11.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 75.89 1.44 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.3 179.35 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.093 1.575 . . . . 0.0 110.524 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 p -170.39 126.27 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.236 179.982 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.263 0.554 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 p -139.4 73.6 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 4' ' ' TRP . 72.6 t80 -130.43 133.58 46.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.502 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 60.47 63.39 1.37 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.59 149.21 4.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.33 -90.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -147.0 68.42 1.16 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.508 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.86 160.29 19.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 110.043 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -160.13 88.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.001 . . . . 0.0 110.302 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER 41.97 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.395 179.703 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.26 -162.8 0.92 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.522 ' OD1' ' CD2' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.4 178.69 4.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -91.95 52.06 1.93 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.278 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.4 t0 67.52 51.22 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.7 mm? -94.79 165.82 16.38 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 45.5 Cg_endo -71.78 -161.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.033 1.543 . . . . 0.0 110.36 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.74 118.12 34.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.12 7.08 23.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.566 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 45.2 m95 -120.29 133.4 55.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.231 . . . . 0.0 109.56 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 9.5 mmm -114.72 167.55 10.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.159 -0.963 . . . . 0.0 110.916 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -120.9 108.93 14.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 10.9 t -109.0 165.22 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.809 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.2 mt-30 -120.63 85.04 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.574 -0.704 . . . . 0.0 109.791 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.2 179.5 7.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -62.05 -34.44 76.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -25.32 63.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.126 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.53 -166.05 28.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 24.8 m -93.08 114.02 26.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.168 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.5 p90 -114.02 -156.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.292 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.511 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 43.5 m-85 -130.61 135.13 47.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 110.337 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.504 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -104.98 115.55 30.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.577 ' CE1' HG23 ' A' ' 35' ' ' THR . 2.8 t-160 -76.93 111.24 12.27 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 mt -68.79 -40.13 16.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.513 -0.742 . . . . 0.0 112.198 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.0 Cg_endo -73.25 -56.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.253 1.133 . . . . 0.0 111.785 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 32' ' ' HIS . 23.5 p -86.33 -22.86 26.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.96 -1.087 . . . . 0.0 110.423 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 83.82 -12.46 52.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -61.91 159.92 13.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -1.208 . . . . 0.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.494 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -121.17 163.0 19.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.386 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 38' ' ' THR . 36.6 mt-30 -147.32 -145.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.065 -1.022 . . . . 0.0 110.385 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.564 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 33.7 m95 -145.95 -39.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 110.069 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 39.3 mt-10 -103.84 165.25 13.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.89 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.7 Cg_endo -71.96 123.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.885 1.466 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.7 Cg_endo -72.76 -19.27 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.887 1.467 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 45' ' ' ARG . . . 53.58 -174.07 0.44 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 44' ' ' GLY . 1.1 mtm180 -44.26 -60.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -1.156 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.66 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.213 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.42 126.91 29.29 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.67 83.88 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.879 1.463 . . . . 0.0 110.31 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.0 t -124.45 166.63 15.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.201 179.999 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.262 0.553 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 t -94.42 159.56 15.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -78.35 104.21 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.292 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' O ' ' A' ' 5' ' ' ASN . 17.8 p-90 -57.01 -174.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 110.215 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 4' ' ' TRP . 3.7 m-20 -61.31 159.68 28.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.335 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.71 -90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.039 1.547 . . . . 0.0 110.277 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.23 -64.56 1.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.126 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 52.38 -170.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.2 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.45 126.23 30.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.17 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.07 162.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.93 -163.44 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.321 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -57.19 -179.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.4 -54.2 2.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.317 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.96 46.99 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.42 -0.8 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? -99.36 168.6 9.36 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.932 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.0 Cg_endo -68.42 -160.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.875 1.46 . . . . 0.0 110.066 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 126.48 36.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 110.643 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 33' ' ' ILE . . . 96.59 -20.19 51.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.552 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 45.8 m95 -89.98 129.07 36.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.909 -1.348 . . . . 0.0 109.957 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 23.2 mmt -106.56 166.47 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 110.704 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -120.18 110.83 17.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 24.2 t -112.17 165.8 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 0.0 110.732 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -120.66 111.09 17.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.755 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.84 179.21 4.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.622 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -60.07 -45.62 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.357 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -27.95 69.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.324 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.42 177.56 22.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 22' ' ' VAL . 6.9 m -78.81 118.52 20.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -1.152 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.5 p90 -114.28 -155.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 110.283 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.456 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 36.4 m-85 -135.36 149.98 49.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.511 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 t90 -118.62 115.87 25.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 2.7 t-160 -76.84 111.47 12.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.155 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 mm -69.37 -40.74 15.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.507 -0.745 . . . . 0.0 112.324 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.9 Cg_endo -73.6 -50.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.293 1.154 . . . . 0.0 112.022 -178.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.554 HG23 ' CE1' ' A' ' 32' ' ' HIS . 38.1 p -86.27 -23.71 26.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 0.0 110.344 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.47 -12.42 51.56 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.3 m -71.88 166.74 21.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -1.209 . . . . 0.0 110.379 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.49 158.35 28.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 110.045 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 64.6 mt-30 -150.22 -173.47 4.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.136 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -136.63 2.21 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.0 110.503 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 17.5 mt-10 -114.48 163.44 19.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.1 Cg_endo -73.12 111.66 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.036 1.545 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HG2' ' CD ' ' A' ' 16' ' ' PRO . 46.2 Cg_endo -72.79 -160.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.488 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.08 65.88 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -97.54 -17.79 19.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' O ' ' OG ' ' A' ' 47' ' ' SER . . . -81.63 135.78 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.233 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 46' ' ' ALA . 1.3 p 62.95 156.23 0.12 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 110.083 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.96 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 t -105.31 155.91 18.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.234 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.232 179.936 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.283 0.563 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -178.19 -164.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.13 -55.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.436 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -52.41 -19.84 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -99.4 104.21 25.59 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 4' ' ' TRP . 47.3 Cg_endo -73.18 -24.94 16.4 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.082 1.569 . . . . 0.0 110.525 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 9' ' ' PHE . 1.2 t-20 -128.52 20.32 6.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 110.289 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . 54.98 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 22.4 t80 57.84 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -74.36 153.15 39.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.58 -172.48 2.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 15' ' ' LEU . 6.5 t70 -48.06 156.42 0.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.103 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 -92.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.59 60.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? -92.19 168.41 12.92 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.0 Cg_endo -70.05 172.96 11.94 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.975 1.513 . . . . 0.0 110.088 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.32 22.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.637 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.17 1.11 22.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.476 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 57.6 m95 -120.48 142.42 49.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.278 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.474 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 1.4 mmt -120.64 167.49 12.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.873 . . . . 0.0 110.392 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 12' ' ' ASP . 47.6 ttt180 -120.23 104.32 9.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.79 . . . . 0.0 109.607 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 29' ' ' TYR . 11.9 t -108.34 164.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.443 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.66 96.64 5.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.17 170.92 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -49.61 -59.21 3.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -31.83 5.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.41 -178.28 25.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 4.8 m -78.97 121.67 25.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -1.163 . . . . 0.0 110.121 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.586 ' CE2' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.63 -160.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.194 -0.941 . . . . 0.0 110.353 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 61.2 m-85 -130.05 119.12 22.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.445 -0.784 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 32' ' ' HIS . 8.7 t90 -88.7 141.2 28.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.578 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.9 t60 -100.42 105.43 16.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.976 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 mt -60.05 -40.05 74.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.627 . . . . 0.0 112.648 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.8 Cg_endo -71.88 -63.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.103 1.054 . . . . 0.0 111.66 -178.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.574 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.1 -38.83 17.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.131 . . . . 0.0 110.744 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 104.98 3.44 42.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.2 m -73.08 156.27 38.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -1.136 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 1.8 p -120.59 160.15 23.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.766 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 27.7 mt-30 -145.16 -141.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 72.0 t-105 -140.09 -58.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 17.8 mt-10 -89.62 165.24 26.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 43.8 Cg_endo -71.43 118.11 5.5 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.92 1.484 . . . . 0.0 110.36 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.12 137.36 26.17 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.972 1.512 . . . . 0.0 110.544 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.86 -131.78 3.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.36 -15.93 25.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -1.111 . . . . 0.0 110.219 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.77 100.6 0.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.169 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.2 p -57.46 144.76 70.89 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.345 -0.847 . . . . 0.0 110.315 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.62 152.69 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.7 p -135.76 153.63 51.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.254 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.92 107.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.64 -29.23 51.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 5' ' ' ASN . 2.4 m95 -67.8 94.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.333 -0.854 . . . . 0.0 110.473 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 4' ' ' TRP . 2.9 t-20 177.2 98.46 0.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -27.16 12.84 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.964 1.507 . . . . 0.0 110.597 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -120.15 65.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 10' ' ' GLU . . . -111.59 153.94 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.178 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -45.53 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 8' ' ' ALA . 15.7 pt-20 -68.2 -160.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.337 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.2 -161.95 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -174.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -120.36 -44.38 2.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 -179.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -175.11 64.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 3.9 mm? -93.32 167.89 13.17 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.237 -0.914 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 41.3 Cg_endo -68.62 -161.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.97 1.511 . . . . 0.0 109.803 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.35 117.62 34.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 110.699 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.13 28.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.595 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 43.2 m95 -98.68 139.93 33.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.32 . . . . 0.0 109.928 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 47.2 mmm -116.65 165.7 12.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 110.884 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.517 ' NH1' ' OG ' ' A' ' 13' ' ' SER . 25.1 ttt180 -120.6 111.84 18.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.289 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.591 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 5.9 t -112.54 163.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 35.9 tt0 -120.47 89.57 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 179.13 6.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -63.1 -33.43 75.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 110.356 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.429 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -72.9 -21.84 60.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.211 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.45 -176.88 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 9.0 m -85.75 113.72 22.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.591 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 40.9 p90 -114.14 -154.9 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 46.6 m-85 -133.99 145.78 49.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.943 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.505 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.4 t90 -115.12 118.89 34.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.116 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.595 ' CD2' ' CE2' ' A' ' 19' ' ' TRP . 2.4 t-160 -79.85 110.12 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.593 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 38.8 mt -69.41 -39.48 12.43 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.715 -0.616 . . . . 0.0 112.408 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.5 Cg_endo -73.59 -53.32 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.162 1.085 . . . . 0.0 111.92 -178.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.53 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 53.4 p -86.39 -21.39 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 110.322 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -8.83 57.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.4 m -70.56 163.28 27.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.27 148.15 44.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 110.218 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 59.2 mt-30 -142.53 -170.97 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.542 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 83.1 m95 -136.5 1.8 2.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.437 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.59 160.27 42.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.91 112.26 3.47 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.084 1.571 . . . . 0.0 110.477 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.577 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo -72.13 123.03 8.91 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.012 1.533 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.56 36.68 0.29 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 85.83 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -1.127 . . . . 0.0 110.339 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.34 -179.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.295 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.497 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -75.97 -55.78 1.8 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 110.277 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 47' ' ' SER . 47.7 Cg_endo -74.21 122.6 7.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.868 1.457 . . . . 0.0 110.27 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -146.51 111.69 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.223 0.535 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -114.36 163.15 15.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 54.15 20.46 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.878 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -53.18 -30.88 39.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -44.5 125.52 4.8 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.75 -25.23 12.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.908 1.478 . . . . 0.0 110.391 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 7' ' ' ASN . 25.5 t-20 -103.21 44.11 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.24 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.42 68.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 110.256 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.69 121.92 16.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.25 -163.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.347 -0.845 . . . . 0.0 110.158 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.9 -168.52 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -43.93 158.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.175 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 14' ' ' ASP . 9.6 p -77.56 -39.84 44.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 40.2 p-10 -178.94 53.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.246 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 4.1 mm? -92.89 168.38 12.47 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.6 Cg_endo -69.67 -160.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.905 1.476 . . . . 0.0 110.472 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 120.1 37.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 110.429 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.68 7.41 45.09 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.558 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 52.3 m95 -119.85 133.53 55.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.226 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 59.6 mmm -120.44 166.6 13.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -121.08 111.34 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.4 t -110.43 161.56 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -121.04 83.94 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 168.32 18.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -54.18 -35.5 62.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.85 -166.28 34.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 24.0 m -101.44 113.4 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 110.073 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 45.7 p90 -114.32 -157.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.604 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 27.6 m-85 -130.02 135.18 47.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -105.4 121.84 44.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.43 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.2 t-160 -83.33 107.35 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.901 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.601 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 52.7 mt -67.42 -38.3 15.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.82 . . . . 0.0 112.372 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 44.6 Cg_endo -73.5 -57.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.067 1.035 . . . . 0.0 111.529 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.508 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 13.9 p -86.89 -34.48 19.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.922 -1.111 . . . . 0.0 110.419 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 98.68 -9.41 62.22 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.6 m -62.89 156.68 23.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.061 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 159.57 24.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 109.554 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 37.5 mt-30 -144.33 -137.4 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 110.496 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -159.0 -48.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 42.1 mt-10 -92.45 165.54 19.22 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.647 -0.658 . . . . 0.0 110.002 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.4 Cg_endo -71.56 122.17 8.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.004 1.529 . . . . 0.0 110.292 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' HD2' HD11 ' A' ' 15' ' ' LEU . 44.7 Cg_endo -72.57 92.71 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.913 1.48 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.22 163.78 9.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -84.62 0.18 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.45 -55.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.147 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.38 152.12 7.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 49' ' ' SER . 46.6 Cg_endo -72.75 86.26 1.07 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.995 1.523 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 63.34 130.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 110.275 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.181 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.45 -170.78 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.951 1.501 . . . . 0.0 110.121 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.06 121.32 30.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 110.56 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.13 6.02 49.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.4 m95 -120.05 136.53 54.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.875 -1.367 . . . . 0.0 109.858 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.938 ' SD ' HD11 ' A' ' 33' ' ' ILE . 2.0 mmt -116.35 166.23 12.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.804 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -120.19 106.37 11.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.529 -0.732 . . . . 0.0 109.423 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.7 t -109.41 162.38 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 0.0 110.733 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.63 80.54 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.826 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.88 169.57 17.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.44 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -59.68 -22.5 62.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -81.3 -32.05 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.14 175.95 28.64 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 51.0 m -81.15 113.19 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.597 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 49.8 p90 -114.39 -156.21 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.511 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.702 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.2 m-85 -131.77 135.25 46.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.484 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 4.9 t90 -107.04 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.863 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.68 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -80.06 109.63 14.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.477 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.938 HD11 ' SD ' ' A' ' 20' ' ' MET . 47.3 mt -67.83 -36.91 10.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 112.616 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.28 -62.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 122.997 0.999 . . . . 0.0 111.833 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.551 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 2.9 t -86.39 -18.16 32.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.918 -1.114 . . . . 0.0 110.536 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 84.41 -13.99 48.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.528 ' H ' HG23 ' A' ' 35' ' ' THR . 8.9 m -59.18 160.99 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -1.17 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 154.15 36.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 41.9 mt-30 -142.04 -175.57 4.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -136.8 1.89 2.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 23.1 mt-10 -120.04 160.22 43.9 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 110.088 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.56 110.68 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.944 1.497 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 123.929 1.489 . . . . 0.0 110.323 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' A' ' 43' ' ' PRO . 4.1 mm? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -71.17 -162.93 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.947 1.498 . . . . 0.0 110.404 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.2 120.23 36.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.477 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.26 -0.08 26.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 56.8 m95 -117.43 141.81 47.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.543 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 34.2 mmm -120.71 165.7 14.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 110.73 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -120.64 105.81 11.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.533 -0.73 . . . . 0.0 109.498 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.6 t -107.91 163.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 110.752 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 10.4 tt0 -121.19 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.737 -0.602 . . . . 0.0 109.767 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.82 174.46 5.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.376 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . 19.8 p -67.8 -6.71 22.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -26.18 12.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.48 -176.23 38.84 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -94.07 118.42 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -1.13 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.2 p90 -114.48 -154.06 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.481 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 64.5 m-85 -135.52 135.54 40.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.4 t90 -107.31 132.51 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.805 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.63 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 5.2 t-160 -93.22 108.07 19.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.111 . . . . 0.0 110.388 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 12.4 mt -63.17 -39.23 49.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.468 -0.77 . . . . 0.0 112.542 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.63 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 46.2 Cg_endo -73.01 -62.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.125 1.066 . . . . 0.0 111.951 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.571 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.6 -30.78 21.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.134 . . . . 0.0 110.933 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.61 6.86 60.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -74.39 152.58 39.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 110.192 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.12 38.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.532 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 56.2 mt-30 -141.97 -143.57 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.131 -0.981 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.425 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 67.6 t-105 -136.83 -54.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.1 mt-10 -92.04 164.95 21.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.448 -0.782 . . . . 0.0 110.239 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.9 Cg_endo -72.5 129.49 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.991 1.522 . . . . 0.0 110.338 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.1 Cg_endo . . . . . 0 C--N 1.306 -1.66 0 O-C-N 123.868 1.457 . . . . 0.0 110.493 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.05 -159.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.949 1.499 . . . . 0.0 110.203 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.46 123.59 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.689 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 8.83 55.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.3 m95 -120.5 138.82 53.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.944 -1.327 . . . . 0.0 109.899 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 82.1 mmm -120.87 170.29 9.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 110.696 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -120.42 110.26 16.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.495 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -112.39 163.8 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 110.87 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 21.9 tt0 -120.91 91.78 3.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 110.02 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -92.02 -172.67 3.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 110.635 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.8 p -67.12 -33.72 76.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.184 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.587 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -73.3 -18.63 61.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.316 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.21 -172.42 22.95 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 54.7 m -85.51 113.85 22.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.124 . . . . 0.0 110.081 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.3 p90 -114.31 -156.26 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' MET . 58.3 m-85 -128.89 142.3 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 3.9 t90 -112.26 126.99 55.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.062 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.564 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 3.1 t-160 -84.69 109.25 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 110.122 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 56.0 mt -65.12 -38.25 27.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 112.404 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.7 Cg_endo -74.0 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.115 1.061 . . . . 0.0 111.891 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.549 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.53 -26.94 24.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.84 -1.163 . . . . 0.0 111.096 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.72 0.22 75.76 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -67.91 154.75 40.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -1.171 . . . . 0.0 110.353 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.53 152.84 37.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 109.877 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 49.8 mt-30 -142.15 -168.86 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.587 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 99.6 m95 -137.51 1.12 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.127 -0.983 . . . . 0.0 110.596 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 4.0 mt-10 -120.3 162.11 35.59 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -74.69 116.02 4.48 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.117 1.588 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.763 0 O-C-N 123.949 1.5 . . . . 0.0 110.452 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.5 Cg_endo -70.07 177.86 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.892 1.469 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.79 122.85 27.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.679 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 4.93 30.5 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 50.4 m95 -120.49 135.79 54.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.977 -1.308 . . . . 0.0 109.985 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 1.058 ' SD ' HD11 ' A' ' 33' ' ' ILE . 78.9 mmm -120.6 165.83 14.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.895 . . . . 0.0 110.815 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -120.76 114.31 21.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.698 . . . . 0.0 109.659 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 5.4 t -116.87 162.16 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.931 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 pt20 -120.7 99.77 6.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 109.872 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -176.93 3.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 26' ' ' SER . 14.2 p -52.45 -66.34 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -42.09 -51.37 4.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.92 -171.21 42.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -85.1 118.84 24.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.0 p90 -114.34 -158.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 42' ' ' PRO . 24.2 m-85 -129.78 129.47 44.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.986 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.85 120.89 40.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.412 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.0 t-160 -82.85 110.28 17.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.998 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.058 HD11 ' SD ' ' A' ' 20' ' ' MET . 30.6 mt -67.66 -40.5 25.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.499 -0.751 . . . . 0.0 112.34 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.2 Cg_endo -73.71 -56.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.286 1.15 . . . . 0.0 111.737 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 15.5 p -86.66 -31.48 21.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.937 -1.102 . . . . 0.0 110.557 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.26 -11.84 69.88 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.5 m -61.16 158.48 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.06 . . . . 0.0 110.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.71 157.5 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 mt-30 -141.73 -144.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.005 . . . . 0.0 110.477 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.439 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 71.1 t-105 -144.57 -55.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.6 mt-10 -90.63 164.81 25.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.506 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 46.2 Cg_endo -73.82 120.59 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 15' ' ' LEU . 49.1 Cg_endo . . . . . 0 C--N 1.307 -1.632 0 O-C-N 123.821 1.432 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.3 mm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.8 Cg_endo -68.38 -160.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.974 1.513 . . . . 0.0 110.033 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.76 39.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.0 110.703 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.4 -15.05 56.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.679 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 54.1 m95 -95.02 139.42 31.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 1.02 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -114.72 163.57 15.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 110.586 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.55 102.81 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.463 -0.773 . . . . 0.0 109.352 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 6.6 t -106.36 162.04 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 110.564 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.5 pt20 -120.87 82.16 1.88 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.52 -0.738 . . . . 0.0 109.953 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.36 161.0 29.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 0.0 110.389 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -54.27 -20.94 7.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -83.99 -32.53 24.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.65 167.28 20.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -79.52 116.3 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 110.233 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 51.4 p90 -114.97 -160.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.698 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE1' HD11 ' A' ' 15' ' ' LEU . 70.7 m-85 -128.95 125.89 38.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.914 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.52 116.08 30.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.577 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.679 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.2 t-160 -78.98 108.94 12.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.777 . . . . 0.0 109.889 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.02 HD11 ' SD ' ' A' ' 20' ' ' MET . 61.7 mt -68.66 -35.69 7.07 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.603 -0.686 . . . . 0.0 112.827 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.6 Cg_endo -72.21 -60.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 122.972 0.985 . . . . 0.0 111.573 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.585 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 3.1 t -86.59 -23.69 25.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.982 -1.074 . . . . 0.0 110.442 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.61 -14.71 62.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.575 ' H ' HG23 ' A' ' 35' ' ' THR . 2.8 m -58.6 157.2 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.179 . . . . 0.0 110.199 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -120.73 162.86 19.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.925 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 30.4 mt-30 -149.4 -156.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -143.56 -35.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.449 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 45.4 mt-10 -91.84 162.97 29.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.6 Cg_endo -73.39 111.38 3.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.02 1.537 . . . . 0.0 110.579 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 0.0 110.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.1 Cg_endo -70.17 -179.2 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.427 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 98.05 2.1 58.24 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.59 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.3 m95 -119.6 132.12 55.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.254 . . . . 0.0 109.938 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HD11 ' A' ' 33' ' ' ILE . 33.9 mmm -120.4 164.81 15.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 0.0 110.646 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -120.84 113.45 20.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t -113.98 161.39 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.82 94.36 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.605 -0.685 . . . . 0.0 109.964 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.27 173.1 7.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.41 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -57.75 -45.32 86.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -32.52 70.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.12 20.86 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 22' ' ' VAL . 45.9 m -80.13 116.57 20.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -1.189 . . . . 0.0 110.186 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 54.6 p90 -114.52 -159.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 110.401 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 20' ' ' MET . 92.5 m-85 -132.7 143.73 49.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.467 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 9.8 t90 -112.25 124.38 52.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.436 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.513 ' ND1' ' OG1' ' A' ' 35' ' ' THR . 4.8 t-160 -86.23 97.42 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.2 mt -58.46 -41.63 90.25 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 112.76 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.7 Cg_endo -69.35 -56.01 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.078 1.041 . . . . 0.0 111.717 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 34.4 p -86.84 -49.67 7.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.887 -1.133 . . . . 0.0 110.457 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -4.41 19.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.1 m -73.62 158.28 35.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.38 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.66 160.46 23.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.987 . . . . 0.0 110.019 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.543 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 70.9 mt-30 -141.98 -171.68 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 93.5 m95 -136.64 2.73 2.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.023 -1.048 . . . . 0.0 110.351 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -133.13 163.78 48.64 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.5 Cg_endo -71.84 125.03 10.65 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.288 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 52.8 Cg_endo . . . . . 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.0 110.75 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.2 mm? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.1 Cg_endo -67.44 -160.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.869 1.458 . . . . 0.0 110.095 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.02 128.97 36.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.988 . . . . 0.0 111.02 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' A' ' 34' ' ' PRO . . . 91.49 -19.97 44.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.708 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 48.6 m95 -88.77 136.31 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.919 -1.342 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.937 ' SD ' HD11 ' A' ' 33' ' ' ILE . 7.2 mmt -119.12 165.11 14.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -120.74 106.63 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.647 -0.658 . . . . 0.0 109.31 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.591 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.1 t -105.95 159.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.547 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.9 pt20 -121.15 82.46 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 0.0 110.213 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.17 162.03 27.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.0 110.294 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -55.07 -20.53 9.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.173 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.48 -31.95 26.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.298 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.91 172.53 28.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 m -87.98 114.37 24.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.216 -1.167 . . . . 0.0 110.117 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.591 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 42.2 p90 -115.0 -156.34 0.6 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.0 110.622 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.713 ' CE1' HD11 ' A' ' 15' ' ' LEU . 65.3 m-85 -131.37 145.84 52.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.359 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.3 t90 -117.74 122.31 43.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.608 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 2.8 t-160 -84.36 98.21 9.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.781 . . . . 0.0 109.903 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.937 HD11 ' SD ' ' A' ' 20' ' ' MET . 19.2 mt -68.8 -51.88 19.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 0.0 111.732 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 41.0 Cg_endo -65.85 -8.67 20.41 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.152 1.08 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.569 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 23.7 m -120.12 -69.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 110.433 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.44 -10.23 5.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 38' ' ' THR . 27.7 m -86.61 165.97 15.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -1.081 . . . . 0.0 110.151 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.04 159.5 25.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.708 ' NE2' ' CH2' ' A' ' 19' ' ' TRP . 19.4 mt-30 -142.49 -161.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 52.7 m95 -140.02 -37.82 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 31.2 mt-10 -94.92 164.33 19.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.219 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.3 Cg_endo -72.7 118.71 5.7 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.322 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 123.939 1.494 . . . . 0.0 110.553 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 15' ' ' LEU . 42.6 Cg_endo -69.77 -165.34 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.0 110.169 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.88 116.88 29.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.47 2.06 40.75 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.516 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 65.2 m95 -120.45 138.06 54.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.987 -1.302 . . . . 0.0 110.476 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.963 ' SD ' HD11 ' A' ' 33' ' ' ILE . 42.6 mmm -121.09 167.2 12.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -120.7 110.28 16.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.738 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 3.4 t -113.8 159.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.614 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.94 79.37 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.959 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.21 162.33 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 0.0 110.32 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -53.88 -22.67 10.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.984 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -80.61 -34.1 35.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.28 -171.21 38.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 23' ' ' GLN . 22.4 m -96.9 114.15 25.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -1.11 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.0 p90 -114.55 -161.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.522 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 54.5 m-85 -131.18 122.37 26.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.0 t90 -91.89 130.77 37.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.13 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.686 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 6.0 t-160 -89.65 105.81 18.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.047 -1.033 . . . . 0.0 109.904 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.963 HD11 ' SD ' ' A' ' 20' ' ' MET . 34.0 mt -59.37 -41.21 85.93 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 0.0 112.61 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.654 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 44.1 Cg_endo -72.08 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.184 1.097 . . . . 0.0 111.935 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.686 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.46 -34.67 20.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 111.004 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 101.08 0.11 54.71 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.87 152.67 42.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.173 . . . . 0.0 109.876 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.71 152.89 36.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.894 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 14.5 mt-30 -141.79 -139.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -151.85 -48.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.893 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 54.2 mt-10 -86.14 163.64 42.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.141 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -73.15 126.45 11.15 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.984 1.518 . . . . 0.0 110.468 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.5 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.951 1.501 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -70.43 -162.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.001 1.527 . . . . 0.0 110.122 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.83 118.43 34.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 105.88 7.13 36.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 47.7 m95 -119.08 123.46 44.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.018 -1.283 . . . . 0.0 109.668 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.4 tpp -106.96 170.17 8.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 111.214 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' MET . 3.1 ttt180 -121.43 110.3 15.9 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.704 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.1 t -110.04 159.65 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.068 -1.02 . . . . 0.0 110.399 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 6.5 tt0 -120.8 93.84 4.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.8 167.02 11.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -49.86 -49.51 49.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.462 ' OG ' ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -54.03 -35.6 62.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.26 -0.9 . . . . 0.0 110.08 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.53 179.52 30.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 55.7 m -86.75 115.1 23.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -1.17 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HB3' ' CE3' ' A' ' 40' ' ' TRP . 46.6 p90 -114.44 -155.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 20' ' ' MET . 52.2 m-85 -136.13 152.47 50.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.559 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 9.3 t90 -118.68 120.1 36.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.644 ' CE1' HG21 ' A' ' 35' ' ' THR . 2.3 t-160 -79.03 93.28 5.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 110.098 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.4 mt -62.86 -39.05 49.43 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.566 -0.709 . . . . 0.0 112.406 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.95 -45.33 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.077 1.041 . . . . 0.0 111.7 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.644 HG21 ' CE1' ' A' ' 32' ' ' HIS . 44.1 p -86.17 -55.06 4.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.184 . . . . 0.0 110.398 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.3 -11.19 8.6 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 38' ' ' THR . 96.0 m -86.4 170.71 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.02 170.96 9.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 38' ' ' THR . 54.3 mt-30 -158.71 -177.48 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 79.5 m95 -136.47 3.11 2.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.243 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 24.4 mt-10 -119.66 160.18 43.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.93 110.26 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.997 1.524 . . . . 0.0 110.357 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.0 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 O-C-N 123.961 1.506 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -70.0 -161.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.932 1.49 . . . . 0.0 110.457 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.93 124.35 38.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.92 8.25 57.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.594 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.6 m95 -120.57 136.64 54.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.251 . . . . 0.0 110.051 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 33' ' ' ILE . 6.8 mmm -120.61 168.29 11.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.432 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -120.78 112.11 18.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.835 . . . . 0.0 109.848 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 7.5 t -113.16 162.43 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -121.09 93.35 4.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.2 171.14 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.969 . . . . 0.0 110.315 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -60.89 -30.79 70.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.392 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -22.67 56.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.7 172.86 18.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.8 m -83.55 117.63 23.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.5 p90 -114.17 -159.12 0.68 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.35 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 95.1 m-85 -132.2 125.77 31.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 8.4 t90 -92.3 127.92 37.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.268 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.682 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 5.4 t-160 -89.15 110.21 20.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.847 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.686 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.2 mt -68.27 -37.0 9.81 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.682 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 43.7 Cg_endo -71.96 -36.22 6.28 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 122.936 0.967 . . . . 0.0 111.685 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.439 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -116.84 -42.93 2.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 110.376 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' HIS . . . 112.34 -2.74 26.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -66.6 151.89 46.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -1.211 . . . . 0.0 110.369 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.566 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -116.7 171.21 8.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 40.4 mt-30 -149.89 -148.59 0.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.01 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -147.4 -37.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.062 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 2.4 mt-10 -101.19 166.08 13.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.7 Cg_endo -72.46 119.42 6.11 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.914 1.481 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.7 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 O-C-N 123.996 1.524 . . . . 0.0 110.437 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.33 -163.07 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.851 1.448 . . . . 0.0 110.478 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.26 126.23 37.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.664 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.75 9.29 60.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.674 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 51.1 m95 -120.33 138.96 53.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.921 -1.341 . . . . 0.0 109.842 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.916 ' SD ' HD11 ' A' ' 33' ' ' ILE . 37.1 mmm -120.06 168.59 11.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.856 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -120.23 110.89 17.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 109.543 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 17.1 t -112.51 166.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.938 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.5 tt0 -120.6 82.88 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 109.685 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.72 176.16 6.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.6 p -63.51 -22.62 66.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.235 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -29.82 27.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.77 -164.88 33.86 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 19.8 m -94.79 113.48 25.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.198 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 47.6 p90 -114.06 -155.55 0.57 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 75.6 m-85 -129.9 139.81 51.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.866 . . . . 0.0 110.418 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.9 t90 -110.85 118.1 35.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.674 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -79.19 110.57 14.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 110.536 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' SD ' ' A' ' 20' ' ' MET . 54.7 mt -68.36 -39.86 17.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 112.054 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 47.0 Cg_endo -75.09 -55.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.282 1.149 . . . . 0.0 111.844 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.483 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 30.1 p -86.29 -14.3 44.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.098 . . . . 0.0 110.565 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.85 5.06 50.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 9.2 m -80.93 160.85 24.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -1.173 . . . . 0.0 109.926 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 152.18 38.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.988 . . . . 0.0 110.078 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 22.8 mt-30 -141.9 -171.21 3.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -137.04 2.01 2.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.4 mt-10 -115.95 155.06 48.32 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.08 110.99 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.009 1.531 . . . . 0.0 110.43 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.6 Cg_endo . . . . . 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.7 Cg_endo -69.63 -165.98 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.872 1.459 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.18 121.73 30.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.46 4.18 57.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.673 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.7 m95 -119.05 131.31 55.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.898 -1.354 . . . . 0.0 110.027 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 13.8 mmt -118.59 168.0 11.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 110.768 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.942 ' CZ ' HG21 ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.19 105.54 11.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.472 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.4 t -107.47 153.76 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -122.53 83.95 2.19 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 26' ' ' SER . 1.2 p-10 -73.93 -166.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.012 -1.055 . . . . 0.0 110.477 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.4 p -83.59 43.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.325 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.487 ' HB2' ' OD2' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -155.37 -36.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 110.32 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 165.19 29.5 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.942 HG21 ' CZ ' ' A' ' 21' ' ' ARG . 13.2 m -86.78 112.86 22.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -1.179 . . . . 0.0 110.151 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.61 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.7 p90 -113.33 -156.58 0.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 110.407 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.532 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 78.9 m-85 -127.27 138.72 53.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.5 t90 -111.44 113.57 26.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.673 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -77.47 107.74 10.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 6.1 mt -68.66 -40.42 18.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 112.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.9 Cg_endo -74.86 -48.93 0.17 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.266 1.14 . . . . 0.0 112.181 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.462 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 32.4 p -86.17 -27.97 24.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.71 49.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.562 HG22 ' N ' ' A' ' 38' ' ' THR . 98.2 m -70.63 169.75 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -1.188 . . . . 0.0 110.257 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.562 ' N ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -121.36 179.44 4.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 110.012 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 57.7 mt-30 -157.69 -162.02 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.943 . . . . 0.0 110.444 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -136.69 -36.51 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 10.7 mt-10 -103.14 164.49 15.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 48.2 Cg_endo -74.38 117.72 5.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.022 1.538 . . . . 0.0 110.447 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 123.845 1.444 . . . . 0.0 110.297 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.88 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.5 Cg_endo -70.25 -161.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.499 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.07 122.73 33.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.696 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 94.8 6.56 60.56 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.1 m95 -120.26 136.13 54.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.26 . . . . 0.0 109.638 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 38.4 ttm -120.46 171.41 8.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 111.264 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' CG ' ' A' ' 20' ' ' MET . 57.2 ttt-85 -121.45 108.7 13.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.742 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 19.6 t -113.48 163.0 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.738 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.0 mt-30 -121.33 112.32 18.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.663 -0.648 . . . . 0.0 109.783 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.7 -178.02 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.149 -0.97 . . . . 0.0 110.476 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -65.54 -24.52 67.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -84.81 -17.96 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.957 . . . . 0.0 110.119 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.23 175.18 13.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 25.9 m -80.01 117.53 20.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.131 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.3 p90 -114.2 -152.78 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.88 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.7 m-85 -133.2 139.09 46.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.072 -1.018 . . . . 0.0 110.593 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 5.9 t90 -110.48 122.53 47.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 109.71 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.725 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 2.7 t-160 -80.41 103.76 10.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.216 -0.928 . . . . 0.0 110.218 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.1 mt -63.52 -37.69 32.25 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.545 -0.722 . . . . 0.0 112.484 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.3 Cg_endo -72.32 -62.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.024 1.013 . . . . 0.0 111.51 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.725 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.65 -35.77 19.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 103.91 -8.35 50.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.7 OUTLIER -58.95 152.19 20.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -1.185 . . . . 0.0 110.105 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.44 153.24 36.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.109 -0.994 . . . . 0.0 109.838 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 19.4 mt-30 -142.24 -142.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.405 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 97.4 m95 -149.54 -38.84 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 35.9 mt-10 -99.24 163.56 18.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -74.08 131.63 15.7 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.494 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.533 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 47.5 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 O-C-N 123.903 1.475 . . . . 0.0 110.461 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 42.0 Cg_endo -69.11 -168.34 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.889 1.468 . . . . 0.0 110.329 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.97 123.55 34.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.129 -0.982 . . . . 0.0 110.72 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 106.02 -3.34 38.29 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.625 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 55.4 m95 -112.81 110.72 21.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.305 . . . . 0.0 109.477 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 25.4 ttt -91.22 171.33 9.31 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.054 0.93 . . . . 0.0 111.302 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' CG ' ' A' ' 20' ' ' MET . 67.4 ttt180 -121.05 107.06 12.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.8 t -108.53 160.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 110.533 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 4.2 mt-30 -121.02 80.04 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 0.0 110.068 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 154.63 40.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 25' ' ' THR . 80.8 p -45.67 -27.91 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -42.7 52.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.04 -176.49 45.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 94.0 m -93.56 114.18 26.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.59 -156.33 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.44 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 98.2 m-85 -131.73 147.09 52.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.272 -0.892 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 8.4 t90 -115.43 119.93 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.479 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.929 ' CD2' ' HG1' ' A' ' 35' ' ' THR . 3.0 t-160 -76.37 83.37 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 109.706 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.1 mt -52.89 -50.41 81.72 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 41.4 Cg_endo -68.71 -11.7 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.199 1.105 . . . . 0.0 111.606 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.929 ' HG1' ' CD2' ' A' ' 32' ' ' HIS . 85.6 m -120.56 -73.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.06 -17.21 2.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -74.62 161.59 29.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 110.099 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 170.38 9.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.542 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 50.3 mt-30 -147.75 -151.21 0.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.186 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -148.19 -42.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.3 mm-40 -98.45 167.53 11.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -73.16 113.46 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 123.909 1.479 . . . . 0.0 110.312 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.4 mm? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.2 Cg_endo -70.22 -166.73 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.817 1.43 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.13 121.64 34.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 110.535 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 114.47 1.83 23.09 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.524 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 77.6 m95 -120.8 136.46 54.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.842 -1.387 . . . . 0.0 110.064 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.494 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 2.2 tpt -120.62 174.15 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 20' ' ' MET . 0.1 OUTLIER -121.0 104.66 9.97 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 48.0 t -106.76 168.96 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.966 . . . . 0.0 110.529 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.524 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.76 86.12 2.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.107 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 152.18 39.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t -49.19 -22.3 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.53 -35.81 19.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.97 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.23 40.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 22' ' ' VAL . 72.8 m -84.05 117.21 23.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 43.9 p90 -114.62 -154.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 89.7 m-85 -132.3 142.75 49.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.512 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 2.9 t90 -112.13 130.23 55.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.038 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.787 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 5.1 t-160 -86.64 100.22 12.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.193 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 59.0 mt -56.52 -42.16 94.86 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 112.556 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.65 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 42.1 Cg_endo -69.11 -66.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.026 1.014 . . . . 0.0 111.882 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.787 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.43 -38.02 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.843 -1.161 . . . . 0.0 110.654 -179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 106.66 -0.56 36.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -61.5 150.17 36.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.247 . . . . 0.0 109.9 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.72 151.9 38.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 4.7 mt-30 -142.0 -139.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.981 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -150.71 -40.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.116 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -103.73 168.29 8.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.088 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.1 Cg_endo -71.7 128.68 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.987 1.52 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.6 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 O-C-N 123.91 1.479 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.762 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.21 -160.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.979 1.515 . . . . 0.0 110.362 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.84 135.05 35.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.628 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 91.04 8.48 64.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 59.7 m95 -120.37 139.49 52.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.263 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 5.4 ttt -120.42 170.51 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 111.349 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 20' ' ' MET . 6.3 ttt-85 -121.96 112.48 18.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.681 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 42.4 t -114.96 168.77 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.518 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.78 92.27 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -86.53 162.91 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 25' ' ' THR . 65.2 p -56.59 -28.44 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.903 . . . . 0.0 110.341 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -79.73 -26.05 40.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.311 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.43 173.62 25.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' VAL . 29.8 m -79.05 116.31 19.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 39.5 p90 -114.42 -154.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.281 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' MET . 80.6 m-85 -136.28 151.35 49.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.521 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 6.0 t90 -120.04 123.59 43.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.664 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 4.0 t-160 -79.05 101.79 8.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 16.3 mt -62.16 -38.14 44.86 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.1 Cg_endo -70.57 -58.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.881 0.938 . . . . 0.0 111.419 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.664 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -92.39 -41.58 10.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 110.56 -3.25 29.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.26 150.97 44.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.132 -1.216 . . . . 0.0 110.121 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.18 149.87 41.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.048 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 24.7 mt-30 -141.78 -167.88 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.466 ' CZ3' ' OG ' ' A' ' 26' ' ' SER . 94.3 m95 -136.79 2.59 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -124.0 164.44 29.41 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.9 Cg_endo -72.16 112.46 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.972 1.511 . . . . 0.0 110.337 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.431 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -70.6 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.094 1.576 . . . . 0.0 110.439 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.37 39.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.5 2.68 35.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.681 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 40.2 m95 -114.97 122.37 46.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.94 -1.33 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 64.6 mmm -106.36 164.15 12.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.46 117.58 28.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.514 -0.741 . . . . 0.0 109.503 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.1 t -118.5 163.59 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.921 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -120.72 96.85 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.933 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.3 175.56 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.503 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.8 p -53.19 -57.16 11.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.361 -0.837 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.9 m -48.79 -43.04 37.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.9 -176.52 39.17 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.7 m -84.75 116.18 23.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.11 -158.15 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 110.199 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 92.3 m-85 -132.01 130.31 41.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 110.031 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 8.2 t90 -98.95 110.72 23.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.681 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.5 t-160 -76.58 111.92 12.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.613 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.8 mt -67.76 -40.17 22.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 112.117 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.4 Cg_endo -74.16 -55.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.243 1.128 . . . . 0.0 111.622 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.414 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 19.9 p -86.64 -8.61 57.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.476 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 60.96 12.92 31.49 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.407 ' HG1' ' CB ' ' A' ' 35' ' ' THR . 5.6 m -87.0 159.69 18.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -1.233 . . . . 0.0 110.078 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.48 156.43 31.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.996 . . . . 0.0 109.675 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 12.9 mt-30 -142.72 -141.43 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 39' ' ' GLN . 93.4 m95 -150.98 -38.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.178 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.512 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 32.2 mt-10 -100.31 163.89 17.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.9 Cg_endo -73.07 127.2 11.86 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.939 1.494 . . . . 0.0 110.399 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 15' ' ' LEU . 44.8 Cg_endo . . . . . 0 C--N 1.305 -1.714 0 O-C-N 124.043 1.549 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -69.8 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 131.97 38.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.03 7.99 73.03 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.687 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.3 m95 -118.09 122.17 42.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.885 -1.362 . . . . 0.0 109.969 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 29.6 mmt -106.38 168.35 9.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.793 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -120.66 107.1 12.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.4 t -106.75 166.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.096 -1.003 . . . . 0.0 110.6 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.2 tt0 -120.39 87.84 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.847 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' CD1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -81.62 169.11 17.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 25' ' ' THR . 57.9 p -58.16 -27.83 64.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.347 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -25.12 41.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.29 179.47 27.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 92.8 m -83.29 116.89 22.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 53.0 p90 -114.15 -154.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 77.4 m-85 -129.85 141.37 50.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 110.416 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.5 t90 -114.65 111.16 20.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.687 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.9 t-160 -76.74 107.18 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.484 -0.76 . . . . 0.0 110.304 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.6 mt -65.8 -40.33 38.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.575 -0.703 . . . . 0.0 111.954 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.45 -53.58 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.299 1.157 . . . . 0.0 111.874 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 20.4 p -86.46 -7.76 58.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.929 -1.107 . . . . 0.0 110.639 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.17 11.66 27.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -87.14 156.99 19.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 0.0 109.962 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.22 153.68 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.114 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' O ' ' CG ' ' A' ' 40' ' ' TRP . 35.3 mt-30 -146.84 -138.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.175 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 95.7 m95 -157.04 -37.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 38.4 mt-10 -89.51 161.95 38.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 115.63 4.42 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.972 1.511 . . . . 0.0 110.304 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.762 0 O-C-N 124.02 1.537 . . . . 0.0 110.469 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 16' ' ' PRO . 4.2 mm? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.5 Cg_endo -67.81 -160.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.374 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.74 128.33 36.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 111.068 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.92 75.07 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.685 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 55.2 m95 -98.33 129.93 45.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.663 -1.493 . . . . 0.0 110.054 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 33' ' ' ILE . 57.0 mmm -114.72 165.27 12.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.396 -0.815 . . . . 0.0 110.816 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -120.7 106.49 11.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 109.64 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -106.4 164.31 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.087 -1.008 . . . . 0.0 110.845 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.8 86.87 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.732 . . . . 0.0 109.988 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 172.96 8.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.424 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.7 p -52.26 -50.46 62.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -52.96 -31.83 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.98 -179.59 22.9 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 58.3 m -79.01 114.67 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 110.056 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.38 -159.51 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 110.535 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 20' ' ' MET . 50.8 m-85 -126.84 125.81 42.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.095 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 11.7 t90 -99.93 116.19 31.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.521 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.685 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.3 t-160 -82.73 109.02 16.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.4 mt -68.22 -39.77 18.18 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 112.138 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.58 -55.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.257 1.135 . . . . 0.0 111.602 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 p -86.64 -10.7 53.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.085 . . . . 0.0 110.315 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 66.26 7.66 39.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -82.25 154.67 25.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.162 -1.199 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.74 151.18 39.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.866 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 13.3 mt-30 -141.91 -141.46 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 66.2 m95 -153.36 -40.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 1.7 mt-10 -93.63 169.19 10.51 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.198 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.4 Cg_endo -72.24 125.91 11.24 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.445 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.8 Cg_endo . . . . . 0 C--N 1.306 -1.682 0 O-C-N 123.971 1.511 . . . . 0.0 110.596 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 44.3 Cg_endo -70.41 -162.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.969 1.51 . . . . 0.0 110.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 118.74 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.368 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.18 5.35 37.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 53.4 m95 -119.88 140.5 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -1.232 . . . . 0.0 109.959 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.923 ' SD ' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -120.67 165.52 14.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.645 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -120.16 106.8 12.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.335 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.7 t -111.75 161.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 111.108 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.82 84.88 2.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.798 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 -175.39 4.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.944 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.1 p -66.86 -28.91 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -27.56 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.45 -166.3 30.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 23.5 m -92.5 114.24 26.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.1 p90 -114.33 -157.74 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.028 . . . . 0.0 110.255 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.581 ' CE2' HD11 ' A' ' 15' ' ' LEU . 73.6 m-85 -135.85 130.23 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 6.8 t90 -98.04 130.36 44.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.55 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 5.4 t-160 -90.84 104.12 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.923 HD11 ' SD ' ' A' ' 20' ' ' MET . 14.5 mt -62.14 -41.35 74.9 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 112.637 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.2 Cg_endo -71.89 -56.18 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.278 1.146 . . . . 0.0 111.728 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 p -86.53 -44.37 11.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 0.0 110.409 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.88 -6.83 33.05 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 5.9 m -69.11 161.07 29.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 110.375 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.38 165.89 14.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 0.0 110.076 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 46.7 mt-30 -147.95 -141.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -146.63 -54.19 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' C ' ' CE1' ' A' ' 30' ' ' TYR . 35.5 mt-10 -90.73 163.11 31.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 0.0 110.308 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HB3' ' OH ' ' A' ' 30' ' ' TYR . 45.4 Cg_endo -73.51 116.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.039 1.547 . . . . 0.0 110.421 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.2 Cg_endo . . . . . 0 C--N 1.305 -1.745 0 O-C-N 123.91 1.479 . . . . 0.0 110.364 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.742 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.904 0.383 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 45.5 Cg_endo -71.78 -161.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.033 1.543 . . . . 0.0 110.36 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.74 118.12 34.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.12 7.08 23.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.566 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 45.2 m95 -120.29 133.4 55.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.231 . . . . 0.0 109.56 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 33' ' ' ILE . 9.5 mmm -114.72 167.55 10.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.159 -0.963 . . . . 0.0 110.916 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -120.9 108.93 14.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 10.9 t -109.0 165.22 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.809 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.2 mt-30 -120.63 85.04 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.574 -0.704 . . . . 0.0 109.791 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.2 179.5 7.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -62.05 -34.44 76.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -25.32 63.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.126 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.53 -166.05 28.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 24.8 m -93.08 114.02 26.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.168 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.5 p90 -114.02 -156.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.292 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 20' ' ' MET . 43.5 m-85 -130.61 135.13 47.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 110.337 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.504 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.3 t90 -104.98 115.55 30.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.567 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 2.8 t-160 -76.93 111.24 12.27 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.9 mt -68.79 -40.13 16.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.513 -0.742 . . . . 0.0 112.198 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.0 Cg_endo -73.25 -56.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.253 1.133 . . . . 0.0 111.785 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.428 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 23.5 p -86.33 -22.86 26.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.96 -1.087 . . . . 0.0 110.423 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 83.82 -12.46 52.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -61.91 159.92 13.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -1.208 . . . . 0.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.17 163.0 19.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.386 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 38' ' ' THR . 36.6 mt-30 -147.32 -145.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.065 -1.022 . . . . 0.0 110.385 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 33.7 m95 -145.95 -39.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 110.069 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 39.3 mt-10 -103.84 165.25 13.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.89 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.7 Cg_endo -71.96 123.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.885 1.466 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.709 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.307 -1.64 0 O-C-N 123.887 1.467 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.0 Cg_endo -68.42 -160.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.875 1.46 . . . . 0.0 110.066 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 126.48 36.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 110.643 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 33' ' ' ILE . . . 96.59 -20.19 51.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 45.8 m95 -89.98 129.07 36.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.909 -1.348 . . . . 0.0 109.957 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.471 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 23.2 mmt -106.56 166.47 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 110.704 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -120.18 110.83 17.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 24.2 t -112.17 165.8 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 0.0 110.732 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.66 111.09 17.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.755 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.84 179.21 4.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.622 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -60.07 -45.62 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.357 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -27.95 69.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.324 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.42 177.56 22.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.9 m -78.81 118.52 20.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -1.152 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.5 p90 -114.28 -155.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 110.283 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.456 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 36.4 m-85 -135.36 149.98 49.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.511 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.4 t90 -118.62 115.87 25.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CG ' ' HG1' ' A' ' 35' ' ' THR . 2.7 t-160 -76.84 111.47 12.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.155 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 mm -69.37 -40.74 15.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.507 -0.745 . . . . 0.0 112.324 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.9 Cg_endo -73.6 -50.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.293 1.154 . . . . 0.0 112.022 -178.184 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.566 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 38.1 p -86.27 -23.71 26.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 0.0 110.344 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.47 -12.42 51.56 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 58.3 m -71.88 166.74 21.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -1.209 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.49 158.35 28.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 110.045 179.494 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 64.6 mt-30 -150.22 -173.47 4.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.136 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -136.63 2.21 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.0 110.503 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 17.5 mt-10 -114.48 163.44 19.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.1 Cg_endo -73.12 111.66 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.036 1.545 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 16' ' ' PRO . 46.2 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.488 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.781 HD11 ' CB ' ' A' ' 42' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.73 0.3 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.0 Cg_endo -70.05 172.96 11.94 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.975 1.513 . . . . 0.0 110.088 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.32 22.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.637 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.17 1.11 22.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 57.6 m95 -120.48 142.42 49.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.278 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.4 mmt -120.64 167.49 12.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.873 . . . . 0.0 110.392 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -120.23 104.32 9.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.79 . . . . 0.0 109.607 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 28' ' ' THR . 11.9 t -108.34 164.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.443 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.66 96.64 5.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.17 170.92 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -49.61 -59.21 3.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -31.83 5.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.41 -178.28 25.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.8 m -78.97 121.67 25.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -1.163 . . . . 0.0 110.121 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.63 -160.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.194 -0.941 . . . . 0.0 110.353 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 61.2 m-85 -130.05 119.12 22.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.445 -0.784 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 32' ' ' HIS . 8.7 t90 -88.7 141.2 28.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.667 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 5.9 t-160 -100.42 105.43 16.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.976 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 20' ' ' MET . 15.0 mt -60.05 -40.05 74.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.627 . . . . 0.0 112.648 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 42.8 Cg_endo -71.88 -63.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.103 1.054 . . . . 0.0 111.66 -178.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.667 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.1 -38.83 17.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.131 . . . . 0.0 110.744 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 104.98 3.44 42.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.2 m -73.08 156.27 38.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -1.136 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 1.8 p -120.59 160.15 23.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.766 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 27.7 mt-30 -145.16 -141.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 72.0 t-105 -140.09 -58.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 17.8 mt-10 -89.62 165.24 26.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.781 ' CB ' HD11 ' A' ' 15' ' ' LEU . 43.8 Cg_endo -71.43 118.11 5.5 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.92 1.484 . . . . 0.0 110.36 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.0 Cg_endo . . . . . 0 C--N 1.307 -1.649 0 O-C-N 123.972 1.512 . . . . 0.0 110.544 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.3 Cg_endo -68.62 -161.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.97 1.511 . . . . 0.0 109.803 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.35 117.62 34.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 110.699 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.13 28.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.6 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 43.2 m95 -98.68 139.93 33.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.32 . . . . 0.0 109.928 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.991 ' SD ' HD11 ' A' ' 33' ' ' ILE . 47.2 mmm -116.65 165.7 12.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 110.884 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -120.6 111.84 18.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 5.9 t -112.54 163.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 35.9 tt0 -120.47 89.57 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 179.13 6.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -63.1 -33.43 75.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 110.356 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -72.9 -21.84 60.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.211 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.45 -176.88 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 m -85.75 113.72 22.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.602 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 40.9 p90 -114.14 -154.9 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 46.6 m-85 -133.99 145.78 49.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.943 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.505 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 5.4 t90 -115.12 118.89 34.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.116 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.595 ' CD2' ' CE2' ' A' ' 19' ' ' TRP . 2.4 t-160 -79.85 110.12 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.991 HD11 ' SD ' ' A' ' 20' ' ' MET . 38.8 mt -69.41 -39.48 12.43 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.715 -0.616 . . . . 0.0 112.408 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.5 Cg_endo -73.59 -53.32 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.162 1.085 . . . . 0.0 111.92 -178.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 53.4 p -86.39 -21.39 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 110.322 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -8.83 57.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.4 m -70.56 163.28 27.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.27 148.15 44.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 110.218 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 59.2 mt-30 -142.53 -170.97 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 83.1 m95 -136.5 1.8 2.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.437 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.59 160.27 42.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.91 112.26 3.47 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.084 1.571 . . . . 0.0 110.477 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 O-C-N 124.012 1.533 . . . . 0.0 110.436 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.6 Cg_endo -69.67 -160.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.905 1.476 . . . . 0.0 110.472 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 120.1 37.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 110.429 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.68 7.41 45.09 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 52.3 m95 -119.85 133.53 55.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.226 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.717 ' SD ' HD11 ' A' ' 33' ' ' ILE . 59.6 mmm -120.44 166.6 13.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -121.08 111.34 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.4 t -110.43 161.56 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -121.04 83.94 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 168.32 18.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -54.18 -35.5 62.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.85 -166.28 34.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 23' ' ' GLN . 24.0 m -101.44 113.4 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 110.073 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 45.7 p90 -114.32 -157.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.604 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.591 ' HE2' HD11 ' A' ' 15' ' ' LEU . 27.6 m-85 -130.02 135.18 47.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.3 t90 -105.4 121.84 44.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.43 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.2 t-160 -83.33 107.35 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.901 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.717 HD11 ' SD ' ' A' ' 20' ' ' MET . 52.7 mt -67.42 -38.3 15.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.82 . . . . 0.0 112.372 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.6 Cg_endo -73.5 -57.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.067 1.035 . . . . 0.0 111.529 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.406 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 13.9 p -86.89 -34.48 19.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.922 -1.111 . . . . 0.0 110.419 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 98.68 -9.41 62.22 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.6 m -62.89 156.68 23.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.061 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.477 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.29 159.57 24.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 109.554 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 37.5 mt-30 -144.33 -137.4 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 110.496 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -159.0 -48.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 42.1 mt-10 -92.45 165.54 19.22 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.647 -0.658 . . . . 0.0 110.002 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.4 Cg_endo -71.56 122.17 8.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.004 1.529 . . . . 0.0 110.292 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.307 -1.624 0 O-C-N 123.913 1.48 . . . . 0.0 110.346 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.332 0.587 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.599 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -112.94 81.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 60.29 21.02 10.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.4 m95 57.07 55.67 5.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 2' ' ' SER . 2.1 m-80 -48.94 165.48 0.26 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 -26.54 15.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.042 1.548 . . . . 0.0 110.475 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -84.12 -71.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 7' ' ' ASN . . . 42.38 -160.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.02 47.52 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.246 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.84 -159.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -79.43 -162.5 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 110.286 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.663 ' H ' HG22 ' A' ' 11' ' ' THR . 2.8 p30 -58.3 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -104.33 -53.42 2.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 13' ' ' SER . 7.6 t70 -177.98 54.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.1 mm? -67.71 171.33 5.42 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.056 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.45 -170.78 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.951 1.501 . . . . 0.0 110.121 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.06 121.32 30.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 110.56 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.13 6.02 49.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.4 m95 -120.05 136.53 54.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.875 -1.367 . . . . 0.0 109.858 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.938 ' SD ' HD11 ' A' ' 33' ' ' ILE . 2.0 mmt -116.35 166.23 12.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.804 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 3.9 ttt180 -120.19 106.37 11.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.529 -0.732 . . . . 0.0 109.423 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.7 t -109.41 162.38 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 0.0 110.733 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.63 80.54 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.826 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.88 169.57 17.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.44 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -59.68 -22.5 62.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -81.3 -32.05 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.14 175.95 28.64 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 51.0 m -81.15 113.19 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.597 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 49.8 p90 -114.39 -156.21 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.511 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.702 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.2 m-85 -131.77 135.25 46.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.484 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 4.9 t90 -107.04 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.863 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.68 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -80.06 109.63 14.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.477 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.938 HD11 ' SD ' ' A' ' 20' ' ' MET . 47.3 mt -67.83 -36.91 10.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 112.616 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.28 -62.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 122.997 0.999 . . . . 0.0 111.833 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.551 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 2.9 t -86.39 -18.16 32.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.918 -1.114 . . . . 0.0 110.536 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 84.41 -13.99 48.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.528 ' H ' HG23 ' A' ' 35' ' ' THR . 8.9 m -59.18 160.99 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -1.17 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 154.15 36.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 41.9 mt-30 -142.04 -175.57 4.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -136.8 1.89 2.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 23.1 mt-10 -120.04 160.22 43.9 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 110.088 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.56 110.68 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.944 1.497 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 47.1 Cg_endo -74.17 110.95 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.929 1.489 . . . . 0.0 110.323 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.94 62.77 0.4 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 105.79 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -1.16 . . . . 0.0 110.003 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.47 99.25 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.32 87.91 9.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.112 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.43 -2.52 11.87 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.012 1.533 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.3 m -89.69 -28.81 19.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.872 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.171 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' O ' ' OD2' ' A' ' 1' ' ' ASP . 4.5 p-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.241 0.543 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.562 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 2.2 t -132.31 104.11 6.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 2' ' ' SER . 15.3 m-85 -162.45 47.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -45.97 156.57 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.44 143.12 25.84 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 -24.01 18.14 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.471 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ALA . 7.8 m-20 -85.33 -25.94 26.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ASN . . . -60.26 -147.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.57 112.66 21.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -48.02 136.16 11.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -92.66 -163.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.339 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' HB2' HD23 ' A' ' 15' ' ' LEU . 9.4 p-10 -42.47 126.82 3.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 20.0 p -75.42 -27.31 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.346 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 13' ' ' SER . 5.7 t0 -179.83 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.494 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' A' ' 43' ' ' PRO . 4.1 mm? -90.53 167.18 17.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.018 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -71.17 -162.93 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.947 1.498 . . . . 0.0 110.404 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.2 120.23 36.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.477 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.26 -0.08 26.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 56.8 m95 -117.43 141.81 47.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.543 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 34.2 mmm -120.71 165.7 14.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 110.73 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -120.64 105.81 11.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.533 -0.73 . . . . 0.0 109.498 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.6 t -107.91 163.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 110.752 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 10.4 tt0 -121.19 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.737 -0.602 . . . . 0.0 109.767 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.82 174.46 5.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.376 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . 19.8 p -67.8 -6.71 22.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -26.18 12.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.48 -176.23 38.84 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -94.07 118.42 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -1.13 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.2 p90 -114.48 -154.06 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.481 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 64.5 m-85 -135.52 135.54 40.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.4 t90 -107.31 132.51 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.805 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.63 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 5.2 t-160 -93.22 108.07 19.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.111 . . . . 0.0 110.388 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 12.4 mt -63.17 -39.23 49.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.468 -0.77 . . . . 0.0 112.542 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.63 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 46.2 Cg_endo -73.01 -62.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.125 1.066 . . . . 0.0 111.951 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.571 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.6 -30.78 21.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.134 . . . . 0.0 110.933 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.61 6.86 60.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -74.39 152.58 39.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 110.192 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.12 38.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.532 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 56.2 mt-30 -141.97 -143.57 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.131 -0.981 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.425 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 67.6 t-105 -136.83 -54.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.1 mt-10 -92.04 164.95 21.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.448 -0.782 . . . . 0.0 110.239 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.9 Cg_endo -72.5 129.49 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.991 1.522 . . . . 0.0 110.338 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.1 Cg_endo -72.95 121.84 7.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.868 1.457 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.02 113.22 1.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.67 -17.38 14.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -1.16 . . . . 0.0 110.121 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' SER . . . -96.74 143.79 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 7.6 t 177.5 138.89 0.23 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 -90.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.052 1.554 . . . . 0.0 110.45 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 m -90.98 158.86 16.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.175 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 2' ' ' SER . 81.0 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 1' ' ' ASP . 0.3 OUTLIER 63.99 86.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 110.229 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.65 -44.5 8.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -51.81 112.44 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.249 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -126.64 138.59 32.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.176 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -27.61 14.33 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.047 1.551 . . . . 0.0 110.477 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -90.51 40.26 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.273 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.85 17.46 15.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.21 84.36 5.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -76.33 170.53 16.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.278 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -94.35 -168.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 11' ' ' THR . 2.7 m-20 -89.7 -162.6 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 110.245 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -105.59 53.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 110.184 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' SER . 19.2 m-20 56.13 53.32 9.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.5 mm? -85.21 168.79 18.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.885 . . . . 0.0 110.071 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.05 -159.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.949 1.499 . . . . 0.0 110.203 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.46 123.59 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.689 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 8.83 55.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.3 m95 -120.5 138.82 53.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.944 -1.327 . . . . 0.0 109.899 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 82.1 mmm -120.87 170.29 9.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 110.696 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -120.42 110.26 16.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.495 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -112.39 163.8 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 110.87 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 21.9 tt0 -120.91 91.78 3.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 110.02 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -92.02 -172.67 3.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 110.635 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.8 p -67.12 -33.72 76.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.184 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.587 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -73.3 -18.63 61.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.316 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.21 -172.42 22.95 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 54.7 m -85.51 113.85 22.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.124 . . . . 0.0 110.081 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.3 p90 -114.31 -156.26 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' MET . 58.3 m-85 -128.89 142.3 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 3.9 t90 -112.26 126.99 55.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.062 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.564 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 3.1 t-160 -84.69 109.25 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 110.122 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 56.0 mt -65.12 -38.25 27.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 112.404 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.7 Cg_endo -74.0 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.115 1.061 . . . . 0.0 111.891 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.549 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.53 -26.94 24.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.84 -1.163 . . . . 0.0 111.096 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.72 0.22 75.76 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -67.91 154.75 40.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -1.171 . . . . 0.0 110.353 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.53 152.84 37.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 109.877 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 49.8 mt-30 -142.15 -168.86 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.587 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 99.6 m95 -137.51 1.12 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.127 -0.983 . . . . 0.0 110.596 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 4.0 mt-10 -120.3 162.11 35.59 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -74.69 116.02 4.48 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.117 1.588 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.29 99.21 1.09 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.949 1.5 . . . . 0.0 110.452 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.71 100.09 1.37 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -113.48 133.25 55.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -1.143 . . . . 0.0 110.265 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.89 -37.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.354 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -73.97 -52.51 4.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.319 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 47' ' ' SER . 47.4 Cg_endo -75.14 130.01 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.785 1.413 . . . . 0.0 110.426 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.59 36.18 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.38 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.168 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.28 0.562 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -113.49 -21.93 10.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.67 88.88 5.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.198 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 4' ' ' TRP . 11.4 t-105 -50.02 141.14 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.51 109.29 0.91 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.945 . . . . 0.0 110.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.81 -90.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.962 1.506 . . . . 0.0 110.513 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' ALA . 3.1 m-80 -82.25 -71.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.226 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 7' ' ' ASN . . . 44.71 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -76.93 99.85 5.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -53.91 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.25 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.553 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -108.86 -168.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 11' ' ' THR . 0.7 OUTLIER -60.13 -167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.304 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 4.8 p -69.06 -47.61 64.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 170.77 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.346 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.0 mm? -66.9 168.11 11.78 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.973 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.5 Cg_endo -70.07 177.86 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.892 1.469 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.79 122.85 27.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.679 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 4.93 30.5 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 50.4 m95 -120.49 135.79 54.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.977 -1.308 . . . . 0.0 109.985 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 1.058 ' SD ' HD11 ' A' ' 33' ' ' ILE . 78.9 mmm -120.6 165.83 14.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.895 . . . . 0.0 110.815 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -120.76 114.31 21.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.698 . . . . 0.0 109.659 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 5.4 t -116.87 162.16 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.931 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 pt20 -120.7 99.77 6.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 109.872 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -176.93 3.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 26' ' ' SER . 14.2 p -52.45 -66.34 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -42.09 -51.37 4.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.92 -171.21 42.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -85.1 118.84 24.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.0 p90 -114.34 -158.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 42' ' ' PRO . 24.2 m-85 -129.78 129.47 44.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.986 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.85 120.89 40.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.412 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.0 t-160 -82.85 110.28 17.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.998 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.058 HD11 ' SD ' ' A' ' 20' ' ' MET . 30.6 mt -67.66 -40.5 25.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.499 -0.751 . . . . 0.0 112.34 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.2 Cg_endo -73.71 -56.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.286 1.15 . . . . 0.0 111.737 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 15.5 p -86.66 -31.48 21.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.937 -1.102 . . . . 0.0 110.557 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.26 -11.84 69.88 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.5 m -61.16 158.48 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.06 . . . . 0.0 110.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.71 157.5 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 mt-30 -141.73 -144.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.005 . . . . 0.0 110.477 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.439 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 71.1 t-105 -144.57 -55.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.6 mt-10 -90.63 164.81 25.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.506 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 46.2 Cg_endo -73.82 120.59 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 15' ' ' LEU . 49.1 Cg_endo -75.31 150.88 37.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.821 1.432 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.82 23.98 77.27 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.547 ' NH2' ' HB2' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -145.95 -37.32 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -1.133 . . . . 0.0 110.342 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . . . -104.01 98.62 8.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -162.35 130.36 2.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.105 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.68 -168.32 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.877 1.462 . . . . 0.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.75 -179.02 2.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.233 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.157 0.503 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.94 172.46 7.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -156.82 -64.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -56.09 -179.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -58.06 156.31 20.73 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.42 -36.08 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.088 1.573 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -146.33 37.6 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.0 -155.66 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD2' ' N ' ' A' ' 10' ' ' GLU . 40.5 p90 -74.59 -159.57 0.09 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 110.129 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.557 ' N ' ' CD2' ' A' ' 9' ' ' PHE . 2.4 tt0 -158.51 147.72 19.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.135 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.6 m -58.48 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.686 ' H ' HG22 ' A' ' 11' ' ' THR . 50.1 p-10 -47.77 149.38 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.285 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 p -80.01 -61.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.21 48.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.581 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.3 mm? -70.97 167.82 25.77 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.8 Cg_endo -68.38 -160.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.974 1.513 . . . . 0.0 110.033 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.76 39.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.0 110.703 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.4 -15.05 56.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.679 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 54.1 m95 -95.02 139.42 31.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 1.02 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -114.72 163.57 15.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 110.586 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.55 102.81 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.463 -0.773 . . . . 0.0 109.352 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 6.6 t -106.36 162.04 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 110.564 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.5 pt20 -120.87 82.16 1.88 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.52 -0.738 . . . . 0.0 109.953 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.36 161.0 29.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 0.0 110.389 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -54.27 -20.94 7.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -83.99 -32.53 24.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.65 167.28 20.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -79.52 116.3 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 110.233 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 51.4 p90 -114.97 -160.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.698 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE1' HD11 ' A' ' 15' ' ' LEU . 70.7 m-85 -128.95 125.89 38.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.914 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.52 116.08 30.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.577 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.679 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.2 t-160 -78.98 108.94 12.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.777 . . . . 0.0 109.889 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.02 HD11 ' SD ' ' A' ' 20' ' ' MET . 61.7 mt -68.66 -35.69 7.07 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.603 -0.686 . . . . 0.0 112.827 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.6 Cg_endo -72.21 -60.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 122.972 0.985 . . . . 0.0 111.573 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.585 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 3.1 t -86.59 -23.69 25.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.982 -1.074 . . . . 0.0 110.442 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.61 -14.71 62.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.575 ' H ' HG23 ' A' ' 35' ' ' THR . 2.8 m -58.6 157.2 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.179 . . . . 0.0 110.199 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -120.73 162.86 19.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.925 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 30.4 mt-30 -149.4 -156.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -143.56 -35.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.449 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 45.4 mt-10 -91.84 162.97 29.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.6 Cg_endo -73.39 111.38 3.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.02 1.537 . . . . 0.0 110.579 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.8 Cg_endo -73.63 79.06 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 0.0 110.436 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.95 39.73 1.67 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -101.51 24.91 9.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -1.16 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.93 22.45 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.49 65.51 1.46 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 110.323 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.61 -6.92 19.94 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 110.539 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 23.2 t -87.14 -23.98 24.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 49' ' ' SER . 1.7 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.277 0.56 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.99 45.94 20.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' TRP . 17.4 m-85 -101.71 -6.28 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 4' ' ' TRP . 13.7 p-90 -177.45 125.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 110.237 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.16 132.56 45.02 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 110.341 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.24 -90.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.936 1.493 . . . . 0.0 110.355 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 7.1 t-20 -108.02 -33.02 7.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.94 . . . . 0.0 109.884 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 56.14 85.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.818 . . . . 0.0 110.229 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -152.33 101.23 2.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.11 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -65.15 170.01 4.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 110.208 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.4 m -64.87 -166.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.687 ' H ' HG22 ' A' ' 11' ' ' THR . 3.8 p30 -54.63 -172.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.122 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 2.5 p -69.58 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 13' ' ' SER . 48.5 m-20 -149.49 50.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? -93.38 167.12 14.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.041 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.1 Cg_endo -70.17 -179.2 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.427 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 98.05 2.1 58.24 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.59 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.3 m95 -119.6 132.12 55.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.254 . . . . 0.0 109.938 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HD11 ' A' ' 33' ' ' ILE . 33.9 mmm -120.4 164.81 15.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 0.0 110.646 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -120.84 113.45 20.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t -113.98 161.39 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.82 94.36 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.605 -0.685 . . . . 0.0 109.964 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.27 173.1 7.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.41 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -57.75 -45.32 86.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -32.52 70.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.12 20.86 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 22' ' ' VAL . 45.9 m -80.13 116.57 20.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -1.189 . . . . 0.0 110.186 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 54.6 p90 -114.52 -159.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 110.401 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 20' ' ' MET . 92.5 m-85 -132.7 143.73 49.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.467 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 9.8 t90 -112.25 124.38 52.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.436 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.513 ' ND1' ' OG1' ' A' ' 35' ' ' THR . 4.8 t-160 -86.23 97.42 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.2 mt -58.46 -41.63 90.25 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 112.76 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.7 Cg_endo -69.35 -56.01 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.078 1.041 . . . . 0.0 111.717 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 34.4 p -86.84 -49.67 7.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.887 -1.133 . . . . 0.0 110.457 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -4.41 19.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.1 m -73.62 158.28 35.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.38 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.66 160.46 23.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.987 . . . . 0.0 110.019 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.543 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 70.9 mt-30 -141.98 -171.68 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 93.5 m95 -136.64 2.73 2.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.023 -1.048 . . . . 0.0 110.351 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -133.13 163.78 48.64 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.5 Cg_endo -71.84 125.03 10.65 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.288 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 52.8 Cg_endo -81.05 64.07 8.83 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.0 110.75 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 43' ' ' PRO . . . 55.77 109.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -60.5 156.36 16.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -1.191 . . . . 0.0 110.149 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.17 -166.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.2 p -167.05 135.53 2.16 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.873 . . . . 0.0 110.103 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 -177.44 2.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.958 1.504 . . . . 0.0 110.519 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -128.47 51.21 2.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.096 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.438 ' CG ' ' OXT' ' A' ' 50' ' ' GLN . 4.7 pt20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.217 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.222 0.534 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.7 74.46 1.66 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -78.83 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CZ3' ' HB1' ' A' ' 17' ' ' ALA . 68.5 t-105 -62.38 105.3 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 110.321 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.74 113.16 24.24 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 4' ' ' TRP . 45.8 Cg_endo -72.33 -24.54 19.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.885 1.466 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 55.45 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.03 -155.37 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -52.94 123.12 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.18 158.28 33.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -93.04 -165.09 1.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.283 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.534 ' H ' HG22 ' A' ' 11' ' ' THR . 0.2 OUTLIER -61.44 -162.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.916 . . . . 0.0 110.26 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.54 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.566 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -140.76 45.86 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.326 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.2 mm? -100.16 168.7 9.02 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.1 Cg_endo -67.44 -160.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.869 1.458 . . . . 0.0 110.095 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' CZ3' ' A' ' 4' ' ' TRP . . . -90.02 128.97 36.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.988 . . . . 0.0 111.02 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' A' ' 34' ' ' PRO . . . 91.49 -19.97 44.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.708 ' CH2' ' NE2' ' A' ' 39' ' ' GLN . 48.6 m95 -88.77 136.31 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.919 -1.342 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.937 ' SD ' HD11 ' A' ' 33' ' ' ILE . 7.2 mmt -119.12 165.11 14.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -120.74 106.63 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.647 -0.658 . . . . 0.0 109.31 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.591 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.1 t -105.95 159.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.547 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.9 pt20 -121.15 82.46 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 0.0 110.213 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.17 162.03 27.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.0 110.294 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -55.07 -20.53 9.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.173 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.48 -31.95 26.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.298 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.91 172.53 28.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 m -87.98 114.37 24.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.216 -1.167 . . . . 0.0 110.117 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.591 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 42.2 p90 -115.0 -156.34 0.6 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.0 110.622 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.713 ' CE1' HD11 ' A' ' 15' ' ' LEU . 65.3 m-85 -131.37 145.84 52.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.359 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.3 t90 -117.74 122.31 43.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.608 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 2.8 t-160 -84.36 98.21 9.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.781 . . . . 0.0 109.903 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.937 HD11 ' SD ' ' A' ' 20' ' ' MET . 19.2 mt -68.8 -51.88 19.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 0.0 111.732 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 41.0 Cg_endo -65.85 -8.67 20.41 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.152 1.08 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.569 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 23.7 m -120.12 -69.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 110.433 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.44 -10.23 5.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 38' ' ' THR . 27.7 m -86.61 165.97 15.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -1.081 . . . . 0.0 110.151 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.04 159.5 25.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.708 ' NE2' ' CH2' ' A' ' 19' ' ' TRP . 19.4 mt-30 -142.49 -161.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 52.7 m95 -140.02 -37.82 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 31.2 mt-10 -94.92 164.33 19.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.219 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.3 Cg_endo -72.7 118.71 5.7 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.322 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.59 -38.1 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.939 1.494 . . . . 0.0 110.553 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.3 136.22 14.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -60.05 141.26 56.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -1.089 . . . . 0.0 110.177 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -158.82 -179.25 7.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER 59.24 150.69 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' SER . 46.1 Cg_endo -73.16 161.38 43.29 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.023 1.538 . . . . 0.0 110.377 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' PRO . 23.4 m 43.13 55.63 4.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.136 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.211 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.227 0.537 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.92 139.35 5.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -79.44 -2.01 39.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -51.12 -68.61 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.91 165.35 13.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 110.32 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 7' ' ' ASN . 45.8 Cg_endo -72.71 -26.65 15.9 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.973 1.512 . . . . 0.0 110.38 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 15.3 t-20 -179.07 -50.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 10' ' ' GLU . . . 51.53 50.9 17.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -57.04 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.358 -0.839 . . . . 0.0 110.903 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' ALA . 3.5 pt-20 -94.38 -159.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.956 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -93.62 -163.43 1.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.372 -0.83 . . . . 0.0 110.22 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 11' ' ' THR . 12.4 p30 -60.28 171.07 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.278 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 89.5 p -84.52 45.35 1.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 13' ' ' SER . 7.7 t0 56.86 66.24 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.329 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? -70.58 172.1 6.8 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 15' ' ' LEU . 42.6 Cg_endo -69.77 -165.34 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.0 110.169 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.88 116.88 29.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.47 2.06 40.75 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.516 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 65.2 m95 -120.45 138.06 54.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.987 -1.302 . . . . 0.0 110.476 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.963 ' SD ' HD11 ' A' ' 33' ' ' ILE . 42.6 mmm -121.09 167.2 12.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -120.7 110.28 16.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.738 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 3.4 t -113.8 159.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.614 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.94 79.37 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.959 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.21 162.33 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 0.0 110.32 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -53.88 -22.67 10.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.984 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -80.61 -34.1 35.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.28 -171.21 38.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 23' ' ' GLN . 22.4 m -96.9 114.15 25.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -1.11 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.0 p90 -114.55 -161.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.522 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 54.5 m-85 -131.18 122.37 26.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.0 t90 -91.89 130.77 37.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.13 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.686 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 6.0 t-160 -89.65 105.81 18.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.047 -1.033 . . . . 0.0 109.904 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.963 HD11 ' SD ' ' A' ' 20' ' ' MET . 34.0 mt -59.37 -41.21 85.93 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 0.0 112.61 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.654 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 44.1 Cg_endo -72.08 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.184 1.097 . . . . 0.0 111.935 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.686 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.46 -34.67 20.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 111.004 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 101.08 0.11 54.71 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.87 152.67 42.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.173 . . . . 0.0 109.876 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.71 152.89 36.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.894 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 14.5 mt-30 -141.79 -139.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -151.85 -48.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.893 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 54.2 mt-10 -86.14 163.64 42.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.141 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -73.15 126.45 11.15 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.984 1.518 . . . . 0.0 110.468 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.5 Cg_endo -74.06 86.58 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.951 1.501 . . . . 0.0 110.326 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.83 85.18 0.29 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 13.5 ttt-85 -110.28 140.88 43.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.153 . . . . 0.0 110.143 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 58.9 104.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 p -81.31 145.19 55.2 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.68 -25.67 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.984 1.518 . . . . 0.0 110.541 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -163.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.235 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.275 0.56 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -152.3 84.82 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.127 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -153.39 -49.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.888 . . . . 0.0 110.292 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -48.28 116.02 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.12 81.87 6.65 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.58 -28.08 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.957 1.504 . . . . 0.0 110.357 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -65.53 -23.94 67.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.044 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.61 111.88 22.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 110.074 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.45 46.52 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 110.309 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -106.63 -174.19 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -105.95 -160.96 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 11' ' ' THR . 13.5 t0 52.79 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.5 -78.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.341 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.83 48.22 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.9 mm? -88.43 167.79 18.13 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.141 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -70.43 -162.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.001 1.527 . . . . 0.0 110.122 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.83 118.43 34.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 105.88 7.13 36.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 47.7 m95 -119.08 123.46 44.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.018 -1.283 . . . . 0.0 109.668 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.4 tpp -106.96 170.17 8.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 111.214 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' MET . 3.1 ttt180 -121.43 110.3 15.9 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.704 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.1 t -110.04 159.65 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.068 -1.02 . . . . 0.0 110.399 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 6.5 tt0 -120.8 93.84 4.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.8 167.02 11.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -49.86 -49.51 49.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.462 ' OG ' ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -54.03 -35.6 62.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.26 -0.9 . . . . 0.0 110.08 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.53 179.52 30.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 55.7 m -86.75 115.1 23.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -1.17 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HB3' ' CE3' ' A' ' 40' ' ' TRP . 46.6 p90 -114.44 -155.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 20' ' ' MET . 52.2 m-85 -136.13 152.47 50.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.559 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 9.3 t90 -118.68 120.1 36.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.644 ' CE1' HG21 ' A' ' 35' ' ' THR . 2.3 t-160 -79.03 93.28 5.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 110.098 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.4 mt -62.86 -39.05 49.43 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.566 -0.709 . . . . 0.0 112.406 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.95 -45.33 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.077 1.041 . . . . 0.0 111.7 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.644 HG21 ' CE1' ' A' ' 32' ' ' HIS . 44.1 p -86.17 -55.06 4.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.184 . . . . 0.0 110.398 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.3 -11.19 8.6 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 38' ' ' THR . 96.0 m -86.4 170.71 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.02 170.96 9.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 38' ' ' THR . 54.3 mt-30 -158.71 -177.48 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 79.5 m95 -136.47 3.11 2.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.243 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 24.4 mt-10 -119.66 160.18 43.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.93 110.26 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.997 1.524 . . . . 0.0 110.357 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.0 Cg_endo -71.73 -172.9 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.961 1.506 . . . . 0.0 110.503 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.2 -130.86 1.26 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 175.71 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.34 109.29 6.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.213 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -105.6 110.65 64.46 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.285 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.22 116.89 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.048 1.551 . . . . 0.0 110.393 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 p -171.33 173.96 4.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.217 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.232 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.185 0.516 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' ASP . 0.2 OUTLIER 174.65 -170.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 21.8 m-85 -102.94 53.92 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.407 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 62.56 88.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -45.4 161.86 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.63 -25.56 17.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 14.8 t-20 -161.63 -39.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 7' ' ' ASN . . . 173.51 -163.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.433 ' O ' ' C ' ' A' ' 10' ' ' GLU . 25.3 m-85 -67.01 139.23 57.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.002 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' PHE . 4.1 mp0 -40.86 146.72 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.755 . . . . 0.0 110.317 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -94.29 -162.33 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.872 . . . . 0.0 110.348 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.8 m-20 32.93 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.726 -0.609 . . . . 0.0 111.224 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.53 -54.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -164.58 46.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.267 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.8 mm? -72.72 167.74 30.69 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -70.0 -161.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.932 1.49 . . . . 0.0 110.457 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.93 124.35 38.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.92 8.25 57.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.594 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.6 m95 -120.57 136.64 54.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.251 . . . . 0.0 110.051 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 33' ' ' ILE . 6.8 mmm -120.61 168.29 11.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.432 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 35.4 ttt180 -120.78 112.11 18.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.835 . . . . 0.0 109.848 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 7.5 t -113.16 162.43 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -121.09 93.35 4.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.2 171.14 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.969 . . . . 0.0 110.315 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -60.89 -30.79 70.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.392 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -22.67 56.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.7 172.86 18.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.8 m -83.55 117.63 23.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.5 p90 -114.17 -159.12 0.68 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.35 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 95.1 m-85 -132.2 125.77 31.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.477 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 8.4 t90 -92.3 127.92 37.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.268 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.682 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 5.4 t-160 -89.15 110.21 20.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.847 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.686 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.2 mt -68.27 -37.0 9.81 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.682 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 43.7 Cg_endo -71.96 -36.22 6.28 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 122.936 0.967 . . . . 0.0 111.685 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.439 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -116.84 -42.93 2.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 110.376 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' HIS . . . 112.34 -2.74 26.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -66.6 151.89 46.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -1.211 . . . . 0.0 110.369 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.566 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -116.7 171.21 8.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 40.4 mt-30 -149.89 -148.59 0.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.01 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -147.4 -37.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.062 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 2.4 mt-10 -101.19 166.08 13.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.7 Cg_endo -72.46 119.42 6.11 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.914 1.481 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.7 Cg_endo -73.62 145.44 37.25 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.996 1.524 . . . . 0.0 110.437 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.82 132.8 5.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.58 80.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.94 172.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -0.865 . . . . 0.0 110.233 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.72 74.3 0.84 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.437 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 46.6 Cg_endo -73.14 104.67 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.034 1.544 . . . . 0.0 110.445 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 15.1 m 59.09 27.18 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.319 0.58 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.91 27.1 6.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -48.29 -41.15 27.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 175.49 -48.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -120.75 112.46 33.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 110.193 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.47 -24.48 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.85 1.447 . . . . 0.0 110.552 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -102.35 42.7 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.43 47.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -102.7 47.58 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.322 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.3 154.43 22.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.128 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -79.26 -171.2 2.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.694 ' HB2' HD21 ' A' ' 15' ' ' LEU . 23.2 m-20 -67.25 111.23 3.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.251 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.04 -6.58 23.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 110.257 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 14' ' ' ASP . 18.2 p-10 -173.01 97.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 12' ' ' ASP . 4.1 mm? -66.69 169.76 7.21 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.33 -163.07 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.851 1.448 . . . . 0.0 110.478 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.26 126.23 37.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.664 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.75 9.29 60.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.674 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 51.1 m95 -120.33 138.96 53.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.921 -1.341 . . . . 0.0 109.842 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.916 ' SD ' HD11 ' A' ' 33' ' ' ILE . 37.1 mmm -120.06 168.59 11.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.856 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -120.23 110.89 17.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 109.543 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 17.1 t -112.51 166.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.938 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.5 tt0 -120.6 82.88 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 109.685 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.72 176.16 6.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.6 p -63.51 -22.62 66.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.235 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -29.82 27.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.77 -164.88 33.86 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 19.8 m -94.79 113.48 25.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.198 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 47.6 p90 -114.06 -155.55 0.57 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 75.6 m-85 -129.9 139.81 51.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.866 . . . . 0.0 110.418 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.9 t90 -110.85 118.1 35.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.674 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -79.19 110.57 14.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 110.536 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' SD ' ' A' ' 20' ' ' MET . 54.7 mt -68.36 -39.86 17.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 112.054 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 47.0 Cg_endo -75.09 -55.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.282 1.149 . . . . 0.0 111.844 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.483 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 30.1 p -86.29 -14.3 44.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.098 . . . . 0.0 110.565 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.85 5.06 50.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 9.2 m -80.93 160.85 24.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -1.173 . . . . 0.0 109.926 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 152.18 38.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.988 . . . . 0.0 110.078 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 22.8 mt-30 -141.9 -171.21 3.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -137.04 2.01 2.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.4 mt-10 -115.95 155.06 48.32 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 46.1 Cg_endo -74.08 110.99 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.009 1.531 . . . . 0.0 110.43 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.6 Cg_endo -73.24 -46.78 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.347 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.2 -158.8 0.73 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.6 -87.8 0.56 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.14 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.37 -160.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.09 146.93 36.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 131.47 17.18 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.064 1.56 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.12 161.85 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.3 t0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.2 0.524 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.98 165.91 10.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.203 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -112.07 -146.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.897 . . . . 0.0 110.257 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -45.61 137.49 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.286 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.72 129.51 76.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.62 -30.91 9.24 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.874 1.46 . . . . 0.0 110.427 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 9' ' ' PHE . 47.7 p-10 -85.78 18.23 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 110.313 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.91 -26.11 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' ASN . 3.0 t80 -124.26 81.54 1.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.63 -161.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -83.18 -159.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.333 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.549 ' H ' HG22 ' A' ' 11' ' ' THR . 11.1 p-10 -41.08 161.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.498 -0.751 . . . . 0.0 110.432 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -101.44 -60.07 1.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.425 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -170.32 74.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? -98.53 170.25 7.25 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.99 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.7 Cg_endo -69.63 -165.98 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.872 1.459 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.18 121.73 30.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.46 4.18 57.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.673 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.7 m95 -119.05 131.31 55.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.898 -1.354 . . . . 0.0 110.027 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 13.8 mmt -118.59 168.0 11.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 110.768 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.942 ' CZ ' HG21 ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.19 105.54 11.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.472 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.4 t -107.47 153.76 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -122.53 83.95 2.19 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 26' ' ' SER . 1.2 p-10 -73.93 -166.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.012 -1.055 . . . . 0.0 110.477 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.4 p -83.59 43.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.325 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.487 ' HB2' ' OD2' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -155.37 -36.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 110.32 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 165.19 29.5 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.942 HG21 ' CZ ' ' A' ' 21' ' ' ARG . 13.2 m -86.78 112.86 22.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -1.179 . . . . 0.0 110.151 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.61 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.7 p90 -113.33 -156.58 0.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 110.407 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.532 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 78.9 m-85 -127.27 138.72 53.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.5 t90 -111.44 113.57 26.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.673 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -77.47 107.74 10.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 6.1 mt -68.66 -40.42 18.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 112.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.9 Cg_endo -74.86 -48.93 0.17 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.266 1.14 . . . . 0.0 112.181 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.462 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 32.4 p -86.17 -27.97 24.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.71 49.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.562 HG22 ' N ' ' A' ' 38' ' ' THR . 98.2 m -70.63 169.75 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -1.188 . . . . 0.0 110.257 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.562 ' N ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -121.36 179.44 4.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 110.012 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.517 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 57.7 mt-30 -157.69 -162.02 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.943 . . . . 0.0 110.444 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -136.69 -36.51 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 10.7 mt-10 -103.14 164.49 15.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 48.2 Cg_endo -74.38 117.72 5.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.022 1.538 . . . . 0.0 110.447 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo -72.52 -3.31 13.2 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.845 1.444 . . . . 0.0 110.297 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.46 -59.92 1.41 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.19 96.6 10.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -1.128 . . . . 0.0 110.218 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 47' ' ' SER . . . -98.61 62.44 1.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER 41.78 72.57 1.07 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.873 . . . . 0.0 110.123 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.8 95.68 0.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.115 1.587 . . . . 0.0 110.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.59 161.72 26.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.64 154.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -126.97 127.63 45.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -51.64 128.56 23.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.915 . . . . 0.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -157.7 80.36 3.24 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.285 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.46 -25.49 15.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.039 1.547 . . . . 0.0 110.365 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 2.2 m-80 -76.91 -53.8 7.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 55.17 177.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.47 126.51 27.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 166.48 15.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -102.17 -161.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 11' ' ' THR . 2.6 t0 56.27 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.418 -0.801 . . . . 0.0 110.386 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -77.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.59 45.53 2.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.88 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? -91.59 169.73 10.77 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.182 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.5 Cg_endo -70.25 -161.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.499 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.07 122.73 33.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.696 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 94.8 6.56 60.56 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.1 m95 -120.26 136.13 54.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.26 . . . . 0.0 109.638 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 38.4 ttm -120.46 171.41 8.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 111.264 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' CG ' ' A' ' 20' ' ' MET . 57.2 ttt-85 -121.45 108.7 13.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.742 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 19.6 t -113.48 163.0 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.738 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.0 mt-30 -121.33 112.32 18.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.663 -0.648 . . . . 0.0 109.783 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.7 -178.02 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.149 -0.97 . . . . 0.0 110.476 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -65.54 -24.52 67.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -84.81 -17.96 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.957 . . . . 0.0 110.119 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.23 175.18 13.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 25.9 m -80.01 117.53 20.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.131 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.3 p90 -114.2 -152.78 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.88 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.7 m-85 -133.2 139.09 46.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.072 -1.018 . . . . 0.0 110.593 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 5.9 t90 -110.48 122.53 47.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 109.71 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.725 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 2.7 t-160 -80.41 103.76 10.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.216 -0.928 . . . . 0.0 110.218 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.1 mt -63.52 -37.69 32.25 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.545 -0.722 . . . . 0.0 112.484 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.3 Cg_endo -72.32 -62.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.024 1.013 . . . . 0.0 111.51 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.725 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.65 -35.77 19.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 103.91 -8.35 50.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.7 OUTLIER -58.95 152.19 20.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -1.185 . . . . 0.0 110.105 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.44 153.24 36.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.109 -0.994 . . . . 0.0 109.838 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 19.4 mt-30 -142.24 -142.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.405 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 97.4 m95 -149.54 -38.84 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 35.9 mt-10 -99.24 163.56 18.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -74.08 131.63 15.7 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.494 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.533 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 47.5 Cg_endo -74.69 176.1 10.24 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.903 1.475 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.5 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -64.58 152.34 42.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.17 111.6 6.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.185 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.522 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -59.05 -56.97 30.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.198 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 47' ' ' SER . 45.3 Cg_endo -72.74 158.05 51.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.008 1.531 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.36 170.95 7.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.125 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.315 0.579 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.65 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.33 -33.69 2.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 42.1 t-105 -49.18 144.73 4.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -128.3 114.97 19.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 110.012 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.3 -158.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.874 1.46 . . . . 0.0 110.358 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 3.7 t-20 -53.66 -34.88 60.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 60.72 -155.2 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD2' ' N ' ' A' ' 10' ' ' GLU . 22.4 p90 -64.28 -158.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' CD2' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -62.07 -173.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -113.61 -169.39 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.604 ' H ' HG22 ' A' ' 11' ' ' THR . 5.6 t0 55.36 92.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -54.08 -79.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.89 64.45 1.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.0 mm? -94.45 168.66 11.02 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 109.977 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 42.0 Cg_endo -69.11 -168.34 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.889 1.468 . . . . 0.0 110.329 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.97 123.55 34.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.129 -0.982 . . . . 0.0 110.72 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 106.02 -3.34 38.29 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.625 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 55.4 m95 -112.81 110.72 21.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.305 . . . . 0.0 109.477 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 25.4 ttt -91.22 171.33 9.31 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.054 0.93 . . . . 0.0 111.302 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' CG ' ' A' ' 20' ' ' MET . 67.4 ttt180 -121.05 107.06 12.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.8 t -108.53 160.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 110.533 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 4.2 mt-30 -121.02 80.04 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 0.0 110.068 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 154.63 40.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 25' ' ' THR . 80.8 p -45.67 -27.91 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -42.7 52.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.04 -176.49 45.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 94.0 m -93.56 114.18 26.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.59 -156.33 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.44 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 98.2 m-85 -131.73 147.09 52.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.272 -0.892 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 8.4 t90 -115.43 119.93 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.479 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.929 ' CD2' ' HG1' ' A' ' 35' ' ' THR . 3.0 t-160 -76.37 83.37 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 109.706 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.1 mt -52.89 -50.41 81.72 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 41.4 Cg_endo -68.71 -11.7 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.199 1.105 . . . . 0.0 111.606 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.929 ' HG1' ' CD2' ' A' ' 32' ' ' HIS . 85.6 m -120.56 -73.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.06 -17.21 2.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -74.62 161.59 29.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 110.099 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 170.38 9.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.542 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 50.3 mt-30 -147.75 -151.21 0.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.186 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -148.19 -42.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.3 mm-40 -98.45 167.53 11.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -73.16 113.46 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.6 Cg_endo -72.9 -91.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.909 1.479 . . . . 0.0 110.312 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' PRO . . . 43.54 65.83 1.42 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -86.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -173.25 -170.56 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.52 82.91 7.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.6 178.72 6.37 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.055 1.555 . . . . 0.0 110.413 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.99 49.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.219 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.22 0.533 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -153.25 -175.09 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 4' ' ' TRP . 26.6 p90 -121.56 -23.05 5.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.084 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.409 ' C ' ' O ' ' A' ' 3' ' ' PHE . 23.7 m95 -43.35 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.43 99.33 0.78 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 7' ' ' ASN . 48.5 Cg_endo -76.04 -158.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.955 1.503 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 27.8 t-20 57.44 36.78 27.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 7' ' ' ASN . . . 176.47 36.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.16 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -122.34 74.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' PHE . 68.5 tt0 53.53 174.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.677 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.4 m -66.85 -166.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.677 ' H ' HG22 ' A' ' 11' ' ' THR . 35.9 m-20 -75.82 -170.86 1.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.295 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -87.2 38.62 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.08 84.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.4 mm? -66.9 168.73 9.82 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.958 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.2 Cg_endo -70.22 -166.73 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.817 1.43 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.13 121.64 34.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 110.535 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 114.47 1.83 23.09 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.524 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 77.6 m95 -120.8 136.46 54.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.842 -1.387 . . . . 0.0 110.064 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.494 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 2.2 tpt -120.62 174.15 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 20' ' ' MET . 0.1 OUTLIER -121.0 104.66 9.97 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 48.0 t -106.76 168.96 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.966 . . . . 0.0 110.529 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.524 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.76 86.12 2.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.107 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 152.18 39.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t -49.19 -22.3 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.53 -35.81 19.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.97 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.23 40.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 22' ' ' VAL . 72.8 m -84.05 117.21 23.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 43.9 p90 -114.62 -154.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 89.7 m-85 -132.3 142.75 49.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.512 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 2.9 t90 -112.13 130.23 55.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.038 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.787 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 5.1 t-160 -86.64 100.22 12.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.193 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 59.0 mt -56.52 -42.16 94.86 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 112.556 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.65 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 42.1 Cg_endo -69.11 -66.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.026 1.014 . . . . 0.0 111.882 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.787 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.43 -38.02 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.843 -1.161 . . . . 0.0 110.654 -179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 106.66 -0.56 36.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -61.5 150.17 36.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.247 . . . . 0.0 109.9 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.72 151.9 38.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 4.7 mt-30 -142.0 -139.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.981 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -150.71 -40.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.116 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -103.73 168.29 8.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.088 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.1 Cg_endo -71.7 128.68 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.987 1.52 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.6 Cg_endo -73.44 155.1 50.81 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.91 1.479 . . . . 0.0 110.348 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' ARG . . . 125.15 165.42 12.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 15.0 ttt180 -176.35 66.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -1.194 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.8 117.84 11.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.257 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.3 t -168.54 105.93 0.52 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.883 . . . . 0.0 110.23 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.21 90.29 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.028 1.541 . . . . 0.0 110.268 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.3 OUTLIER -90.95 -175.08 4.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.294 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 49' ' ' SER . 19.7 mt-30 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 1' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.304 0.573 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -156.57 -38.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CG ' ' N ' ' A' ' 4' ' ' TRP . 28.8 p90 -66.95 -43.78 82.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 110.339 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.595 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 15.2 p-90 -61.04 -22.35 64.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.945 . . . . 0.0 110.244 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -129.44 74.22 81.06 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 46.6 Cg_endo -75.07 -89.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.05 1.553 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 11.2 p30 -66.29 -26.93 67.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 59.1 76.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.349 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.32 49.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -105.71 151.58 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.211 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -112.78 -168.26 1.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.617 ' H ' HG22 ' A' ' 11' ' ' THR . 10.5 p-10 -53.37 141.96 22.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -43.38 -84.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.203 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -153.44 58.37 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.762 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? -89.37 165.52 25.55 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.21 -160.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.979 1.515 . . . . 0.0 110.362 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.84 135.05 35.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.628 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 91.04 8.48 64.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 59.7 m95 -120.37 139.49 52.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.263 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 5.4 ttt -120.42 170.51 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 111.349 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 20' ' ' MET . 6.3 ttt-85 -121.96 112.48 18.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.681 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 42.4 t -114.96 168.77 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.518 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.78 92.27 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -86.53 162.91 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 25' ' ' THR . 65.2 p -56.59 -28.44 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.903 . . . . 0.0 110.341 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -79.73 -26.05 40.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.311 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.43 173.62 25.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' VAL . 29.8 m -79.05 116.31 19.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 39.5 p90 -114.42 -154.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.281 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' MET . 80.6 m-85 -136.28 151.35 49.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.521 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 6.0 t90 -120.04 123.59 43.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.664 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 4.0 t-160 -79.05 101.79 8.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 16.3 mt -62.16 -38.14 44.86 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.1 Cg_endo -70.57 -58.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.881 0.938 . . . . 0.0 111.419 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.664 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -92.39 -41.58 10.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 110.56 -3.25 29.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.26 150.97 44.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.132 -1.216 . . . . 0.0 110.121 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.18 149.87 41.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.048 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 24.7 mt-30 -141.78 -167.88 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.466 ' CZ3' ' OG ' ' A' ' 26' ' ' SER . 94.3 m95 -136.79 2.59 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -124.0 164.44 29.41 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.9 Cg_endo -72.16 112.46 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.972 1.511 . . . . 0.0 110.337 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo -72.9 151.92 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.431 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.19 -155.95 26.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 22.7 ttt-85 -134.85 163.46 29.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.25 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 61.45 144.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 110.272 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.585 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -172.39 -61.55 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 47' ' ' SER . 45.8 Cg_endo -71.7 173.96 11.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.951 1.5 . . . . 0.0 110.418 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 p -163.49 123.99 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.209 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.325 0.583 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.7 t -152.5 -82.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 4' ' ' TRP . 1.1 m-85 -81.31 -158.91 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.513 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER 174.76 -31.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -116.69 89.34 27.96 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.32 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.975 1.513 . . . . 0.0 110.388 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -126.27 65.27 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.933 . . . . 0.0 110.042 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.54 -156.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.94 127.26 25.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -125.96 16.47 7.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -66.53 -162.35 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.297 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.664 ' H ' HG22 ' A' ' 11' ' ' THR . 13.1 p30 -43.07 151.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.872 . . . . 0.0 110.227 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -103.15 -64.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 11.8 p-10 -164.31 51.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.5 mm? -71.73 165.76 46.43 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -70.6 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.094 1.576 . . . . 0.0 110.439 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.37 39.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.5 2.68 35.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.681 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 40.2 m95 -114.97 122.37 46.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.94 -1.33 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 64.6 mmm -106.36 164.15 12.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.46 117.58 28.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.514 -0.741 . . . . 0.0 109.503 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.1 t -118.5 163.59 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.921 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -120.72 96.85 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.933 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.3 175.56 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.503 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.8 p -53.19 -57.16 11.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.361 -0.837 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.9 m -48.79 -43.04 37.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.9 -176.52 39.17 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.7 m -84.75 116.18 23.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.11 -158.15 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 110.199 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 92.3 m-85 -132.01 130.31 41.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 110.031 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 8.2 t90 -98.95 110.72 23.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.681 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.5 t-160 -76.58 111.92 12.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.613 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.8 mt -67.76 -40.17 22.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 112.117 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.4 Cg_endo -74.16 -55.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.243 1.128 . . . . 0.0 111.622 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.414 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 19.9 p -86.64 -8.61 57.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.476 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 60.96 12.92 31.49 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.407 ' HG1' ' CB ' ' A' ' 35' ' ' THR . 5.6 m -87.0 159.69 18.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -1.233 . . . . 0.0 110.078 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.48 156.43 31.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.996 . . . . 0.0 109.675 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 12.9 mt-30 -142.72 -141.43 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 39' ' ' GLN . 93.4 m95 -150.98 -38.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.178 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 32.2 mt-10 -100.31 163.89 17.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.9 Cg_endo -73.07 127.2 11.86 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.939 1.494 . . . . 0.0 110.399 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 15' ' ' LEU . 44.8 Cg_endo -72.67 79.66 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.043 1.549 . . . . 0.0 110.314 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.74 -176.63 18.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -73.4 144.21 46.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -1.129 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 45.17 -98.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER 61.17 135.09 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.022 -1.049 . . . . 0.0 110.13 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.74 173.1 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.926 1.487 . . . . 0.0 110.487 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.63 144.21 22.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.286 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.245 0.545 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 1' ' ' ASP . 0.2 OUTLIER 43.55 79.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -107.4 53.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.169 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 171.3 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 110.207 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -145.5 135.55 11.81 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.134 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.21 -92.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.934 1.491 . . . . 0.0 110.443 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -102.07 48.52 0.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 110.274 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.29 159.72 17.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.21 120.03 5.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.257 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.18 -175.93 3.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -72.16 -160.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' H ' HG22 ' A' ' 11' ' ' THR . 1.3 p30 -42.31 138.71 1.64 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -75.57 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 110.395 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' C ' HD22 ' A' ' 15' ' ' LEU . 47.0 m-20 -131.36 47.89 2.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.6 mm? -99.61 167.95 10.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -69.8 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 131.97 38.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.03 7.99 73.03 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.687 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.3 m95 -118.09 122.17 42.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.885 -1.362 . . . . 0.0 109.969 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 29.6 mmt -106.38 168.35 9.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.793 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -120.66 107.1 12.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.4 t -106.75 166.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.096 -1.003 . . . . 0.0 110.6 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.2 tt0 -120.39 87.84 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.847 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' CD1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -81.62 169.11 17.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 25' ' ' THR . 57.9 p -58.16 -27.83 64.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.347 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -25.12 41.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.29 179.47 27.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 92.8 m -83.29 116.89 22.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 53.0 p90 -114.15 -154.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 77.4 m-85 -129.85 141.37 50.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 110.416 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.5 t90 -114.65 111.16 20.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.687 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.9 t-160 -76.74 107.18 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.484 -0.76 . . . . 0.0 110.304 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.6 mt -65.8 -40.33 38.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.575 -0.703 . . . . 0.0 111.954 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.45 -53.58 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.299 1.157 . . . . 0.0 111.874 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 20.4 p -86.46 -7.76 58.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.929 -1.107 . . . . 0.0 110.639 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.17 11.66 27.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -87.14 156.99 19.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 0.0 109.962 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.22 153.68 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.114 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' O ' ' CG ' ' A' ' 40' ' ' TRP . 35.3 mt-30 -146.84 -138.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.175 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 95.7 m95 -157.04 -37.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 38.4 mt-10 -89.51 161.95 38.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 115.63 4.42 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.972 1.511 . . . . 0.0 110.304 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 45.0 Cg_endo -72.04 127.99 13.47 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.02 1.537 . . . . 0.0 110.469 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.66 -94.25 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -116.0 120.17 38.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -1.188 . . . . 0.0 110.204 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.62 72.9 1.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.549 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -54.17 -58.78 12.15 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.375 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' CD ' ' CB ' ' A' ' 47' ' ' SER . 46.5 Cg_endo -73.27 83.0 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.531 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.69 -25.56 13.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.25 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.186 0.517 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 p -59.16 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.275 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.55 -77.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -53.42 169.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.284 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.38 148.41 40.44 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.258 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.02 -31.6 7.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.975 1.513 . . . . 0.0 110.384 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.27 47.91 0.87 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.89 -90.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.366 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -173.44 86.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.27 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.88 -170.86 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 110.253 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -70.68 -173.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.047 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 11' ' ' THR . 38.9 p-10 -64.26 -173.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.48 ' OG ' HD21 ' A' ' 15' ' ' LEU . 2.2 p -86.57 49.63 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 13' ' ' SER . 66.7 m-20 56.36 50.25 13.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 16' ' ' PRO . 4.2 mm? -68.74 171.43 6.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.011 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.5 Cg_endo -67.81 -160.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.374 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.74 128.33 36.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 111.068 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.92 75.07 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.685 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 55.2 m95 -98.33 129.93 45.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.663 -1.493 . . . . 0.0 110.054 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 33' ' ' ILE . 57.0 mmm -114.72 165.27 12.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.396 -0.815 . . . . 0.0 110.816 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 12.7 ttt180 -120.7 106.49 11.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 109.64 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -106.4 164.31 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.087 -1.008 . . . . 0.0 110.845 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.8 86.87 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.732 . . . . 0.0 109.988 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 172.96 8.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.424 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.7 p -52.26 -50.46 62.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -52.96 -31.83 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.98 -179.59 22.9 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 58.3 m -79.01 114.67 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 110.056 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.38 -159.51 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 110.535 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 20' ' ' MET . 50.8 m-85 -126.84 125.81 42.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.095 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 11.7 t90 -99.93 116.19 31.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.521 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.685 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.3 t-160 -82.73 109.02 16.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.4 mt -68.22 -39.77 18.18 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 112.138 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.58 -55.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.257 1.135 . . . . 0.0 111.602 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 p -86.64 -10.7 53.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.085 . . . . 0.0 110.315 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 66.26 7.66 39.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -82.25 154.67 25.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.162 -1.199 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.74 151.18 39.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.866 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 13.3 mt-30 -141.91 -141.46 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 66.2 m95 -153.36 -40.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 1.7 mt-10 -93.63 169.19 10.51 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.198 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.4 Cg_endo -72.24 125.91 11.24 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.445 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.8 Cg_endo -72.99 107.6 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.971 1.511 . . . . 0.0 110.596 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.06 153.89 5.73 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.43 142.4 45.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 59.19 -170.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.19 107.43 53.9 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.88 -160.81 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.02 1.537 . . . . 0.0 110.408 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.6 m -139.55 178.02 7.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.167 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p -66.08 -22.73 66.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -0.96 . . . . 0.0 110.284 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.19 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.252 -0.905 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 8.8 m95 50.05 -162.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.63 118.7 62.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.237 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.3 -32.25 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.679 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 1.5 t30 -74.13 -27.55 60.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.206 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 66.09 -164.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -78.57 139.18 38.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.34 148.28 3.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -83.96 -161.52 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.636 ' HB2' HD23 ' A' ' 15' ' ' LEU . 4.7 p-10 -54.22 -167.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.41 -86.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -128.95 61.5 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.323 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 12' ' ' ASP . 4.1 mm? -85.9 168.24 20.4 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.073 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 44.3 Cg_endo -70.41 -162.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.969 1.51 . . . . 0.0 110.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 118.74 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.368 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.18 5.35 37.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 53.4 m95 -119.88 140.5 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -1.232 . . . . 0.0 109.959 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.923 ' SD ' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -120.67 165.52 14.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.645 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 29.9 ttt180 -120.16 106.8 12.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.335 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.7 t -111.75 161.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 111.108 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.82 84.88 2.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.798 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 -175.39 4.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.944 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.1 p -66.86 -28.91 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -27.56 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.45 -166.3 30.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 23.5 m -92.5 114.24 26.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.1 p90 -114.33 -157.74 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.028 . . . . 0.0 110.255 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.581 ' CE2' HD11 ' A' ' 15' ' ' LEU . 73.6 m-85 -135.85 130.23 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 6.8 t90 -98.04 130.36 44.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.55 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 5.4 t-160 -90.84 104.12 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.923 HD11 ' SD ' ' A' ' 20' ' ' MET . 14.5 mt -62.14 -41.35 74.9 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 112.637 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.2 Cg_endo -71.89 -56.18 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.278 1.146 . . . . 0.0 111.728 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 p -86.53 -44.37 11.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 0.0 110.409 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.88 -6.83 33.05 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 5.9 m -69.11 161.07 29.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 110.375 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.38 165.89 14.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 0.0 110.076 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 46.7 mt-30 -147.95 -141.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -146.63 -54.19 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' C ' ' CE1' ' A' ' 30' ' ' TYR . 35.5 mt-10 -90.73 163.11 31.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 0.0 110.308 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HB3' ' OH ' ' A' ' 30' ' ' TYR . 45.4 Cg_endo -73.51 116.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.039 1.547 . . . . 0.0 110.421 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.2 Cg_endo -73.29 130.83 15.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.91 1.479 . . . . 0.0 110.364 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.06 126.23 5.59 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -49.24 107.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -1.144 . . . . 0.0 110.243 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' PRO . . . -48.69 126.13 11.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 75.89 1.44 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 46' ' ' ALA . 46.6 Cg_endo -73.3 179.35 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.093 1.575 . . . . 0.0 110.524 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 p -170.39 126.27 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.236 179.982 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.263 0.554 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 p -139.4 73.6 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 4' ' ' TRP . 72.6 t80 -130.43 133.58 46.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.51 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 60.47 63.39 1.37 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.59 149.21 4.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.33 -90.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -147.0 68.42 1.16 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.508 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.86 160.29 19.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 110.043 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -160.13 88.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.001 . . . . 0.0 110.302 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER 41.97 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.395 179.703 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.618 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -104.26 -162.8 0.92 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.645 ' OD1' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.4 178.69 4.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -91.95 52.06 1.93 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.278 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.488 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.4 t0 67.52 51.22 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.742 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.7 mm? -94.79 165.82 16.38 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 45.5 Cg_endo -71.78 -161.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.033 1.543 . . . . 0.0 110.36 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.74 118.12 34.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.12 7.08 23.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.566 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 45.2 m95 -120.29 133.4 55.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.231 . . . . 0.0 109.56 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 33' ' ' ILE . 9.5 mmm -114.72 167.55 10.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.159 -0.963 . . . . 0.0 110.916 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -120.9 108.93 14.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 10.9 t -109.0 165.22 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.809 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.2 mt-30 -120.63 85.04 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.574 -0.704 . . . . 0.0 109.791 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.2 179.5 7.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -62.05 -34.44 76.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -25.32 63.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.126 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.53 -166.05 28.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 24.8 m -93.08 114.02 26.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.168 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.5 p90 -114.02 -156.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.292 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 20' ' ' MET . 43.5 m-85 -130.61 135.13 47.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 110.337 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.504 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.3 t90 -104.98 115.55 30.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.567 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 2.8 t-160 -76.93 111.24 12.27 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.9 mt -68.79 -40.13 16.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.513 -0.742 . . . . 0.0 112.198 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.0 Cg_endo -73.25 -56.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.253 1.133 . . . . 0.0 111.785 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.428 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 23.5 p -86.33 -22.86 26.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.96 -1.087 . . . . 0.0 110.423 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 83.82 -12.46 52.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -61.91 159.92 13.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -1.208 . . . . 0.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.17 163.0 19.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.386 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 38' ' ' THR . 36.6 mt-30 -147.32 -145.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.065 -1.022 . . . . 0.0 110.385 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 33.7 m95 -145.95 -39.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 110.069 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 39.3 mt-10 -103.84 165.25 13.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.89 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.7 Cg_endo -71.96 123.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.885 1.466 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.709 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo -72.76 -19.27 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.887 1.467 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 45' ' ' ARG . . . 53.58 -174.07 0.44 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 mtm180 -44.26 -60.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -1.156 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 61.66 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.213 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.42 126.91 29.29 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.67 83.88 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.879 1.463 . . . . 0.0 110.31 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.0 t -124.45 166.63 15.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.201 179.999 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.262 0.553 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 t -94.42 159.56 15.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -78.35 104.21 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.292 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' O ' ' A' ' 5' ' ' ASN . 17.8 p-90 -57.01 -174.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 110.215 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 4' ' ' TRP . 3.7 m-20 -61.31 159.68 28.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.335 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.71 -90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.039 1.547 . . . . 0.0 110.277 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.23 -64.56 1.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.126 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 5' ' ' ASN . . . 52.38 -170.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.2 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.45 126.23 30.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.17 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.07 162.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -108.93 -163.44 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.321 -179.893 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.607 ' H ' HG22 ' A' ' 11' ' ' THR . 2.2 p30 -57.19 -179.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.4 -54.2 2.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.317 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.56 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -150.96 46.99 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.42 -0.8 . . . . 0.0 110.177 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 15' ' ' LEU . 4.2 mm? -99.36 168.6 9.36 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.932 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.0 Cg_endo -68.42 -160.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.875 1.46 . . . . 0.0 110.066 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 126.48 36.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 110.643 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 33' ' ' ILE . . . 96.59 -20.19 51.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 45.8 m95 -89.98 129.07 36.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.909 -1.348 . . . . 0.0 109.957 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.471 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 23.2 mmt -106.56 166.47 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 110.704 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -120.18 110.83 17.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 24.2 t -112.17 165.8 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 0.0 110.732 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.66 111.09 17.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.755 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.84 179.21 4.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.622 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -60.07 -45.62 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.357 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -27.95 69.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.324 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.42 177.56 22.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.9 m -78.81 118.52 20.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -1.152 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.5 p90 -114.28 -155.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 110.283 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.456 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 36.4 m-85 -135.36 149.98 49.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.511 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.4 t90 -118.62 115.87 25.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CG ' ' HG1' ' A' ' 35' ' ' THR . 2.7 t-160 -76.84 111.47 12.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.155 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 mm -69.37 -40.74 15.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.507 -0.745 . . . . 0.0 112.324 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.9 Cg_endo -73.6 -50.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.293 1.154 . . . . 0.0 112.022 -178.184 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.566 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 38.1 p -86.27 -23.71 26.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 0.0 110.344 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.47 -12.42 51.56 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 58.3 m -71.88 166.74 21.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -1.209 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.49 158.35 28.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 110.045 179.494 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 64.6 mt-30 -150.22 -173.47 4.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.136 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -136.63 2.21 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.0 110.503 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 17.5 mt-10 -114.48 163.44 19.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.1 Cg_endo -73.12 111.66 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.036 1.545 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 16' ' ' PRO . 46.2 Cg_endo -72.79 -160.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.488 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.08 65.88 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -97.54 -17.79 19.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.63 135.78 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.233 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 p 62.95 156.23 0.12 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 110.083 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.96 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 t -105.31 155.91 18.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.234 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.232 179.936 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.283 0.563 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -178.19 -164.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.13 -55.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.457 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -52.41 -19.84 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -99.4 104.21 25.59 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 4' ' ' TRP . 47.3 Cg_endo -73.18 -24.94 16.4 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.082 1.569 . . . . 0.0 110.525 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 9' ' ' PHE . 1.2 t-20 -128.52 20.32 6.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 110.289 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . 54.98 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 22.4 t80 57.84 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -74.36 153.15 39.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -108.58 -172.48 2.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 11' ' ' THR . 6.5 t70 -48.06 156.42 0.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.103 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 -92.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.59 60.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.781 HD11 ' CB ' ' A' ' 42' ' ' PRO . 3.9 mm? -92.19 168.41 12.92 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.0 Cg_endo -70.05 172.96 11.94 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.975 1.513 . . . . 0.0 110.088 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.32 22.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.637 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.17 1.11 22.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 57.6 m95 -120.48 142.42 49.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.278 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.4 mmt -120.64 167.49 12.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.873 . . . . 0.0 110.392 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -120.23 104.32 9.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.79 . . . . 0.0 109.607 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 28' ' ' THR . 11.9 t -108.34 164.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.443 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.66 96.64 5.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.17 170.92 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -49.61 -59.21 3.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -31.83 5.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.41 -178.28 25.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.8 m -78.97 121.67 25.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -1.163 . . . . 0.0 110.121 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.63 -160.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.194 -0.941 . . . . 0.0 110.353 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 61.2 m-85 -130.05 119.12 22.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.445 -0.784 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 32' ' ' HIS . 8.7 t90 -88.7 141.2 28.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.667 ' CE1' ' HG1' ' A' ' 35' ' ' THR . 5.9 t-160 -100.42 105.43 16.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.976 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 20' ' ' MET . 15.0 mt -60.05 -40.05 74.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.627 . . . . 0.0 112.648 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HG2' ' CE1' ' A' ' 32' ' ' HIS . 42.8 Cg_endo -71.88 -63.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.103 1.054 . . . . 0.0 111.66 -178.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.667 ' HG1' ' CE1' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.1 -38.83 17.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.131 . . . . 0.0 110.744 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 104.98 3.44 42.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.2 m -73.08 156.27 38.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -1.136 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 1.8 p -120.59 160.15 23.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.766 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 27.7 mt-30 -145.16 -141.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 72.0 t-105 -140.09 -58.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 17.8 mt-10 -89.62 165.24 26.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.781 ' CB ' HD11 ' A' ' 15' ' ' LEU . 43.8 Cg_endo -71.43 118.11 5.5 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.92 1.484 . . . . 0.0 110.36 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.0 Cg_endo -73.12 137.36 26.17 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.972 1.512 . . . . 0.0 110.544 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.86 -131.78 3.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.36 -15.93 25.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -1.111 . . . . 0.0 110.219 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.77 100.6 0.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.169 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.2 p -57.46 144.76 70.89 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.345 -0.847 . . . . 0.0 110.315 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.62 152.69 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.7 p -135.76 153.63 51.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.254 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.92 107.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.64 -29.23 51.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 5' ' ' ASN . 2.4 m95 -67.8 94.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.333 -0.854 . . . . 0.0 110.473 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 4' ' ' TRP . 2.9 t-20 177.2 98.46 0.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -27.16 12.84 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.964 1.507 . . . . 0.0 110.597 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -120.15 65.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 10' ' ' GLU . . . -111.59 153.94 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.178 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -45.53 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 8' ' ' ALA . 15.7 pt-20 -68.2 -160.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.337 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -100.2 -161.95 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.593 ' HB2' HD23 ' A' ' 15' ' ' LEU . 3.0 p30 -61.21 -174.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 110.31 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -120.36 -44.38 2.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 -179.866 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -175.11 64.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 15' ' ' LEU . 3.9 mm? -93.32 167.89 13.17 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.237 -0.914 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.3 Cg_endo -68.62 -161.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.97 1.511 . . . . 0.0 109.803 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.35 117.62 34.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 110.699 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.13 28.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.6 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 43.2 m95 -98.68 139.93 33.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.32 . . . . 0.0 109.928 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.991 ' SD ' HD11 ' A' ' 33' ' ' ILE . 47.2 mmm -116.65 165.7 12.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 110.884 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.517 ' NH1' ' OG ' ' A' ' 13' ' ' SER . 25.1 ttt180 -120.6 111.84 18.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.289 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 5.9 t -112.54 163.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 35.9 tt0 -120.47 89.57 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 179.13 6.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -63.1 -33.43 75.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 110.356 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -72.9 -21.84 60.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.211 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.45 -176.88 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 m -85.75 113.72 22.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.602 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 40.9 p90 -114.14 -154.9 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 46.6 m-85 -133.99 145.78 49.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.943 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.505 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 5.4 t90 -115.12 118.89 34.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.116 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.595 ' CD2' ' CE2' ' A' ' 19' ' ' TRP . 2.4 t-160 -79.85 110.12 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.991 HD11 ' SD ' ' A' ' 20' ' ' MET . 38.8 mt -69.41 -39.48 12.43 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.715 -0.616 . . . . 0.0 112.408 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.5 Cg_endo -73.59 -53.32 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.162 1.085 . . . . 0.0 111.92 -178.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 53.4 p -86.39 -21.39 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 110.322 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -8.83 57.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.4 m -70.56 163.28 27.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.27 148.15 44.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 110.218 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 59.2 mt-30 -142.53 -170.97 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 83.1 m95 -136.5 1.8 2.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.437 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.59 160.27 42.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.91 112.26 3.47 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.084 1.571 . . . . 0.0 110.477 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo -72.13 123.03 8.91 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.012 1.533 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.56 36.68 0.29 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 85.83 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -1.127 . . . . 0.0 110.339 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.34 -179.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.295 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -75.97 -55.78 1.8 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 110.277 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 47' ' ' SER . 47.7 Cg_endo -74.21 122.6 7.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.868 1.457 . . . . 0.0 110.27 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -146.51 111.69 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.223 0.535 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -114.36 163.15 15.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 54.15 20.46 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.878 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -53.18 -30.88 39.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -44.5 125.52 4.8 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.75 -25.23 12.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.908 1.478 . . . . 0.0 110.391 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.559 ' O ' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -103.21 44.11 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.42 68.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 110.256 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.69 121.92 16.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.25 -163.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.347 -0.845 . . . . 0.0 110.158 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -88.9 -168.52 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.609 ' H ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -43.93 158.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.175 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 14' ' ' ASP . 9.6 p -77.56 -39.84 44.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 40.2 p-10 -178.94 53.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.246 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 30' ' ' TYR . 4.1 mm? -92.89 168.38 12.47 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.6 Cg_endo -69.67 -160.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.905 1.476 . . . . 0.0 110.472 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 120.1 37.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 110.429 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.68 7.41 45.09 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 52.3 m95 -119.85 133.53 55.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.226 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.717 ' SD ' HD11 ' A' ' 33' ' ' ILE . 59.6 mmm -120.44 166.6 13.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 6.0 ttt180 -121.08 111.34 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.4 t -110.43 161.56 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -121.04 83.94 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 168.32 18.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -54.18 -35.5 62.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.85 -166.28 34.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 23' ' ' GLN . 24.0 m -101.44 113.4 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 110.073 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 45.7 p90 -114.32 -157.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.604 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.591 ' HE2' HD11 ' A' ' 15' ' ' LEU . 27.6 m-85 -130.02 135.18 47.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 31' ' ' TRP . 7.3 t90 -105.4 121.84 44.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.43 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.2 t-160 -83.33 107.35 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.901 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.717 HD11 ' SD ' ' A' ' 20' ' ' MET . 52.7 mt -67.42 -38.3 15.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.82 . . . . 0.0 112.372 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.6 Cg_endo -73.5 -57.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.067 1.035 . . . . 0.0 111.529 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.406 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 13.9 p -86.89 -34.48 19.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.922 -1.111 . . . . 0.0 110.419 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 98.68 -9.41 62.22 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.6 m -62.89 156.68 23.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.061 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.477 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.29 159.57 24.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 109.554 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 37.5 mt-30 -144.33 -137.4 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 110.496 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -159.0 -48.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 42.1 mt-10 -92.45 165.54 19.22 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.647 -0.658 . . . . 0.0 110.002 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.4 Cg_endo -71.56 122.17 8.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.004 1.529 . . . . 0.0 110.292 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.57 92.71 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.913 1.48 . . . . 0.0 110.346 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.22 163.78 9.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -84.62 0.18 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.45 -55.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.147 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.38 152.12 7.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 49' ' ' SER . 46.6 Cg_endo -72.75 86.26 1.07 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.995 1.523 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 63.34 130.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 110.275 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.181 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.45 -170.78 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.951 1.501 . . . . 0.0 110.121 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.06 121.32 30.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 110.56 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.13 6.02 49.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.4 m95 -120.05 136.53 54.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.875 -1.367 . . . . 0.0 109.858 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.938 ' SD ' HD11 ' A' ' 33' ' ' ILE . 2.0 mmt -116.35 166.23 12.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.804 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -120.19 106.37 11.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.529 -0.732 . . . . 0.0 109.423 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.7 t -109.41 162.38 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 0.0 110.733 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.63 80.54 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.826 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.88 169.57 17.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.44 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -59.68 -22.5 62.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -81.3 -32.05 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.14 175.95 28.64 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 51.0 m -81.15 113.19 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.597 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 49.8 p90 -114.39 -156.21 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.511 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.702 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.2 m-85 -131.77 135.25 46.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.484 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 4.9 t90 -107.04 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.863 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.68 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -80.06 109.63 14.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.477 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.938 HD11 ' SD ' ' A' ' 20' ' ' MET . 47.3 mt -67.83 -36.91 10.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 112.616 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.28 -62.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 122.997 0.999 . . . . 0.0 111.833 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.551 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 2.9 t -86.39 -18.16 32.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.918 -1.114 . . . . 0.0 110.536 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 84.41 -13.99 48.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.528 ' H ' HG23 ' A' ' 35' ' ' THR . 8.9 m -59.18 160.99 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -1.17 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 154.15 36.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 41.9 mt-30 -142.04 -175.57 4.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -136.8 1.89 2.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 23.1 mt-10 -120.04 160.22 43.9 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 110.088 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.56 110.68 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.944 1.497 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 47.1 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 O-C-N 123.929 1.489 . . . . 0.0 110.323 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' A' ' 43' ' ' PRO . 4.1 mm? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -71.17 -162.93 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.947 1.498 . . . . 0.0 110.404 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.2 120.23 36.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.477 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.26 -0.08 26.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 56.8 m95 -117.43 141.81 47.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.543 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 34.2 mmm -120.71 165.7 14.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 110.73 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -120.64 105.81 11.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.533 -0.73 . . . . 0.0 109.498 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.6 t -107.91 163.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 110.752 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 10.4 tt0 -121.19 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.737 -0.602 . . . . 0.0 109.767 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.82 174.46 5.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.376 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . 19.8 p -67.8 -6.71 22.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -26.18 12.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.48 -176.23 38.84 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -94.07 118.42 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -1.13 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.2 p90 -114.48 -154.06 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.481 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 64.5 m-85 -135.52 135.54 40.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.4 t90 -107.31 132.51 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.805 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.609 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.7 t60 -93.22 108.07 19.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.111 . . . . 0.0 110.388 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 12.4 mt -63.17 -39.23 49.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.468 -0.77 . . . . 0.0 112.542 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 46.2 Cg_endo -73.01 -62.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.125 1.066 . . . . 0.0 111.951 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.579 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.6 -30.78 21.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.134 . . . . 0.0 110.933 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.61 6.86 60.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -74.39 152.58 39.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 110.192 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.12 38.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.532 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 56.2 mt-30 -141.97 -143.57 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.131 -0.981 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.425 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 67.6 t-105 -136.83 -54.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.1 mt-10 -92.04 164.95 21.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.448 -0.782 . . . . 0.0 110.239 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.9 Cg_endo -72.5 129.49 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.991 1.522 . . . . 0.0 110.338 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.1 Cg_endo . . . . . 0 C--N 1.306 -1.66 0 O-C-N 123.868 1.457 . . . . 0.0 110.493 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.05 -159.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.949 1.499 . . . . 0.0 110.203 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.46 123.59 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.689 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 8.83 55.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.3 m95 -120.5 138.82 53.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.944 -1.327 . . . . 0.0 109.899 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 82.1 mmm -120.87 170.29 9.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 110.696 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -120.42 110.26 16.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.495 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -112.39 163.8 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 110.87 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 21.9 tt0 -120.91 91.78 3.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 110.02 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -92.02 -172.67 3.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 110.635 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.8 p -67.12 -33.72 76.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.184 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.587 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -73.3 -18.63 61.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.316 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.21 -172.42 22.95 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 54.7 m -85.51 113.85 22.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.124 . . . . 0.0 110.081 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.3 p90 -114.31 -156.26 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' MET . 58.3 m-85 -128.89 142.3 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 3.9 t90 -112.26 126.99 55.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.062 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.545 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.7 t60 -84.69 109.25 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 110.122 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 56.0 mt -65.12 -38.25 27.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 112.404 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.7 Cg_endo -74.0 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.115 1.061 . . . . 0.0 111.891 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.545 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.53 -26.94 24.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.84 -1.163 . . . . 0.0 111.096 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.72 0.22 75.76 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -67.91 154.75 40.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -1.171 . . . . 0.0 110.353 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.53 152.84 37.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 109.877 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 49.8 mt-30 -142.15 -168.86 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.587 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 99.6 m95 -137.51 1.12 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.127 -0.983 . . . . 0.0 110.596 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 4.0 mt-10 -120.3 162.11 35.59 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -74.69 116.02 4.48 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.117 1.588 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.305 -1.763 0 O-C-N 123.949 1.5 . . . . 0.0 110.452 179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.579 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.5 Cg_endo -70.07 177.86 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.892 1.469 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.79 122.85 27.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.679 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 4.93 30.5 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 50.4 m95 -120.49 135.79 54.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.977 -1.308 . . . . 0.0 109.985 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 1.058 ' SD ' HD11 ' A' ' 33' ' ' ILE . 78.9 mmm -120.6 165.83 14.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.895 . . . . 0.0 110.815 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -120.76 114.31 21.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.698 . . . . 0.0 109.659 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 5.4 t -116.87 162.16 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.931 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 pt20 -120.7 99.77 6.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 109.872 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -176.93 3.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 26' ' ' SER . 14.2 p -52.45 -66.34 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -42.09 -51.37 4.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.92 -171.21 42.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -85.1 118.84 24.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.0 p90 -114.34 -158.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 42' ' ' PRO . 24.2 m-85 -129.78 129.47 44.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.986 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.85 120.89 40.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.412 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.0 t-160 -82.85 110.28 17.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.998 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.058 HD11 ' SD ' ' A' ' 20' ' ' MET . 30.6 mt -67.66 -40.5 25.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.499 -0.751 . . . . 0.0 112.34 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.2 Cg_endo -73.71 -56.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.286 1.15 . . . . 0.0 111.737 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 15.5 p -86.66 -31.48 21.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.937 -1.102 . . . . 0.0 110.557 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.26 -11.84 69.88 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.5 m -61.16 158.48 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.06 . . . . 0.0 110.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.71 157.5 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 mt-30 -141.73 -144.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.005 . . . . 0.0 110.477 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.439 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 71.1 t-105 -144.57 -55.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.6 mt-10 -90.63 164.81 25.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.506 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 46.2 Cg_endo -73.82 120.59 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 15' ' ' LEU . 49.1 Cg_endo . . . . . 0 C--N 1.307 -1.632 0 O-C-N 123.821 1.432 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.3 mm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.8 Cg_endo -68.38 -160.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.974 1.513 . . . . 0.0 110.033 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.76 39.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.0 110.703 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.4 -15.05 56.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.679 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 54.1 m95 -95.02 139.42 31.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 1.02 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -114.72 163.57 15.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 110.586 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.55 102.81 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.463 -0.773 . . . . 0.0 109.352 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 6.6 t -106.36 162.04 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 110.564 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.87 82.16 1.88 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.52 -0.738 . . . . 0.0 109.953 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.36 161.0 29.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 0.0 110.389 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -54.27 -20.94 7.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -83.99 -32.53 24.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.65 167.28 20.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -79.52 116.3 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 110.233 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 51.4 p90 -114.97 -160.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.698 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE1' HD11 ' A' ' 15' ' ' LEU . 70.7 m-85 -128.95 125.89 38.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.914 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.52 116.08 30.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.577 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.679 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.2 t-160 -78.98 108.94 12.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.777 . . . . 0.0 109.889 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.02 HD11 ' SD ' ' A' ' 20' ' ' MET . 61.7 mt -68.66 -35.69 7.07 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.603 -0.686 . . . . 0.0 112.827 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.6 Cg_endo -72.21 -60.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 122.972 0.985 . . . . 0.0 111.573 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.585 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 3.1 t -86.59 -23.69 25.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.982 -1.074 . . . . 0.0 110.442 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.61 -14.71 62.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.575 ' H ' HG23 ' A' ' 35' ' ' THR . 2.8 m -58.6 157.2 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.179 . . . . 0.0 110.199 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -120.73 162.86 19.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.925 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 30.4 mt-30 -149.4 -156.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -143.56 -35.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.449 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 45.4 mt-10 -91.84 162.97 29.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.6 Cg_endo -73.39 111.38 3.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.02 1.537 . . . . 0.0 110.579 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 0.0 110.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.674 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.1 Cg_endo -70.17 -179.2 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.427 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 98.05 2.1 58.24 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.59 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.3 m95 -119.6 132.12 55.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.254 . . . . 0.0 109.938 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HD11 ' A' ' 33' ' ' ILE . 33.9 mmm -120.4 164.81 15.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 0.0 110.646 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -120.84 113.45 20.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t -113.98 161.39 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.82 94.36 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.605 -0.685 . . . . 0.0 109.964 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.27 173.1 7.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.41 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -57.75 -45.32 86.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -32.52 70.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.12 20.86 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 22' ' ' VAL . 45.9 m -80.13 116.57 20.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -1.189 . . . . 0.0 110.186 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 54.6 p90 -114.52 -159.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 110.401 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 20' ' ' MET . 92.5 m-85 -132.7 143.73 49.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.8 t90 -112.25 124.38 52.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.436 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.513 ' ND1' ' OG1' ' A' ' 35' ' ' THR . 4.8 t-160 -86.23 97.42 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.2 mt -58.46 -41.63 90.25 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 112.76 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.7 Cg_endo -69.35 -56.01 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.078 1.041 . . . . 0.0 111.717 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 34.4 p -86.84 -49.67 7.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.887 -1.133 . . . . 0.0 110.457 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -4.41 19.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.1 m -73.62 158.28 35.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.38 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.66 160.46 23.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.987 . . . . 0.0 110.019 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.543 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 70.9 mt-30 -141.98 -171.68 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 93.5 m95 -136.64 2.73 2.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.023 -1.048 . . . . 0.0 110.351 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -133.13 163.78 48.64 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.5 Cg_endo -71.84 125.03 10.65 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.288 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 52.8 Cg_endo . . . . . 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.0 110.75 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.2 mm? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.1 Cg_endo -67.44 -160.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.869 1.458 . . . . 0.0 110.095 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.02 128.97 36.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.988 . . . . 0.0 111.02 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' A' ' 34' ' ' PRO . . . 91.49 -19.97 44.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.608 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 48.6 m95 -88.77 136.31 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.919 -1.342 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.937 ' SD ' HD11 ' A' ' 33' ' ' ILE . 7.2 mmt -119.12 165.11 14.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -120.74 106.63 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.647 -0.658 . . . . 0.0 109.31 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.591 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.1 t -105.95 159.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.547 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.9 pt20 -121.15 82.46 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 0.0 110.213 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.17 162.03 27.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.0 110.294 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -55.07 -20.53 9.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.173 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.48 -31.95 26.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.298 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.91 172.53 28.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 m -87.98 114.37 24.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.216 -1.167 . . . . 0.0 110.117 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.591 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 42.2 p90 -115.0 -156.34 0.6 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.0 110.622 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.713 ' CE1' HD11 ' A' ' 15' ' ' LEU . 65.3 m-85 -131.37 145.84 52.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.359 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.3 t90 -117.74 122.31 43.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.608 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 2.8 t-160 -84.36 98.21 9.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.781 . . . . 0.0 109.903 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.937 HD11 ' SD ' ' A' ' 20' ' ' MET . 19.2 mt -68.8 -51.88 19.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 0.0 111.732 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 41.0 Cg_endo -65.85 -8.67 20.41 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.152 1.08 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.569 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 23.7 m -120.12 -69.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 110.433 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.44 -10.23 5.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 38' ' ' THR . 27.7 m -86.61 165.97 15.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -1.081 . . . . 0.0 110.151 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.04 159.5 25.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.567 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 34.1 mt-30 -142.49 -161.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 52.7 m95 -140.02 -37.82 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 31.2 mt-10 -94.92 164.33 19.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.219 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.3 Cg_endo -72.7 118.71 5.7 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.322 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 123.939 1.494 . . . . 0.0 110.553 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 15' ' ' LEU . 42.6 Cg_endo -69.77 -165.34 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.0 110.169 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.88 116.88 29.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.47 2.06 40.75 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.516 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 65.2 m95 -120.45 138.06 54.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.987 -1.302 . . . . 0.0 110.476 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.963 ' SD ' HD11 ' A' ' 33' ' ' ILE . 42.6 mmm -121.09 167.2 12.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -120.7 110.28 16.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.738 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 3.4 t -113.8 159.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.614 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.94 79.37 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.959 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.21 162.33 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 0.0 110.32 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -53.88 -22.67 10.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.984 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -80.61 -34.1 35.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.28 -171.21 38.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 23' ' ' GLN . 22.4 m -96.9 114.15 25.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -1.11 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.0 p90 -114.55 -161.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.522 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 54.5 m-85 -131.18 122.37 26.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.0 t90 -91.89 130.77 37.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.13 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.61 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.0 t60 -89.65 105.81 18.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.047 -1.033 . . . . 0.0 109.904 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.963 HD11 ' SD ' ' A' ' 20' ' ' MET . 34.0 mt -59.37 -41.21 85.93 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 0.0 112.61 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.1 Cg_endo -72.08 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.184 1.097 . . . . 0.0 111.935 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.46 -34.67 20.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 111.004 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 101.08 0.11 54.71 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.87 152.67 42.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.173 . . . . 0.0 109.876 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.71 152.89 36.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.894 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 14.5 mt-30 -141.79 -139.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -151.85 -48.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.893 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 54.2 mt-10 -86.14 163.64 42.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.141 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -73.15 126.45 11.15 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.984 1.518 . . . . 0.0 110.468 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.5 Cg_endo . . . . . 0 C--N 1.306 -1.685 0 O-C-N 123.951 1.501 . . . . 0.0 110.326 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -70.43 -162.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.001 1.527 . . . . 0.0 110.122 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.83 118.43 34.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 105.88 7.13 36.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 47.7 m95 -119.08 123.46 44.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.018 -1.283 . . . . 0.0 109.668 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.4 tpp -106.96 170.17 8.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 111.214 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' MET . 3.1 ttt180 -121.43 110.3 15.9 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.704 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.1 t -110.04 159.65 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.068 -1.02 . . . . 0.0 110.399 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 6.5 tt0 -120.8 93.84 4.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.8 167.02 11.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -49.86 -49.51 49.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.462 ' OG ' ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -54.03 -35.6 62.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.26 -0.9 . . . . 0.0 110.08 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.53 179.52 30.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 55.7 m -86.75 115.1 23.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -1.17 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HB3' ' CE3' ' A' ' 40' ' ' TRP . 46.6 p90 -114.44 -155.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 20' ' ' MET . 52.2 m-85 -136.13 152.47 50.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.559 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.3 t90 -118.68 120.1 36.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.644 ' CE1' HG21 ' A' ' 35' ' ' THR . 2.3 t-160 -79.03 93.28 5.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 110.098 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.4 mt -62.86 -39.05 49.43 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.566 -0.709 . . . . 0.0 112.406 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.95 -45.33 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.077 1.041 . . . . 0.0 111.7 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.644 HG21 ' CE1' ' A' ' 32' ' ' HIS . 44.1 p -86.17 -55.06 4.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.184 . . . . 0.0 110.398 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.3 -11.19 8.6 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 38' ' ' THR . 96.0 m -86.4 170.71 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.02 170.96 9.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 38' ' ' THR . 54.3 mt-30 -158.71 -177.48 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 79.5 m95 -136.47 3.11 2.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.243 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 24.4 mt-10 -119.66 160.18 43.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.93 110.26 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.997 1.524 . . . . 0.0 110.357 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.0 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 O-C-N 123.961 1.506 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -70.0 -161.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.932 1.49 . . . . 0.0 110.457 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.93 124.35 38.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.92 8.25 57.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.594 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.6 m95 -120.57 136.64 54.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.251 . . . . 0.0 110.051 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 33' ' ' ILE . 6.8 mmm -120.61 168.29 11.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.432 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -120.78 112.11 18.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.835 . . . . 0.0 109.848 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 7.5 t -113.16 162.43 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -121.09 93.35 4.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.2 171.14 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.969 . . . . 0.0 110.315 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -60.89 -30.79 70.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.392 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -22.67 56.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.7 172.86 18.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.8 m -83.55 117.63 23.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.5 p90 -114.17 -159.12 0.68 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.35 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 95.1 m-85 -132.2 125.77 31.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.4 t90 -92.3 127.92 37.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.268 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.601 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.1 t60 -89.15 110.21 20.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.847 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.686 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.2 mt -68.27 -37.0 9.81 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -71.96 -36.22 6.28 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 122.936 0.967 . . . . 0.0 111.685 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -116.84 -42.93 2.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 110.376 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' HIS . . . 112.34 -2.74 26.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -66.6 151.89 46.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -1.211 . . . . 0.0 110.369 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.566 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -116.7 171.21 8.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 40.4 mt-30 -149.89 -148.59 0.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.01 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -147.4 -37.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.062 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 2.4 mt-10 -101.19 166.08 13.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.7 Cg_endo -72.46 119.42 6.11 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.914 1.481 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.7 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 O-C-N 123.996 1.524 . . . . 0.0 110.437 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.33 -163.07 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.851 1.448 . . . . 0.0 110.478 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.26 126.23 37.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.664 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.75 9.29 60.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.674 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 51.1 m95 -120.33 138.96 53.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.921 -1.341 . . . . 0.0 109.842 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.916 ' SD ' HD11 ' A' ' 33' ' ' ILE . 37.1 mmm -120.06 168.59 11.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.856 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -120.23 110.89 17.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 109.543 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 17.1 t -112.51 166.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.938 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 2.5 tt0 -120.6 82.88 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 109.685 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.72 176.16 6.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.6 p -63.51 -22.62 66.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.235 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -29.82 27.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.77 -164.88 33.86 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 19.8 m -94.79 113.48 25.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.198 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 47.6 p90 -114.06 -155.55 0.57 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 75.6 m-85 -129.9 139.81 51.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.866 . . . . 0.0 110.418 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.9 t90 -110.85 118.1 35.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.674 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -79.19 110.57 14.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 110.536 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' SD ' ' A' ' 20' ' ' MET . 54.7 mt -68.36 -39.86 17.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 112.054 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 47.0 Cg_endo -75.09 -55.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.282 1.149 . . . . 0.0 111.844 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.483 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 30.1 p -86.29 -14.3 44.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.098 . . . . 0.0 110.565 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.85 5.06 50.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 9.2 m -80.93 160.85 24.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -1.173 . . . . 0.0 109.926 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 152.18 38.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.988 . . . . 0.0 110.078 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 22.8 mt-30 -141.9 -171.21 3.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -137.04 2.01 2.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.4 mt-10 -115.95 155.06 48.32 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.08 110.99 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.009 1.531 . . . . 0.0 110.43 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.6 Cg_endo . . . . . 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.347 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.7 Cg_endo -69.63 -165.98 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.872 1.459 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.18 121.73 30.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.46 4.18 57.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.673 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.7 m95 -119.05 131.31 55.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.898 -1.354 . . . . 0.0 110.027 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 13.8 mmt -118.59 168.0 11.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 110.768 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.942 ' CZ ' HG21 ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.19 105.54 11.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.472 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.4 t -107.47 153.76 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -122.53 83.95 2.19 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 26' ' ' SER . 1.2 p-10 -73.93 -166.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.012 -1.055 . . . . 0.0 110.477 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.4 p -83.59 43.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.325 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.487 ' HB2' ' OD2' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -155.37 -36.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 110.32 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 165.19 29.5 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.942 HG21 ' CZ ' ' A' ' 21' ' ' ARG . 13.2 m -86.78 112.86 22.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -1.179 . . . . 0.0 110.151 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.61 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.7 p90 -113.33 -156.58 0.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 110.407 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.532 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 78.9 m-85 -127.27 138.72 53.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.5 t90 -111.44 113.57 26.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.673 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -77.47 107.74 10.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 6.1 mt -68.66 -40.42 18.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 112.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.9 Cg_endo -74.86 -48.93 0.17 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.266 1.14 . . . . 0.0 112.181 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.462 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 32.4 p -86.17 -27.97 24.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.71 49.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.562 HG22 ' N ' ' A' ' 38' ' ' THR . 98.2 m -70.63 169.75 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -1.188 . . . . 0.0 110.257 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.562 ' N ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -121.36 179.44 4.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 110.012 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 57.7 mt-30 -157.69 -162.02 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.943 . . . . 0.0 110.444 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -136.69 -36.51 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 10.7 mt-10 -103.14 164.49 15.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 48.2 Cg_endo -74.38 117.72 5.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.022 1.538 . . . . 0.0 110.447 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.679 0 O-C-N 123.845 1.444 . . . . 0.0 110.297 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.88 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.5 Cg_endo -70.25 -161.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.499 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.07 122.73 33.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.696 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 94.8 6.56 60.56 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.1 m95 -120.26 136.13 54.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.26 . . . . 0.0 109.638 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 38.4 ttm -120.46 171.41 8.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 111.264 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' CG ' ' A' ' 20' ' ' MET . 57.2 ttt-85 -121.45 108.7 13.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.742 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 19.6 t -113.48 163.0 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.738 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.0 mt-30 -121.33 112.32 18.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.663 -0.648 . . . . 0.0 109.783 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.7 -178.02 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.149 -0.97 . . . . 0.0 110.476 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -65.54 -24.52 67.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -84.81 -17.96 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.957 . . . . 0.0 110.119 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.23 175.18 13.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 25.9 m -80.01 117.53 20.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.131 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.3 p90 -114.2 -152.78 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.88 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.7 m-85 -133.2 139.09 46.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.072 -1.018 . . . . 0.0 110.593 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.9 t90 -110.48 122.53 47.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 109.71 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.581 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.8 t60 -80.41 103.76 10.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.216 -0.928 . . . . 0.0 110.218 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.1 mt -63.52 -37.69 32.25 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.545 -0.722 . . . . 0.0 112.484 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.3 Cg_endo -72.32 -62.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.024 1.013 . . . . 0.0 111.51 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.65 -35.77 19.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 103.91 -8.35 50.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.7 OUTLIER -58.95 152.19 20.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -1.185 . . . . 0.0 110.105 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.44 153.24 36.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.109 -0.994 . . . . 0.0 109.838 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 19.4 mt-30 -142.24 -142.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.405 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 97.4 m95 -149.54 -38.84 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 35.9 mt-10 -99.24 163.56 18.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -74.08 131.63 15.7 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.494 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.533 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 47.5 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 O-C-N 123.903 1.475 . . . . 0.0 110.461 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 42.0 Cg_endo -69.11 -168.34 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.889 1.468 . . . . 0.0 110.329 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.97 123.55 34.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.129 -0.982 . . . . 0.0 110.72 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 106.02 -3.34 38.29 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.625 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 55.4 m95 -112.81 110.72 21.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.305 . . . . 0.0 109.477 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 25.4 ttt -91.22 171.33 9.31 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.054 0.93 . . . . 0.0 111.302 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' CG ' ' A' ' 20' ' ' MET . 67.4 ttt180 -121.05 107.06 12.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.8 t -108.53 160.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 110.533 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 4.2 mt-30 -121.02 80.04 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 0.0 110.068 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 154.63 40.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 25' ' ' THR . 80.8 p -45.67 -27.91 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -42.7 52.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.04 -176.49 45.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 94.0 m -93.56 114.18 26.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.59 -156.33 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.44 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 98.2 m-85 -131.73 147.09 52.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.272 -0.892 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 8.4 t90 -115.43 119.93 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.479 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.929 ' CD2' ' HG1' ' A' ' 35' ' ' THR . 3.0 t-160 -76.37 83.37 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 109.706 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.1 mt -52.89 -50.41 81.72 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 41.4 Cg_endo -68.71 -11.7 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.199 1.105 . . . . 0.0 111.606 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.929 ' HG1' ' CD2' ' A' ' 32' ' ' HIS . 85.6 m -120.56 -73.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.06 -17.21 2.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -74.62 161.59 29.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 110.099 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 170.38 9.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.542 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 50.3 mt-30 -147.75 -151.21 0.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.186 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -148.19 -42.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.3 mm-40 -98.45 167.53 11.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -73.16 113.46 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 123.909 1.479 . . . . 0.0 110.312 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.4 mm? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.2 Cg_endo -70.22 -166.73 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.817 1.43 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.13 121.64 34.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 110.535 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 114.47 1.83 23.09 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.524 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 77.6 m95 -120.8 136.46 54.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.842 -1.387 . . . . 0.0 110.064 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.494 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 2.2 tpt -120.62 174.15 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 20' ' ' MET . 0.1 OUTLIER -121.0 104.66 9.97 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 48.0 t -106.76 168.96 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.966 . . . . 0.0 110.529 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.524 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.76 86.12 2.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.107 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 152.18 39.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t -49.19 -22.3 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.53 -35.81 19.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.97 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.23 40.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 22' ' ' VAL . 72.8 m -84.05 117.21 23.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 43.9 p90 -114.62 -154.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 89.7 m-85 -132.3 142.75 49.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 2.9 t90 -112.13 130.23 55.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.038 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.618 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.5 t60 -86.64 100.22 12.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.193 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 59.0 mt -56.52 -42.16 94.86 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 112.556 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.1 Cg_endo -69.11 -66.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.026 1.014 . . . . 0.0 111.882 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.43 -38.02 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.843 -1.161 . . . . 0.0 110.654 -179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 106.66 -0.56 36.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -61.5 150.17 36.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.247 . . . . 0.0 109.9 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.72 151.9 38.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 4.7 mt-30 -142.0 -139.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.981 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -150.71 -40.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.116 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -103.73 168.29 8.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.088 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.1 Cg_endo -71.7 128.68 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.987 1.52 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.6 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 O-C-N 123.91 1.479 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.762 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.21 -160.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.979 1.515 . . . . 0.0 110.362 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.84 135.05 35.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.628 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 91.04 8.48 64.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 59.7 m95 -120.37 139.49 52.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.263 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 5.4 ttt -120.42 170.51 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 111.349 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 20' ' ' MET . 6.3 ttt-85 -121.96 112.48 18.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.681 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 42.4 t -114.96 168.77 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.518 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.78 92.27 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -86.53 162.91 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 25' ' ' THR . 65.2 p -56.59 -28.44 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.903 . . . . 0.0 110.341 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -79.73 -26.05 40.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.311 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.43 173.62 25.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' VAL . 29.8 m -79.05 116.31 19.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 39.5 p90 -114.42 -154.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.281 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' MET . 80.6 m-85 -136.28 151.35 49.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.521 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 6.0 t90 -120.04 123.59 43.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.591 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.2 t60 -79.05 101.79 8.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 16.3 mt -62.16 -38.14 44.86 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.1 Cg_endo -70.57 -58.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.881 0.938 . . . . 0.0 111.419 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.586 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -92.39 -41.58 10.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 110.56 -3.25 29.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.26 150.97 44.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.132 -1.216 . . . . 0.0 110.121 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.18 149.87 41.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.048 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 24.7 mt-30 -141.78 -167.88 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.466 ' CZ3' ' OG ' ' A' ' 26' ' ' SER . 94.3 m95 -136.79 2.59 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -124.0 164.44 29.41 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.9 Cg_endo -72.16 112.46 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.972 1.511 . . . . 0.0 110.337 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.431 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.682 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -70.6 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.094 1.576 . . . . 0.0 110.439 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.37 39.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.5 2.68 35.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.681 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 40.2 m95 -114.97 122.37 46.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.94 -1.33 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 64.6 mmm -106.36 164.15 12.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.46 117.58 28.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.514 -0.741 . . . . 0.0 109.503 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.1 t -118.5 163.59 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.921 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.496 ' NE2' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.72 96.85 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.933 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.3 175.56 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.503 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.8 p -53.19 -57.16 11.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.361 -0.837 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.9 m -48.79 -43.04 37.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.9 -176.52 39.17 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' NE2' ' A' ' 23' ' ' GLN . 1.7 m -84.75 116.18 23.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.11 -158.15 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 110.199 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 92.3 m-85 -132.01 130.31 41.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 110.031 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.2 t90 -98.95 110.72 23.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.681 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.5 t-160 -76.58 111.92 12.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.613 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.8 mt -67.76 -40.17 22.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 112.117 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.4 Cg_endo -74.16 -55.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.243 1.128 . . . . 0.0 111.622 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.414 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 19.9 p -86.64 -8.61 57.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.476 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 60.96 12.92 31.49 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.407 ' HG1' ' CB ' ' A' ' 35' ' ' THR . 5.6 m -87.0 159.69 18.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -1.233 . . . . 0.0 110.078 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.48 156.43 31.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.996 . . . . 0.0 109.675 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 12.9 mt-30 -142.72 -141.43 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 39' ' ' GLN . 93.4 m95 -150.98 -38.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.178 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.512 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 32.2 mt-10 -100.31 163.89 17.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.9 Cg_endo -73.07 127.2 11.86 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.939 1.494 . . . . 0.0 110.399 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 15' ' ' LEU . 44.8 Cg_endo . . . . . 0 C--N 1.305 -1.714 0 O-C-N 124.043 1.549 . . . . 0.0 110.314 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.597 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -69.8 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 131.97 38.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.03 7.99 73.03 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.687 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.3 m95 -118.09 122.17 42.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.885 -1.362 . . . . 0.0 109.969 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 29.6 mmt -106.38 168.35 9.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.793 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -120.66 107.1 12.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.4 t -106.75 166.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.096 -1.003 . . . . 0.0 110.6 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.2 tt0 -120.39 87.84 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.847 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' CD1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -81.62 169.11 17.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 25' ' ' THR . 57.9 p -58.16 -27.83 64.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.347 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -25.12 41.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.29 179.47 27.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 92.8 m -83.29 116.89 22.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 53.0 p90 -114.15 -154.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 77.4 m-85 -129.85 141.37 50.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 110.416 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.5 t90 -114.65 111.16 20.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.687 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.9 t-160 -76.74 107.18 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.484 -0.76 . . . . 0.0 110.304 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.6 mt -65.8 -40.33 38.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.575 -0.703 . . . . 0.0 111.954 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.45 -53.58 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.299 1.157 . . . . 0.0 111.874 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 20.4 p -86.46 -7.76 58.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.929 -1.107 . . . . 0.0 110.639 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.17 11.66 27.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -87.14 156.99 19.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 0.0 109.962 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.22 153.68 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.114 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' O ' ' CG ' ' A' ' 40' ' ' TRP . 35.3 mt-30 -146.84 -138.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.175 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 95.7 m95 -157.04 -37.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 38.4 mt-10 -89.51 161.95 38.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 115.63 4.42 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.972 1.511 . . . . 0.0 110.304 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.762 0 O-C-N 124.02 1.537 . . . . 0.0 110.469 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 16' ' ' PRO . 4.2 mm? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.5 Cg_endo -67.81 -160.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.374 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.74 128.33 36.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 111.068 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.92 75.07 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.685 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 55.2 m95 -98.33 129.93 45.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.663 -1.493 . . . . 0.0 110.054 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 33' ' ' ILE . 57.0 mmm -114.72 165.27 12.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.396 -0.815 . . . . 0.0 110.816 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -120.7 106.49 11.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 109.64 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -106.4 164.31 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.087 -1.008 . . . . 0.0 110.845 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.8 86.87 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.732 . . . . 0.0 109.988 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 172.96 8.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.424 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.7 p -52.26 -50.46 62.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -52.96 -31.83 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.98 -179.59 22.9 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 58.3 m -79.01 114.67 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 110.056 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.38 -159.51 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 110.535 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 20' ' ' MET . 50.8 m-85 -126.84 125.81 42.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.095 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 11.7 t90 -99.93 116.19 31.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.521 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.685 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.3 t-160 -82.73 109.02 16.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.4 mt -68.22 -39.77 18.18 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 112.138 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.58 -55.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.257 1.135 . . . . 0.0 111.602 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 p -86.64 -10.7 53.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.085 . . . . 0.0 110.315 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 66.26 7.66 39.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -82.25 154.67 25.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.162 -1.199 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.74 151.18 39.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.866 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 13.3 mt-30 -141.91 -141.46 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 66.2 m95 -153.36 -40.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 1.7 mt-10 -93.63 169.19 10.51 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.198 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.4 Cg_endo -72.24 125.91 11.24 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.445 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.8 Cg_endo . . . . . 0 C--N 1.306 -1.682 0 O-C-N 123.971 1.511 . . . . 0.0 110.596 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.1 mm? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 44.3 Cg_endo -70.41 -162.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.969 1.51 . . . . 0.0 110.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 118.74 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.368 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.18 5.35 37.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 53.4 m95 -119.88 140.5 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -1.232 . . . . 0.0 109.959 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.923 ' SD ' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -120.67 165.52 14.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.645 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -120.16 106.8 12.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.335 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.7 t -111.75 161.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 111.108 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.82 84.88 2.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.798 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 -175.39 4.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.944 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.1 p -66.86 -28.91 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -27.56 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.45 -166.3 30.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 23.5 m -92.5 114.24 26.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.1 p90 -114.33 -157.74 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.028 . . . . 0.0 110.255 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.581 ' CE2' HD11 ' A' ' 15' ' ' LEU . 73.6 m-85 -135.85 130.23 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 6.8 t90 -98.04 130.36 44.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.55 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 5.4 t-160 -90.84 104.12 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.923 HD11 ' SD ' ' A' ' 20' ' ' MET . 14.5 mt -62.14 -41.35 74.9 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 112.637 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.2 Cg_endo -71.89 -56.18 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.278 1.146 . . . . 0.0 111.728 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 p -86.53 -44.37 11.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 0.0 110.409 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.88 -6.83 33.05 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 5.9 m -69.11 161.07 29.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 110.375 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.38 165.89 14.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 0.0 110.076 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 46.7 mt-30 -147.95 -141.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -146.63 -54.19 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' C ' ' CE1' ' A' ' 30' ' ' TYR . 35.5 mt-10 -90.73 163.11 31.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 0.0 110.308 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HB3' ' OH ' ' A' ' 30' ' ' TYR . 45.4 Cg_endo -73.51 116.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.039 1.547 . . . . 0.0 110.421 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.2 Cg_endo . . . . . 0 C--N 1.305 -1.745 0 O-C-N 123.91 1.479 . . . . 0.0 110.364 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.742 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.904 0.383 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 45.5 Cg_endo -71.78 -161.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.033 1.543 . . . . 0.0 110.36 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.74 118.12 34.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.12 7.08 23.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.566 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 45.2 m95 -120.29 133.4 55.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.231 . . . . 0.0 109.56 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 33' ' ' ILE . 9.5 mmm -114.72 167.55 10.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.159 -0.963 . . . . 0.0 110.916 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -120.9 108.93 14.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 10.9 t -109.0 165.22 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.809 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.2 mt-30 -120.63 85.04 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.574 -0.704 . . . . 0.0 109.791 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.2 179.5 7.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -62.05 -34.44 76.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -25.32 63.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.126 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.53 -166.05 28.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 24.8 m -93.08 114.02 26.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.168 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.5 p90 -114.02 -156.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.292 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 20' ' ' MET . 43.5 m-85 -130.61 135.13 47.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 110.337 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.504 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -104.98 115.55 30.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.567 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 2.8 t-160 -76.93 111.24 12.27 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.9 mt -68.79 -40.13 16.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.513 -0.742 . . . . 0.0 112.198 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.0 Cg_endo -73.25 -56.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.253 1.133 . . . . 0.0 111.785 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.428 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 23.5 p -86.33 -22.86 26.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.96 -1.087 . . . . 0.0 110.423 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 83.82 -12.46 52.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -61.91 159.92 13.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -1.208 . . . . 0.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.17 163.0 19.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.386 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 38' ' ' THR . 36.6 mt-30 -147.32 -145.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.065 -1.022 . . . . 0.0 110.385 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 33.7 m95 -145.95 -39.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 110.069 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 39.3 mt-10 -103.84 165.25 13.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.89 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.7 Cg_endo -71.96 123.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.885 1.466 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.709 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.307 -1.64 0 O-C-N 123.887 1.467 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.0 Cg_endo -68.42 -160.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.875 1.46 . . . . 0.0 110.066 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 126.48 36.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 110.643 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 33' ' ' ILE . . . 96.59 -20.19 51.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 45.8 m95 -89.98 129.07 36.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.909 -1.348 . . . . 0.0 109.957 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.471 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 23.2 mmt -106.56 166.47 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 110.704 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -120.18 110.83 17.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 24.2 t -112.17 165.8 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 0.0 110.732 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.66 111.09 17.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.755 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.84 179.21 4.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.622 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -60.07 -45.62 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.357 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -27.95 69.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.324 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.42 177.56 22.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.9 m -78.81 118.52 20.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -1.152 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.5 p90 -114.28 -155.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 110.283 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.456 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 36.4 m-85 -135.36 149.98 49.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.511 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 t90 -118.62 115.87 25.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CG ' ' HG1' ' A' ' 35' ' ' THR . 2.7 t-160 -76.84 111.47 12.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.155 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 mm -69.37 -40.74 15.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.507 -0.745 . . . . 0.0 112.324 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.9 Cg_endo -73.6 -50.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.293 1.154 . . . . 0.0 112.022 -178.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.566 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 38.1 p -86.27 -23.71 26.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 0.0 110.344 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.47 -12.42 51.56 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 58.3 m -71.88 166.74 21.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -1.209 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.49 158.35 28.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 110.045 179.494 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 64.6 mt-30 -150.22 -173.47 4.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.136 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -136.63 2.21 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.0 110.503 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 17.5 mt-10 -114.48 163.44 19.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.1 Cg_endo -73.12 111.66 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.036 1.545 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 16' ' ' PRO . 46.2 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.488 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.781 HD11 ' CB ' ' A' ' 42' ' ' PRO . 3.9 mm? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.73 0.3 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.0 Cg_endo -70.05 172.96 11.94 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.975 1.513 . . . . 0.0 110.088 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.32 22.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.637 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.17 1.11 22.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 57.6 m95 -120.48 142.42 49.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.278 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.4 mmt -120.64 167.49 12.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.873 . . . . 0.0 110.392 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -120.23 104.32 9.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.79 . . . . 0.0 109.607 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 28' ' ' THR . 11.9 t -108.34 164.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.443 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.66 96.64 5.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.17 170.92 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -49.61 -59.21 3.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -31.83 5.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.41 -178.28 25.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.8 m -78.97 121.67 25.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -1.163 . . . . 0.0 110.121 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.63 -160.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.194 -0.941 . . . . 0.0 110.353 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 61.2 m-85 -130.05 119.12 22.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.445 -0.784 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 32' ' ' HIS . 8.7 t90 -88.7 141.2 28.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.603 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.9 t60 -100.42 105.43 16.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.976 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 20' ' ' MET . 15.0 mt -60.05 -40.05 74.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.627 . . . . 0.0 112.648 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.8 Cg_endo -71.88 -63.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.103 1.054 . . . . 0.0 111.66 -178.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.574 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.1 -38.83 17.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.131 . . . . 0.0 110.744 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 104.98 3.44 42.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.2 m -73.08 156.27 38.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -1.136 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 1.8 p -120.59 160.15 23.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.766 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 27.7 mt-30 -145.16 -141.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 72.0 t-105 -140.09 -58.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 17.8 mt-10 -89.62 165.24 26.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.781 ' CB ' HD11 ' A' ' 15' ' ' LEU . 43.8 Cg_endo -71.43 118.11 5.5 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.92 1.484 . . . . 0.0 110.36 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.0 Cg_endo . . . . . 0 C--N 1.307 -1.649 0 O-C-N 123.972 1.512 . . . . 0.0 110.544 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.3 Cg_endo -68.62 -161.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.97 1.511 . . . . 0.0 109.803 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.35 117.62 34.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 110.699 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.13 28.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.6 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 43.2 m95 -98.68 139.93 33.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.32 . . . . 0.0 109.928 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.991 ' SD ' HD11 ' A' ' 33' ' ' ILE . 47.2 mmm -116.65 165.7 12.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 110.884 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 -120.6 111.84 18.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 5.9 t -112.54 163.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 35.9 tt0 -120.47 89.57 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 179.13 6.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -63.1 -33.43 75.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 110.356 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -72.9 -21.84 60.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.211 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.45 -176.88 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 m -85.75 113.72 22.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.602 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 40.9 p90 -114.14 -154.9 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 46.6 m-85 -133.99 145.78 49.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.943 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.505 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.4 t90 -115.12 118.89 34.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.116 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.595 ' CD2' ' CE2' ' A' ' 19' ' ' TRP . 2.4 t-160 -79.85 110.12 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.991 HD11 ' SD ' ' A' ' 20' ' ' MET . 38.8 mt -69.41 -39.48 12.43 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.715 -0.616 . . . . 0.0 112.408 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.5 Cg_endo -73.59 -53.32 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.162 1.085 . . . . 0.0 111.92 -178.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 53.4 p -86.39 -21.39 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 110.322 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -8.83 57.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.4 m -70.56 163.28 27.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.27 148.15 44.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 110.218 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 59.2 mt-30 -142.53 -170.97 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 83.1 m95 -136.5 1.8 2.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.437 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.59 160.27 42.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.91 112.26 3.47 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.084 1.571 . . . . 0.0 110.477 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 O-C-N 124.012 1.533 . . . . 0.0 110.436 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 30' ' ' TYR . 4.1 mm? . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.6 Cg_endo -69.67 -160.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.905 1.476 . . . . 0.0 110.472 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 120.1 37.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 110.429 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.68 7.41 45.09 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 52.3 m95 -119.85 133.53 55.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.226 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.717 ' SD ' HD11 ' A' ' 33' ' ' ILE . 59.6 mmm -120.44 166.6 13.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -121.08 111.34 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.4 t -110.43 161.56 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -121.04 83.94 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 168.32 18.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -54.18 -35.5 62.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.85 -166.28 34.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 23' ' ' GLN . 24.0 m -101.44 113.4 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 110.073 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 45.7 p90 -114.32 -157.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.604 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.591 ' HE2' HD11 ' A' ' 15' ' ' LEU . 27.6 m-85 -130.02 135.18 47.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -105.4 121.84 44.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.43 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.2 t-160 -83.33 107.35 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.901 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.717 HD11 ' SD ' ' A' ' 20' ' ' MET . 52.7 mt -67.42 -38.3 15.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.82 . . . . 0.0 112.372 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.6 Cg_endo -73.5 -57.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.067 1.035 . . . . 0.0 111.529 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.406 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 13.9 p -86.89 -34.48 19.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.922 -1.111 . . . . 0.0 110.419 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 98.68 -9.41 62.22 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.6 m -62.89 156.68 23.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.061 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.477 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.29 159.57 24.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 109.554 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 37.5 mt-30 -144.33 -137.4 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 110.496 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -159.0 -48.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 42.1 mt-10 -92.45 165.54 19.22 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.647 -0.658 . . . . 0.0 110.002 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.4 Cg_endo -71.56 122.17 8.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.004 1.529 . . . . 0.0 110.292 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 C--N 1.307 -1.624 0 O-C-N 123.913 1.48 . . . . 0.0 110.346 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.332 0.587 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' OD1' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -112.94 81.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 60.29 21.02 10.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.4 m95 57.07 55.67 5.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.175 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 2' ' ' SER . 3.1 m120 -48.94 165.48 0.26 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.86 -26.54 15.54 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.042 1.548 . . . . 0.0 110.475 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -84.12 -71.07 0.53 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.223 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 7' ' ' ASN . . . 42.38 -160.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.353 -0.842 . . . . 0.0 110.257 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.02 47.52 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.916 . . . . 0.0 110.246 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.84 -159.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 110.354 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.663 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -79.43 -162.5 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.411 -0.806 . . . . 0.0 110.286 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.663 ' H ' HG22 ' A' ' 11' ' ' THR . 2.8 p30 -58.3 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -104.33 -53.42 2.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 110.211 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 13' ' ' SER . 7.6 t70 -177.98 54.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.1 mm? -67.71 171.33 5.42 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.056 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.45 -170.78 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.951 1.501 . . . . 0.0 110.121 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.06 121.32 30.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 110.56 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.13 6.02 49.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.4 m95 -120.05 136.53 54.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.875 -1.367 . . . . 0.0 109.858 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.938 ' SD ' HD11 ' A' ' 33' ' ' ILE . 2.0 mmt -116.35 166.23 12.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.804 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 3.9 ttt180 -120.19 106.37 11.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.529 -0.732 . . . . 0.0 109.423 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.7 t -109.41 162.38 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.102 -0.999 . . . . 0.0 110.733 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.63 80.54 1.64 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.826 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.88 169.57 17.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.44 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.9 t -59.68 -22.5 62.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.044 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -81.3 -32.05 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.14 175.95 28.64 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 51.0 m -81.15 113.19 19.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 110.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.597 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 49.8 p90 -114.39 -156.21 0.59 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.511 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.702 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.2 m-85 -131.77 135.25 46.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.484 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 4.9 t90 -107.04 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.863 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.68 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -80.06 109.63 14.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -0.834 . . . . 0.0 110.477 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.938 HD11 ' SD ' ' A' ' 20' ' ' MET . 47.3 mt -67.83 -36.91 10.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 112.616 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.28 -62.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 122.997 0.999 . . . . 0.0 111.833 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.551 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 2.9 t -86.39 -18.16 32.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.918 -1.114 . . . . 0.0 110.536 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 84.41 -13.99 48.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.528 ' H ' HG23 ' A' ' 35' ' ' THR . 8.9 m -59.18 160.99 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -1.17 . . . . 0.0 110.114 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 154.15 36.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.312 -0.868 . . . . 0.0 110.129 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 41.9 mt-30 -142.04 -175.57 4.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 110.03 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -136.8 1.89 2.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 110.434 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 23.1 mt-10 -120.04 160.22 43.9 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.144 -0.972 . . . . 0.0 110.088 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.56 110.68 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.944 1.497 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 47.1 Cg_endo -74.17 110.95 3.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.929 1.489 . . . . 0.0 110.323 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.94 62.77 0.4 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 105.79 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -1.16 . . . . 0.0 110.003 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.47 99.25 3.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.32 87.91 9.96 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 110.112 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.43 -2.52 11.87 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.012 1.533 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.3 m -89.69 -28.81 19.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.304 -0.872 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.171 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' OD2' ' O ' ' A' ' 1' ' ' ASP . 4.5 p-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.241 0.543 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.562 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 2.2 t -132.31 104.11 6.57 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.936 . . . . 0.0 110.24 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.562 ' CG ' ' O ' ' A' ' 2' ' ' SER . 15.3 m-85 -162.45 47.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -45.97 156.57 0.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.093 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.44 143.12 25.84 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.235 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.9 -24.01 18.14 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.051 1.553 . . . . 0.0 110.471 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -85.33 -25.94 26.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ASN . . . -60.26 -147.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.57 112.66 21.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.887 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -48.02 136.16 11.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -92.66 -163.79 1.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.339 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' HB2' HD23 ' A' ' 15' ' ' LEU . 9.4 p-10 -42.47 126.82 3.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 110.225 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 20.0 p -75.42 -27.31 58.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 110.346 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 13' ' ' SER . 5.7 t0 -179.83 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.494 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' A' ' 43' ' ' PRO . 4.1 mm? -90.53 167.18 17.15 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.018 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -71.17 -162.93 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.947 1.498 . . . . 0.0 110.404 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.2 120.23 36.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.477 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.26 -0.08 26.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 56.8 m95 -117.43 141.81 47.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.543 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 34.2 mmm -120.71 165.7 14.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 110.73 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -120.64 105.81 11.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.533 -0.73 . . . . 0.0 109.498 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.6 t -107.91 163.78 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 110.752 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 10.4 tt0 -121.19 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.737 -0.602 . . . . 0.0 109.767 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.82 174.46 5.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.376 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . 19.8 p -67.8 -6.71 22.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -0.91 . . . . 0.0 110.186 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.84 -26.18 12.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.48 -176.23 38.84 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 30.5 m -94.07 118.42 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -1.13 . . . . 0.0 110.201 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.2 p90 -114.48 -154.06 0.54 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.93 . . . . 0.0 110.272 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.481 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 64.5 m-85 -135.52 135.54 40.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.4 t90 -107.31 132.51 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.352 -0.842 . . . . 0.0 109.805 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.609 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.7 t60 -93.22 108.07 19.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.111 . . . . 0.0 110.388 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 12.4 mt -63.17 -39.23 49.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.468 -0.77 . . . . 0.0 112.542 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 46.2 Cg_endo -73.01 -62.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.125 1.066 . . . . 0.0 111.951 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.579 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.6 -30.78 21.56 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.134 . . . . 0.0 110.933 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.61 6.86 60.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -74.39 152.58 39.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 110.192 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.12 38.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 110.089 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.532 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 56.2 mt-30 -141.97 -143.57 0.15 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.131 -0.981 . . . . 0.0 110.432 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.425 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 67.6 t-105 -136.83 -54.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.1 mt-10 -92.04 164.95 21.46 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.448 -0.782 . . . . 0.0 110.239 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.9 Cg_endo -72.5 129.49 14.81 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.991 1.522 . . . . 0.0 110.338 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.1 Cg_endo -72.95 121.84 7.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.868 1.457 . . . . 0.0 110.493 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.02 113.22 1.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.67 -17.38 14.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -1.16 . . . . 0.0 110.121 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' SER . . . -96.74 143.79 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 7.6 t 177.5 138.89 0.23 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 110.208 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.8 -90.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.052 1.554 . . . . 0.0 110.45 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 m -90.98 158.86 16.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.175 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 2' ' ' SER . 81.0 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.194 0.521 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 1' ' ' ASP . 0.3 OUTLIER 63.99 86.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 110.229 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.65 -44.5 8.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -51.81 112.44 0.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 110.249 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -126.64 138.59 32.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.176 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -27.61 14.33 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.047 1.551 . . . . 0.0 110.477 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -90.51 40.26 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.273 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.85 17.46 15.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.301 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.21 84.36 5.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -76.33 170.53 16.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 110.278 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -94.35 -168.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.197 -0.939 . . . . 0.0 110.171 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 11' ' ' THR . 2.7 m-20 -89.7 -162.6 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 110.245 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -105.59 53.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 110.184 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' SER . 19.2 m-20 56.13 53.32 9.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.5 mm? -85.21 168.79 18.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.285 -0.885 . . . . 0.0 110.071 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.05 -159.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.949 1.499 . . . . 0.0 110.203 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.46 123.59 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.689 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 8.83 55.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.3 m95 -120.5 138.82 53.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.944 -1.327 . . . . 0.0 109.899 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.87 ' SD ' HD11 ' A' ' 33' ' ' ILE . 82.1 mmm -120.87 170.29 9.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.0 110.696 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -120.42 110.26 16.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 109.495 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -112.39 163.8 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.966 . . . . 0.0 110.87 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 21.9 tt0 -120.91 91.78 3.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 110.02 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -92.02 -172.67 3.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.154 -0.966 . . . . 0.0 110.635 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.8 p -67.12 -33.72 76.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.184 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.587 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -73.3 -18.63 61.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 110.316 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.21 -172.42 22.95 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 54.7 m -85.51 113.85 22.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -1.124 . . . . 0.0 110.081 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.3 p90 -114.31 -156.26 0.59 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.355 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' MET . 58.3 m-85 -128.89 142.3 51.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 3.9 t90 -112.26 126.99 55.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.871 . . . . 0.0 110.062 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.545 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.7 t60 -84.69 109.25 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.884 . . . . 0.0 110.122 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.87 HD11 ' SD ' ' A' ' 20' ' ' MET . 56.0 mt -65.12 -38.25 27.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.458 -0.776 . . . . 0.0 112.404 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.7 Cg_endo -74.0 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.115 1.061 . . . . 0.0 111.891 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.545 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.53 -26.94 24.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.84 -1.163 . . . . 0.0 111.096 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.72 0.22 75.76 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -67.91 154.75 40.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -1.171 . . . . 0.0 110.353 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.53 152.84 37.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.219 -0.926 . . . . 0.0 109.877 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 49.8 mt-30 -142.15 -168.86 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.587 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 99.6 m95 -137.51 1.12 2.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.127 -0.983 . . . . 0.0 110.596 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 4.0 mt-10 -120.3 162.11 35.59 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.124 -0.985 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -74.69 116.02 4.48 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.117 1.588 . . . . 0.0 110.452 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.29 99.21 1.09 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.949 1.5 . . . . 0.0 110.452 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.71 100.09 1.37 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -113.48 133.25 55.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -1.143 . . . . 0.0 110.265 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.89 -37.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.354 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -73.97 -52.51 4.43 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 110.319 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 47' ' ' SER . 47.4 Cg_endo -75.14 130.01 12.74 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.785 1.413 . . . . 0.0 110.426 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.59 36.18 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 110.38 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.168 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.28 0.562 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -113.49 -21.93 10.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.67 88.88 5.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 110.198 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 4' ' ' TRP . 11.4 t-105 -50.02 141.14 11.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.51 109.29 0.91 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.945 . . . . 0.0 110.215 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.81 -90.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.962 1.506 . . . . 0.0 110.513 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' ALA . 3.1 m-80 -82.25 -71.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.226 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 7' ' ' ASN . . . 44.71 -168.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 110.241 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -76.93 99.85 5.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -53.91 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.25 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.553 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -108.86 -168.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -0.889 . . . . 0.0 110.236 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.553 ' H ' HG22 ' A' ' 11' ' ' THR . 0.7 OUTLIER -60.13 -167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.304 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 4.8 p -69.06 -47.61 64.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.231 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 170.77 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 110.346 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.579 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.0 mm? -66.9 168.11 11.78 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.904 . . . . 0.0 109.973 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.5 Cg_endo -70.07 177.86 5.36 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.892 1.469 . . . . 0.0 110.25 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.79 122.85 27.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.15 -0.969 . . . . 0.0 110.679 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.35 4.93 30.5 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.548 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 50.4 m95 -120.49 135.79 54.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.977 -1.308 . . . . 0.0 109.985 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 1.058 ' SD ' HD11 ' A' ' 33' ' ' ILE . 78.9 mmm -120.6 165.83 14.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.895 . . . . 0.0 110.815 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -120.76 114.31 21.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.584 -0.698 . . . . 0.0 109.659 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 5.4 t -116.87 162.16 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.931 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 pt20 -120.7 99.77 6.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 109.872 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.08 -176.93 3.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 26' ' ' SER . 14.2 p -52.45 -66.34 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -42.09 -51.37 4.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.92 -171.21 42.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.7 m -85.1 118.84 24.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 110.388 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.0 p90 -114.34 -158.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 110.397 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 42' ' ' PRO . 24.2 m-85 -129.78 129.47 44.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.986 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.85 120.89 40.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.412 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.575 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.0 t-160 -82.85 110.28 17.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.38 -0.825 . . . . 0.0 109.998 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.058 HD11 ' SD ' ' A' ' 20' ' ' MET . 30.6 mt -67.66 -40.5 25.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.499 -0.751 . . . . 0.0 112.34 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.2 Cg_endo -73.71 -56.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.286 1.15 . . . . 0.0 111.737 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 15.5 p -86.66 -31.48 21.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.937 -1.102 . . . . 0.0 110.557 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 94.26 -11.84 69.88 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.5 m -61.16 158.48 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.06 . . . . 0.0 110.448 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.71 157.5 29.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 109.756 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 mt-30 -141.73 -144.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.005 . . . . 0.0 110.477 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.439 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 71.1 t-105 -144.57 -55.75 0.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 3.6 mt-10 -90.63 164.81 25.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.506 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 46.2 Cg_endo -73.82 120.59 6.47 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.446 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 15' ' ' LEU . 49.1 Cg_endo -75.31 150.88 37.45 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.821 1.432 . . . . 0.0 110.476 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.82 23.98 77.27 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.547 ' NH2' ' HB2' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -145.95 -37.32 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -1.133 . . . . 0.0 110.342 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . . . -104.01 98.62 8.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.9 t -162.35 130.36 2.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 110.105 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.68 -168.32 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.877 1.462 . . . . 0.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.75 -179.02 2.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.191 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.233 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.157 0.503 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.94 172.46 7.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -156.82 -64.36 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -56.09 -179.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -58.06 156.31 20.73 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.42 -36.08 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.088 1.573 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -146.33 37.6 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.232 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 51.0 -155.66 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.355 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD2' ' N ' ' A' ' 10' ' ' GLU . 40.5 p90 -74.59 -159.57 0.09 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 110.129 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.557 ' N ' ' CD2' ' A' ' 9' ' ' PHE . 2.4 tt0 -158.51 147.72 19.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.135 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.6 m -58.48 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.686 ' H ' HG22 ' A' ' 11' ' ' THR . 50.1 p-10 -47.77 149.38 1.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 110.285 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 p -80.01 -61.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.21 48.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 110.384 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.3 mm? -70.97 167.82 25.77 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.8 Cg_endo -68.38 -160.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.974 1.513 . . . . 0.0 110.033 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.92 123.76 39.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.0 110.703 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.4 -15.05 56.5 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.679 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 54.1 m95 -95.02 139.42 31.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 0.0 110.113 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 1.02 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -114.72 163.57 15.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 110.586 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.55 102.81 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.463 -0.773 . . . . 0.0 109.352 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 6.6 t -106.36 162.04 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 110.564 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.87 82.16 1.88 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.52 -0.738 . . . . 0.0 109.953 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.36 161.0 29.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.93 . . . . 0.0 110.389 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -54.27 -20.94 7.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 110.267 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -83.99 -32.53 24.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.65 167.28 20.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -79.52 116.3 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 110.233 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 51.4 p90 -114.97 -160.29 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.698 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE1' HD11 ' A' ' 15' ' ' LEU . 70.7 m-85 -128.95 125.89 38.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.746 . . . . 0.0 109.914 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.4 t90 -99.52 116.08 30.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.577 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.679 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.2 t-160 -78.98 108.94 12.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.777 . . . . 0.0 109.889 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.02 HD11 ' SD ' ' A' ' 20' ' ' MET . 61.7 mt -68.66 -35.69 7.07 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.603 -0.686 . . . . 0.0 112.827 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.6 Cg_endo -72.21 -60.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 122.972 0.985 . . . . 0.0 111.573 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.585 ' CG2' ' ND1' ' A' ' 32' ' ' HIS . 3.1 t -86.59 -23.69 25.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.982 -1.074 . . . . 0.0 110.442 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 90.61 -14.71 62.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.575 ' H ' HG23 ' A' ' 35' ' ' THR . 2.8 m -58.6 157.2 9.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.179 . . . . 0.0 110.199 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.6 OUTLIER -120.73 162.86 19.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.925 179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 30.4 mt-30 -149.4 -156.42 0.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.09 -1.006 . . . . 0.0 110.174 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -143.56 -35.89 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.18 -0.95 . . . . 0.0 110.449 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 45.4 mt-10 -91.84 162.97 29.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.6 Cg_endo -73.39 111.38 3.27 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.02 1.537 . . . . 0.0 110.579 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.8 Cg_endo -73.63 79.06 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 0.0 110.436 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.95 39.73 1.67 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -101.51 24.91 9.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -1.16 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.93 22.45 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.28 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.49 65.51 1.46 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 110.323 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.61 -6.92 19.94 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.04 1.547 . . . . 0.0 110.539 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 23.2 t -87.14 -23.98 24.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 49' ' ' SER . 1.7 mt-30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.251 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.277 0.56 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.99 45.94 20.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.895 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' TRP . 17.4 m-85 -101.71 -6.28 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.221 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.52 ' O ' ' CG ' ' A' ' 4' ' ' TRP . 13.7 p-90 -177.45 125.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.941 . . . . 0.0 110.237 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.16 132.56 45.02 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.246 -0.909 . . . . 0.0 110.341 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.24 -90.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.936 1.493 . . . . 0.0 110.355 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 7.1 t-20 -108.02 -33.02 7.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.94 . . . . 0.0 109.884 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 56.14 85.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.392 -0.818 . . . . 0.0 110.229 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -152.33 101.23 2.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.11 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -65.15 170.01 4.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 110.208 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.4 m -64.87 -166.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.687 ' H ' HG22 ' A' ' 11' ' ' THR . 3.8 p30 -54.63 -172.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 110.122 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.41 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 2.5 p -69.58 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 13' ' ' SER . 48.5 m-20 -149.49 50.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.674 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.6 mm? -93.38 167.12 14.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 110.041 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.1 Cg_endo -70.17 -179.2 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.91 1.479 . . . . 0.0 110.427 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 129.24 34.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 98.05 2.1 58.24 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.59 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.3 m95 -119.6 132.12 55.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.254 . . . . 0.0 109.938 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HD11 ' A' ' 33' ' ' ILE . 33.9 mmm -120.4 164.81 15.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 0.0 110.646 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -120.84 113.45 20.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t -113.98 161.39 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.063 -1.023 . . . . 0.0 110.732 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.7 pt20 -120.82 94.36 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.605 -0.685 . . . . 0.0 109.964 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.27 173.1 7.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 110.41 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 p -57.75 -45.32 86.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -32.52 70.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.12 20.86 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 22' ' ' VAL . 45.9 m -80.13 116.57 20.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.179 -1.189 . . . . 0.0 110.186 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 54.6 p90 -114.52 -159.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 110.401 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 20' ' ' MET . 92.5 m-85 -132.7 143.73 49.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.8 t90 -112.25 124.38 52.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.934 . . . . 0.0 110.436 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.513 ' ND1' ' OG1' ' A' ' 35' ' ' THR . 4.8 t-160 -86.23 97.42 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.2 mt -58.46 -41.63 90.25 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.562 -0.711 . . . . 0.0 112.76 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 41.7 Cg_endo -69.35 -56.01 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.078 1.041 . . . . 0.0 111.717 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 34.4 p -86.84 -49.67 7.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.887 -1.133 . . . . 0.0 110.457 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -4.41 19.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 3.1 m -73.62 158.28 35.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.38 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.66 160.46 23.23 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.122 -0.987 . . . . 0.0 110.019 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.543 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 70.9 mt-30 -141.98 -171.68 3.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.175 -0.953 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.582 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 93.5 m95 -136.64 2.73 2.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.023 -1.048 . . . . 0.0 110.351 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -133.13 163.78 48.64 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 110.268 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.5 Cg_endo -71.84 125.03 10.65 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.028 1.541 . . . . 0.0 110.288 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 52.8 Cg_endo -81.05 64.07 8.83 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.0 110.75 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 43' ' ' PRO . . . 55.77 109.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -60.5 156.36 16.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -1.191 . . . . 0.0 110.149 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.17 -166.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.2 p -167.05 135.53 2.16 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.873 . . . . 0.0 110.103 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 -177.44 2.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.958 1.504 . . . . 0.0 110.519 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -128.47 51.21 2.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.096 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.438 ' OXT' ' CG ' ' A' ' 50' ' ' GLN . 4.7 pt20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.217 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.222 0.534 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.7 74.46 1.66 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 110.222 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -78.83 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CZ3' ' HB1' ' A' ' 17' ' ' ALA . 68.5 t-105 -62.38 105.3 0.6 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 110.321 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.74 113.16 24.24 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 4' ' ' TRP . 45.8 Cg_endo -72.33 -24.54 19.47 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.885 1.466 . . . . 0.0 110.508 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 55.45 3.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.208 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.03 -155.37 0.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.229 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -52.94 123.12 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 110.304 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.18 158.28 33.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -93.04 -165.09 1.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.283 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.534 ' H ' HG22 ' A' ' 11' ' ' THR . 0.2 OUTLIER -61.44 -162.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.916 . . . . 0.0 110.26 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.54 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.35 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.566 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -140.76 45.86 1.79 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.893 . . . . 0.0 110.326 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.2 mm? -100.16 168.7 9.02 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.835 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.1 Cg_endo -67.44 -160.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.869 1.458 . . . . 0.0 110.095 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' CZ3' ' A' ' 4' ' ' TRP . . . -90.02 128.97 36.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.988 . . . . 0.0 111.02 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HG3' ' A' ' 34' ' ' PRO . . . 91.49 -19.97 44.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.608 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 48.6 m95 -88.77 136.31 33.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.919 -1.342 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.937 ' SD ' HD11 ' A' ' 33' ' ' ILE . 7.2 mmt -119.12 165.11 14.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 110.865 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -120.74 106.63 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.647 -0.658 . . . . 0.0 109.31 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.591 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.1 t -105.95 159.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.052 -1.03 . . . . 0.0 110.547 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.9 pt20 -121.15 82.46 1.93 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.51 -0.744 . . . . 0.0 110.213 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.17 162.03 27.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.0 110.294 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 p -55.07 -20.53 9.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.173 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -83.48 -31.95 26.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 110.298 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.91 172.53 28.35 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 m -87.98 114.37 24.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.216 -1.167 . . . . 0.0 110.117 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.591 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 42.2 p90 -115.0 -156.34 0.6 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.0 110.622 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.713 ' CE1' HD11 ' A' ' 15' ' ' LEU . 65.3 m-85 -131.37 145.84 52.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 110.359 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.3 t90 -117.74 122.31 43.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.608 ' ND1' ' CZ2' ' A' ' 19' ' ' TRP . 2.8 t-160 -84.36 98.21 9.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.451 -0.781 . . . . 0.0 109.903 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.937 HD11 ' SD ' ' A' ' 20' ' ' MET . 19.2 mt -68.8 -51.88 19.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.814 . . . . 0.0 111.732 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 41.0 Cg_endo -65.85 -8.67 20.41 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.152 1.08 . . . . 0.0 111.222 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.569 ' HB ' ' CG ' ' A' ' 32' ' ' HIS . 23.7 m -120.12 -69.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 110.433 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.44 -10.23 5.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' N ' ' A' ' 38' ' ' THR . 27.7 m -86.61 165.97 15.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -1.081 . . . . 0.0 110.151 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 37' ' ' THR . 0.0 OUTLIER -121.04 159.5 25.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.127 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.567 ' OE1' ' CH2' ' A' ' 19' ' ' TRP . 34.1 mt-30 -142.49 -161.91 1.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 52.7 m95 -140.02 -37.82 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 31.2 mt-10 -94.92 164.33 19.74 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.219 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.3 Cg_endo -72.7 118.71 5.7 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.322 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.59 -38.1 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.939 1.494 . . . . 0.0 110.553 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.3 136.22 14.82 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -60.05 141.26 56.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -1.089 . . . . 0.0 110.177 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 47' ' ' SER . . . -158.82 -179.25 7.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 110.274 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' ALA . 0.4 OUTLIER 59.24 150.69 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 110.23 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' SER . 46.1 Cg_endo -73.16 161.38 43.29 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.023 1.538 . . . . 0.0 110.377 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' PRO . 23.4 m 43.13 55.63 4.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.136 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.211 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.227 0.537 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.92 139.35 5.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.187 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -79.44 -2.01 39.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 0.0 110.297 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -51.12 -68.61 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.8 HD22 ' HB2' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -111.91 165.35 13.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 110.32 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 7' ' ' ASN . 45.8 Cg_endo -72.71 -26.65 15.9 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.973 1.512 . . . . 0.0 110.38 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 15.3 t-20 -179.07 -50.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.8 ' HB2' HD22 ' A' ' 5' ' ' ASN . . . 51.53 50.9 17.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.296 -0.878 . . . . 0.0 110.19 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -57.04 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.358 -0.839 . . . . 0.0 110.903 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 8' ' ' ALA . 3.5 pt-20 -94.38 -159.05 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.956 . . . . 0.0 110.372 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.66 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -93.62 -163.43 1.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.372 -0.83 . . . . 0.0 110.22 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.66 ' H ' HG22 ' A' ' 11' ' ' THR . 12.4 p30 -60.28 171.07 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.278 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 14' ' ' ASP . 89.5 p -84.52 45.35 1.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.228 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 13' ' ' SER . 7.7 t0 56.86 66.24 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.329 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD12 ' HD2' ' A' ' 16' ' ' PRO . 3.9 mm? -70.58 172.1 6.8 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.263 -0.898 . . . . 0.0 109.768 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HD2' HD12 ' A' ' 15' ' ' LEU . 42.6 Cg_endo -69.77 -165.34 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.0 110.169 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.88 116.88 29.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.47 2.06 40.75 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.516 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 65.2 m95 -120.45 138.06 54.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.987 -1.302 . . . . 0.0 110.476 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.963 ' SD ' HD11 ' A' ' 33' ' ' ILE . 42.6 mmm -121.09 167.2 12.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.881 . . . . 0.0 110.33 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -120.7 110.28 16.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.738 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 3.4 t -113.8 159.45 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.614 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.94 79.37 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.466 -0.771 . . . . 0.0 109.959 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.21 162.33 29.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 0.0 110.32 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -53.88 -22.67 10.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.923 . . . . 0.0 109.984 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p -80.61 -34.1 35.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.28 -171.21 38.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 23' ' ' GLN . 22.4 m -96.9 114.15 25.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -1.11 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.0 p90 -114.55 -161.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 110.522 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 54.5 m-85 -131.18 122.37 26.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 110.176 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 9.0 t90 -91.89 130.77 37.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.13 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.61 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.0 t60 -89.65 105.81 18.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.047 -1.033 . . . . 0.0 109.904 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.963 HD11 ' SD ' ' A' ' 20' ' ' MET . 34.0 mt -59.37 -41.21 85.93 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 0.0 112.61 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.1 Cg_endo -72.08 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.184 1.097 . . . . 0.0 111.935 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.46 -34.67 20.01 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 111.004 -179.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 101.08 0.11 54.71 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.87 152.67 42.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.173 . . . . 0.0 109.876 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.71 152.89 36.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.083 -1.011 . . . . 0.0 109.894 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 14.5 mt-30 -141.79 -139.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -151.85 -48.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.893 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 54.2 mt-10 -86.14 163.64 42.0 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.141 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 Cg_endo -73.15 126.45 11.15 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.984 1.518 . . . . 0.0 110.468 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.5 Cg_endo -74.06 86.58 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.951 1.501 . . . . 0.0 110.326 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.83 85.18 0.29 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 13.5 ttt-85 -110.28 140.88 43.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -1.153 . . . . 0.0 110.143 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 58.9 104.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 110.121 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.8 p -81.31 145.19 55.2 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.219 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.68 -25.67 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.984 1.518 . . . . 0.0 110.541 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -163.69 0.9 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.235 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.275 0.56 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -152.3 84.82 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.127 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -153.39 -49.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.888 . . . . 0.0 110.292 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 34.3 m95 -48.28 116.02 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 110.31 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.12 81.87 6.65 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.58 -28.08 14.73 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.957 1.504 . . . . 0.0 110.357 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -65.53 -23.94 67.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.044 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.61 111.88 22.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 110.074 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.45 46.52 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 110.309 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -106.63 -174.19 2.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.124 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -105.95 -160.96 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.583 ' H ' HG22 ' A' ' 11' ' ' THR . 13.5 t0 52.79 92.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.5 -78.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.341 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.83 48.22 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? -88.43 167.79 18.13 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.223 -0.923 . . . . 0.0 110.141 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -70.43 -162.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.001 1.527 . . . . 0.0 110.122 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.83 118.43 34.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.517 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 105.88 7.13 36.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 47.7 m95 -119.08 123.46 44.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.018 -1.283 . . . . 0.0 109.668 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.504 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.4 tpp -106.96 170.17 8.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.92 . . . . 0.0 111.214 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' MET . 3.1 ttt180 -121.43 110.3 15.9 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.704 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.1 t -110.04 159.65 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.068 -1.02 . . . . 0.0 110.399 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 6.5 tt0 -120.8 93.84 4.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.8 167.02 11.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.5 p -49.86 -49.51 49.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.462 ' OG ' ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -54.03 -35.6 62.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.26 -0.9 . . . . 0.0 110.08 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.53 179.52 30.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 55.7 m -86.75 115.1 23.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.211 -1.17 . . . . 0.0 110.116 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HB3' ' CE3' ' A' ' 40' ' ' TRP . 46.6 p90 -114.44 -155.67 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.366 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 20' ' ' MET . 52.2 m-85 -136.13 152.47 50.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.93 . . . . 0.0 110.559 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 9.3 t90 -118.68 120.1 36.42 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.605 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.644 ' CE1' HG21 ' A' ' 35' ' ' THR . 2.3 t-160 -79.03 93.28 5.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.968 . . . . 0.0 110.098 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.4 mt -62.86 -39.05 49.43 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.566 -0.709 . . . . 0.0 112.406 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -72.95 -45.33 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.077 1.041 . . . . 0.0 111.7 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.644 HG21 ' CE1' ' A' ' 32' ' ' HIS . 44.1 p -86.17 -55.06 4.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.184 . . . . 0.0 110.398 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.3 -11.19 8.6 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.581 HG22 ' N ' ' A' ' 38' ' ' THR . 96.0 m -86.4 170.71 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -1.148 . . . . 0.0 110.203 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.581 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.02 170.96 9.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.402 -0.811 . . . . 0.0 109.958 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 38' ' ' THR . 54.3 mt-30 -158.71 -177.48 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 79.5 m95 -136.47 3.11 2.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.243 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 24.4 mt-10 -119.66 160.18 43.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.93 110.26 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.997 1.524 . . . . 0.0 110.357 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.0 Cg_endo -71.73 -172.9 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.961 1.506 . . . . 0.0 110.503 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.2 -130.86 1.26 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.07 175.71 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -1.171 . . . . 0.0 110.293 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.34 109.29 6.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.902 . . . . 0.0 110.213 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -105.6 110.65 64.46 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.886 . . . . 0.0 110.285 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.22 116.89 4.89 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.048 1.551 . . . . 0.0 110.393 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.0 p -171.33 173.96 4.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.217 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.232 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.401 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.185 0.516 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' ASP . 0.2 OUTLIER 174.65 -170.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.216 -0.928 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.407 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 21.8 m-85 -102.94 53.92 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.407 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 62.56 88.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.205 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -45.4 161.86 0.24 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.233 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.63 -25.56 17.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.049 1.552 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 14.8 t-20 -161.63 -39.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 110.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 7' ' ' ASN . . . 173.51 -163.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.222 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.433 ' O ' ' C ' ' A' ' 10' ' ' GLU . 25.3 m-85 -67.01 139.23 57.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 110.002 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' PHE . 4.1 mp0 -40.86 146.72 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.755 . . . . 0.0 110.317 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -94.29 -162.33 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.872 . . . . 0.0 110.348 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' HB3' HD23 ' A' ' 15' ' ' LEU . 1.8 m-20 32.93 -153.05 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.726 -0.609 . . . . 0.0 111.224 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.53 -54.72 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -164.58 46.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.34 -0.85 . . . . 0.0 110.267 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.8 mm? -72.72 167.74 30.69 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -70.0 -161.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.932 1.49 . . . . 0.0 110.457 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.93 124.35 38.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.92 8.25 57.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.594 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 56.6 m95 -120.57 136.64 54.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.073 -1.251 . . . . 0.0 110.051 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.686 ' SD ' HD11 ' A' ' 33' ' ' ILE . 6.8 mmm -120.61 168.29 11.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.432 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 35.4 ttt180 -120.78 112.11 18.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.835 . . . . 0.0 109.848 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 7.5 t -113.16 162.43 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -121.09 93.35 4.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.092 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.2 171.14 9.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.969 . . . . 0.0 110.315 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -60.89 -30.79 70.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -0.939 . . . . 0.0 110.392 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -22.67 56.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.138 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.7 172.86 18.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 1.8 m -83.55 117.63 23.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -1.156 . . . . 0.0 110.151 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.5 p90 -114.17 -159.12 0.68 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.35 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 95.1 m-85 -132.2 125.77 31.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.4 t90 -92.3 127.92 37.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.268 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.601 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.1 t60 -89.15 110.21 20.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.974 . . . . 0.0 109.847 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.686 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.2 mt -68.27 -37.0 9.81 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.7 Cg_endo -71.96 -36.22 6.28 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 122.936 0.967 . . . . 0.0 111.685 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -116.84 -42.93 2.91 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 110.376 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' HIS . . . 112.34 -2.74 26.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -66.6 151.89 46.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -1.211 . . . . 0.0 110.369 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.566 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -116.7 171.21 8.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 40.4 mt-30 -149.89 -148.59 0.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.084 -1.01 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -147.4 -37.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.062 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 2.4 mt-10 -101.19 166.08 13.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 110.136 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.7 Cg_endo -72.46 119.42 6.11 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.914 1.481 . . . . 0.0 110.378 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 46.7 Cg_endo -73.62 145.44 37.25 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.996 1.524 . . . . 0.0 110.437 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.82 132.8 5.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.58 80.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.133 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -47.94 172.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -0.865 . . . . 0.0 110.233 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.72 74.3 0.84 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.904 . . . . 0.0 110.176 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.437 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 46.6 Cg_endo -73.14 104.67 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.034 1.544 . . . . 0.0 110.445 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 15.1 m 59.09 27.18 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.261 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.319 0.58 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.91 27.1 6.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -48.29 -41.15 27.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.281 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 175.49 -48.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -120.75 112.46 33.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 0.0 110.193 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.47 -24.48 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.85 1.447 . . . . 0.0 110.552 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -102.35 42.7 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.43 47.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -102.7 47.58 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.322 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.3 154.43 22.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.128 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -79.26 -171.2 2.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.261 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.694 ' HB2' HD21 ' A' ' 15' ' ' LEU . 23.2 m-20 -67.25 111.23 3.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.157 -0.964 . . . . 0.0 110.251 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.04 -6.58 23.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 110.257 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 14' ' ' ASP . 18.2 p-10 -173.01 97.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 110.189 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.694 HD21 ' HB2' ' A' ' 12' ' ' ASP . 4.1 mm? -66.69 169.76 7.21 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.072 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.3 Cg_endo -70.33 -163.07 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.851 1.448 . . . . 0.0 110.478 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.26 126.23 37.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.664 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.75 9.29 60.01 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.674 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 51.1 m95 -120.33 138.96 53.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.921 -1.341 . . . . 0.0 109.842 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.916 ' SD ' HD11 ' A' ' 33' ' ' ILE . 37.1 mmm -120.06 168.59 11.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 110.856 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -120.23 110.89 17.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 109.543 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 17.1 t -112.51 166.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.938 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 2.5 tt0 -120.6 82.88 1.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.559 -0.713 . . . . 0.0 109.685 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.72 176.16 6.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.453 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.6 p -63.51 -22.62 66.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.235 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -29.82 27.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.77 -164.88 33.86 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 19.8 m -94.79 113.48 25.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.198 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 47.6 p90 -114.06 -155.55 0.57 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 75.6 m-85 -129.9 139.81 51.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.866 . . . . 0.0 110.418 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 5.9 t90 -110.85 118.1 35.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 110.023 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.674 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -79.19 110.57 14.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 110.536 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.916 HD11 ' SD ' ' A' ' 20' ' ' MET . 54.7 mt -68.36 -39.86 17.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.676 -0.64 . . . . 0.0 112.054 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 47.0 Cg_endo -75.09 -55.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.282 1.149 . . . . 0.0 111.844 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.483 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 30.1 p -86.29 -14.3 44.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.098 . . . . 0.0 110.565 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.85 5.06 50.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 9.2 m -80.93 160.85 24.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.205 -1.173 . . . . 0.0 109.926 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 152.18 38.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.12 -0.988 . . . . 0.0 110.078 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 22.8 mt-30 -141.9 -171.21 3.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -137.04 2.01 2.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 110.545 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 19.4 mt-10 -115.95 155.06 48.32 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 110.23 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 46.1 Cg_endo -74.08 110.99 3.2 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.009 1.531 . . . . 0.0 110.43 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 46.6 Cg_endo -73.24 -46.78 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.909 1.479 . . . . 0.0 110.347 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.2 -158.8 0.73 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.6 -87.8 0.56 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.14 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.37 -160.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 110.178 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.09 146.93 36.19 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 131.47 17.18 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.064 1.56 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.12 161.85 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.3 t0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.2 0.524 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.98 165.91 10.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.203 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -112.07 -146.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.897 . . . . 0.0 110.257 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -45.61 137.49 5.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.286 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.72 129.51 76.4 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.62 -30.91 9.24 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.874 1.46 . . . . 0.0 110.427 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 9' ' ' PHE . 47.7 p-10 -85.78 18.23 3.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.338 -0.851 . . . . 0.0 110.313 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.91 -26.11 0.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.134 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 7' ' ' ASN . 3.0 t80 -124.26 81.54 1.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.63 -161.3 1.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 110.345 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -83.18 -159.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.333 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.549 ' H ' HG22 ' A' ' 11' ' ' THR . 11.1 p-10 -41.08 161.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.498 -0.751 . . . . 0.0 110.432 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -101.44 -60.07 1.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.425 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -170.32 74.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.24 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? -98.53 170.25 7.25 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.99 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.7 Cg_endo -69.63 -165.98 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.872 1.459 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.18 121.73 30.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 110.583 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.46 4.18 57.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.673 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.7 m95 -119.05 131.31 55.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.898 -1.354 . . . . 0.0 110.027 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 13.8 mmt -118.59 168.0 11.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 110.768 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.942 ' CZ ' HG21 ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.19 105.54 11.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 109.472 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.4 t -107.47 153.76 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -122.53 83.95 2.19 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 26' ' ' SER . 1.2 p-10 -73.93 -166.33 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.012 -1.055 . . . . 0.0 110.477 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.4 p -83.59 43.16 0.88 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.325 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.487 ' HB2' ' OD2' ' A' ' 24' ' ' ASP . 0.5 OUTLIER -155.37 -36.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 110.32 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 165.19 29.5 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.942 HG21 ' CZ ' ' A' ' 21' ' ' ARG . 13.2 m -86.78 112.86 22.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -1.179 . . . . 0.0 110.151 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.61 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.7 p90 -113.33 -156.58 0.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.005 -1.059 . . . . 0.0 110.407 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.532 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 78.9 m-85 -127.27 138.72 53.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.5 t90 -111.44 113.57 26.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.673 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.8 t-160 -77.47 107.74 10.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 110.138 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 6.1 mt -68.66 -40.42 18.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 112.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.9 Cg_endo -74.86 -48.93 0.17 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.266 1.14 . . . . 0.0 112.181 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.462 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 32.4 p -86.17 -27.97 24.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.888 -1.133 . . . . 0.0 110.471 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.71 49.2 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.562 HG22 ' N ' ' A' ' 38' ' ' THR . 98.2 m -70.63 169.75 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -1.188 . . . . 0.0 110.257 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.562 ' N ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -121.36 179.44 4.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 110.012 179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.517 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 57.7 mt-30 -157.69 -162.02 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.19 -0.943 . . . . 0.0 110.444 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -136.69 -36.51 0.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 10.7 mt-10 -103.14 164.49 15.41 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 48.2 Cg_endo -74.38 117.72 5.08 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.022 1.538 . . . . 0.0 110.447 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo -72.52 -3.31 13.2 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.845 1.444 . . . . 0.0 110.297 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.46 -59.92 1.41 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.19 96.6 10.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -1.128 . . . . 0.0 110.218 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 47' ' ' SER . . . -98.61 62.44 1.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.197 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER 41.78 72.57 1.07 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.873 . . . . 0.0 110.123 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.8 95.68 0.65 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.115 1.587 . . . . 0.0 110.468 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.59 161.72 26.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.179 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.24 0.543 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.64 154.64 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.264 -0.897 . . . . 0.0 110.16 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -126.97 127.63 45.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 110.274 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -51.64 128.56 23.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.235 -0.915 . . . . 0.0 110.09 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -157.7 80.36 3.24 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.151 -0.968 . . . . 0.0 110.285 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.46 -25.49 15.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.039 1.547 . . . . 0.0 110.365 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 2.2 m-80 -76.91 -53.8 7.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 55.17 177.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.296 -0.877 . . . . 0.0 110.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.47 126.51 27.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.902 . . . . 0.0 110.168 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.11 166.48 15.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.7 OUTLIER -102.17 -161.68 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 11' ' ' THR . 2.6 t0 56.27 102.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.418 -0.801 . . . . 0.0 110.386 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -77.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.59 45.53 2.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.88 HD11 ' CE1' ' A' ' 30' ' ' TYR . 4.5 mm? -91.59 169.73 10.77 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.354 -0.841 . . . . 0.0 110.182 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.5 Cg_endo -70.25 -161.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.952 1.501 . . . . 0.0 110.499 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.07 122.73 33.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.696 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 94.8 6.56 60.56 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 60.1 m95 -120.26 136.13 54.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.26 . . . . 0.0 109.638 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 38.4 ttm -120.46 171.41 8.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 111.264 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' CG ' ' A' ' 20' ' ' MET . 57.2 ttt-85 -121.45 108.7 13.97 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.742 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 19.6 t -113.48 163.0 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.738 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 5.0 mt-30 -121.33 112.32 18.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.663 -0.648 . . . . 0.0 109.783 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.7 -178.02 3.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.149 -0.97 . . . . 0.0 110.476 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -65.54 -24.52 67.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -0.877 . . . . 0.0 110.42 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -84.81 -17.96 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.957 . . . . 0.0 110.119 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.23 175.18 13.77 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 25.9 m -80.01 117.53 20.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.131 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 52.3 p90 -114.2 -152.78 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.88 ' CE1' HD11 ' A' ' 15' ' ' LEU . 84.7 m-85 -133.2 139.09 46.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.072 -1.018 . . . . 0.0 110.593 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.9 t90 -110.48 122.53 47.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 109.71 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.581 ' CD2' ' OG1' ' A' ' 35' ' ' THR . 1.8 t60 -80.41 103.76 10.49 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.216 -0.928 . . . . 0.0 110.218 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.1 mt -63.52 -37.69 32.25 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.545 -0.722 . . . . 0.0 112.484 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.3 Cg_endo -72.32 -62.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.024 1.013 . . . . 0.0 111.51 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.65 -35.77 19.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 103.91 -8.35 50.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.7 OUTLIER -58.95 152.19 20.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -1.185 . . . . 0.0 110.105 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.427 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.44 153.24 36.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.109 -0.994 . . . . 0.0 109.838 179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 19.4 mt-30 -142.24 -142.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 110.405 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CH2' ' HB3' ' A' ' 26' ' ' SER . 97.4 m95 -149.54 -38.84 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 35.9 mt-10 -99.24 163.56 18.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 110.111 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -74.08 131.63 15.7 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.017 1.535 . . . . 0.0 110.494 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.533 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 47.5 Cg_endo -74.69 176.1 10.24 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.903 1.475 . . . . 0.0 110.461 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.5 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -64.58 152.34 42.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -1.113 . . . . 0.0 110.101 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.17 111.6 6.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.243 -0.911 . . . . 0.0 110.185 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.522 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -59.05 -56.97 30.65 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 110.198 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 47' ' ' SER . 45.3 Cg_endo -72.74 158.05 51.02 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.008 1.531 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.36 170.95 7.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.125 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.315 0.579 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.65 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.138 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.33 -33.69 2.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 42.1 t-105 -49.18 144.73 4.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.182 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -128.3 114.97 19.94 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 110.012 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.3 -158.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.874 1.46 . . . . 0.0 110.358 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 3.7 t-20 -53.66 -34.88 60.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.267 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 60.72 -155.2 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.305 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD2' ' N ' ' A' ' 10' ' ' GLU . 22.4 p90 -64.28 -158.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' N ' ' CD2' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -62.07 -173.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.374 -0.829 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -113.61 -169.39 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 110.189 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.604 ' H ' HG22 ' A' ' 11' ' ' THR . 5.6 t0 55.36 92.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -54.08 -79.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.89 64.45 1.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.424 -0.797 . . . . 0.0 110.354 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.0 mm? -94.45 168.66 11.02 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.222 -0.924 . . . . 0.0 109.977 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 42.0 Cg_endo -69.11 -168.34 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.889 1.468 . . . . 0.0 110.329 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.97 123.55 34.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.129 -0.982 . . . . 0.0 110.72 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 106.02 -3.34 38.29 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.071 -1.211 . . . . 0.0 110.071 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.625 ' CZ2' ' ND1' ' A' ' 32' ' ' HIS . 55.4 m95 -112.81 110.72 21.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.982 -1.305 . . . . 0.0 109.477 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.526 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 25.4 ttt -91.22 171.33 9.31 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.054 0.93 . . . . 0.0 111.302 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' CG ' ' A' ' 20' ' ' MET . 67.4 ttt180 -121.05 107.06 12.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 3.8 t -108.53 160.2 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 110.533 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 4.2 mt-30 -121.02 80.04 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.719 . . . . 0.0 110.068 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 154.63 40.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 110.255 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 25' ' ' THR . 80.8 p -45.67 -27.91 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -42.7 52.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 110.248 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.04 -176.49 45.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 94.0 m -93.56 114.18 26.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -1.133 . . . . 0.0 110.202 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.59 -156.33 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 110.44 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 98.2 m-85 -131.73 147.09 52.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.272 -0.892 . . . . 0.0 110.476 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 8.4 t90 -115.43 119.93 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 110.479 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.929 ' CD2' ' HG1' ' A' ' 35' ' ' THR . 3.0 t-160 -76.37 83.37 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 109.706 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 14.1 mt -52.89 -50.41 81.72 Favored Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.585 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 41.4 Cg_endo -68.71 -11.7 32.6 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.199 1.105 . . . . 0.0 111.606 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.929 ' HG1' ' CD2' ' A' ' 32' ' ' HIS . 85.6 m -120.56 -73.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.911 -1.118 . . . . 0.0 110.549 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.06 -17.21 2.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -74.62 161.59 29.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.45 -1.029 . . . . 0.0 110.099 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.84 170.38 9.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 110.084 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.542 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 50.3 mt-30 -147.75 -151.21 0.38 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.958 . . . . 0.0 110.186 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -148.19 -42.36 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.3 mm-40 -98.45 167.53 11.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.9 Cg_endo -73.16 113.46 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.027 1.541 . . . . 0.0 110.398 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 46.6 Cg_endo -72.9 -91.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.909 1.479 . . . . 0.0 110.312 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' PRO . . . 43.54 65.83 1.42 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -86.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -1.143 . . . . 0.0 110.21 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -173.25 -170.56 0.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.196 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.52 82.91 7.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.6 178.72 6.37 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.055 1.555 . . . . 0.0 110.413 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.99 49.2 1.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.219 -179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.22 0.533 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -153.25 -175.09 5.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.329 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 4' ' ' TRP . 26.6 p90 -121.56 -23.05 5.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.084 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.409 ' C ' ' O ' ' A' ' 3' ' ' PHE . 23.7 m95 -43.35 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.292 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.43 99.33 0.78 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 110.173 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 7' ' ' ASN . 48.5 Cg_endo -76.04 -158.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.955 1.503 . . . . 0.0 110.314 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' O ' ' HB2' ' A' ' 8' ' ' ALA . 27.8 t-20 57.44 36.78 27.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 7' ' ' ASN . . . 176.47 36.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.89 . . . . 0.0 110.16 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -122.34 74.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' PHE . 68.5 tt0 53.53 174.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.677 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.4 m -66.85 -166.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.677 ' H ' HG22 ' A' ' 11' ' ' THR . 35.9 m-20 -75.82 -170.86 1.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.295 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 p -87.2 38.62 0.82 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.08 84.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.4 mm? -66.9 168.73 9.82 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.958 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 43.2 Cg_endo -70.22 -166.73 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.817 1.43 . . . . 0.0 110.12 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.13 121.64 34.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.027 . . . . 0.0 110.535 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' CA ' ' HD3' ' A' ' 34' ' ' PRO . . . 114.47 1.83 23.09 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.524 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 77.6 m95 -120.8 136.46 54.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.842 -1.387 . . . . 0.0 110.064 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.494 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 2.2 tpt -120.62 174.15 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.736 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 20' ' ' MET . 0.1 OUTLIER -121.0 104.66 9.97 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 48.0 t -106.76 168.96 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.966 . . . . 0.0 110.529 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.524 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.76 86.12 2.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.107 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 152.18 39.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t -49.19 -22.3 0.97 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.217 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.53 -35.81 19.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.147 -0.97 . . . . 0.0 110.233 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.23 40.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 22' ' ' VAL . 72.8 m -84.05 117.21 23.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -1.164 . . . . 0.0 110.329 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 43.9 p90 -114.62 -154.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.198 -0.939 . . . . 0.0 110.079 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 89.7 m-85 -132.3 142.75 49.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.512 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 2.9 t90 -112.13 130.23 55.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.038 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.618 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.5 t60 -86.64 100.22 12.29 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.193 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 59.0 mt -56.52 -42.16 94.86 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.784 . . . . 0.0 112.556 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.1 Cg_endo -69.11 -66.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.026 1.014 . . . . 0.0 111.882 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -86.43 -38.02 17.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.843 -1.161 . . . . 0.0 110.654 -179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 106.66 -0.56 36.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -61.5 150.17 36.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.081 -1.247 . . . . 0.0 109.9 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.72 151.9 38.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 0.0 110.296 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 4.7 mt-30 -142.0 -139.13 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.981 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -150.71 -40.17 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.116 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -103.73 168.29 8.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.886 . . . . 0.0 110.088 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.1 Cg_endo -71.7 128.68 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.987 1.52 . . . . 0.0 110.286 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.6 Cg_endo -73.44 155.1 50.81 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.91 1.479 . . . . 0.0 110.348 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' ARG . . . 125.15 165.42 12.1 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 15.0 ttt180 -176.35 66.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -1.194 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.8 117.84 11.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -0.933 . . . . 0.0 110.257 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.3 t -168.54 105.93 0.52 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.883 . . . . 0.0 110.23 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.21 90.29 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.028 1.541 . . . . 0.0 110.268 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 50' ' ' GLN . 0.3 OUTLIER -90.95 -175.08 4.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.294 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 49' ' ' SER . 19.7 mt-30 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.304 0.573 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -156.57 -38.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.106 -0.996 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' CG ' ' N ' ' A' ' 4' ' ' TRP . 28.8 p90 -66.95 -43.78 82.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 110.339 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.595 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 15.2 p-90 -61.04 -22.35 64.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.945 . . . . 0.0 110.244 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -129.44 74.22 81.06 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.229 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 46.6 Cg_endo -75.07 -89.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.05 1.553 . . . . 0.0 110.333 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 11.2 p30 -66.29 -26.93 67.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 59.1 76.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.349 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.32 49.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.297 -0.877 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -105.71 151.58 24.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 110.211 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -112.78 -168.26 1.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.617 ' H ' HG22 ' A' ' 11' ' ' THR . 10.5 p-10 -53.37 141.96 22.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -43.38 -84.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 110.203 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -153.44 58.37 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.762 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.6 mm? -89.37 165.52 25.55 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 110.15 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.9 Cg_endo -71.21 -160.31 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.979 1.515 . . . . 0.0 110.362 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.84 135.05 35.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.628 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' O ' ' CD ' ' A' ' 34' ' ' PRO . . . 91.04 8.48 64.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 59.7 m95 -120.37 139.49 52.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.263 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 31' ' ' TRP . 5.4 ttt -120.42 170.51 9.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 111.349 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' CG ' ' A' ' 20' ' ' MET . 6.3 ttt-85 -121.96 112.48 18.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.681 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 42.4 t -114.96 168.77 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.079 -1.013 . . . . 0.0 110.645 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.518 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -120.78 92.27 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 110.088 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' OD2' ' CE1' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -86.53 162.91 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 25' ' ' THR . 65.2 p -56.59 -28.44 60.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.256 -0.903 . . . . 0.0 110.341 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.466 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -79.73 -26.05 40.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.959 . . . . 0.0 110.311 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.43 173.62 25.18 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' VAL . 29.8 m -79.05 116.31 19.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.169 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 39.5 p90 -114.42 -154.96 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 110.281 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' MET . 80.6 m-85 -136.28 151.35 49.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.521 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 20' ' ' MET . 6.0 t90 -120.04 123.59 43.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.591 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 2.2 t60 -79.05 101.79 8.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 110.151 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 16.3 mt -62.16 -38.14 44.86 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.1 Cg_endo -70.57 -58.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 122.881 0.938 . . . . 0.0 111.419 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.586 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -92.39 -41.58 10.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.859 -1.151 . . . . 0.0 110.536 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 110.56 -3.25 29.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -64.26 150.97 44.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.132 -1.216 . . . . 0.0 110.121 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.18 149.87 41.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.048 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 24.7 mt-30 -141.78 -167.88 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 110.124 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.466 ' CZ3' ' OG ' ' A' ' 26' ' ' SER . 94.3 m95 -136.79 2.59 2.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.329 -0.857 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.6 mt-10 -124.0 164.44 29.41 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.9 Cg_endo -72.16 112.46 3.43 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.972 1.511 . . . . 0.0 110.337 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo -72.9 151.92 51.43 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.054 1.555 . . . . 0.0 110.431 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.19 -155.95 26.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 22.7 ttt-85 -134.85 163.46 29.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -1.167 . . . . 0.0 110.25 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 61.45 144.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.277 -0.89 . . . . 0.0 110.272 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.585 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -172.39 -61.55 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 47' ' ' SER . 45.8 Cg_endo -71.7 173.96 11.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.951 1.5 . . . . 0.0 110.418 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.3 p -163.49 123.99 2.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.209 179.953 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.325 0.583 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.7 t -152.5 -82.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 4' ' ' TRP . 1.1 m-85 -81.31 -158.91 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.099 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.513 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER 174.76 -31.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -116.69 89.34 27.96 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.205 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.32 -90.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.975 1.513 . . . . 0.0 110.388 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -126.27 65.27 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -0.933 . . . . 0.0 110.042 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.54 -156.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.889 . . . . 0.0 110.257 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.94 127.26 25.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 110.349 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -125.96 16.47 7.94 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 12' ' ' ASP . 1.1 m -66.53 -162.35 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.248 0.547 . . . . 0.0 110.297 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.664 ' H ' HG22 ' A' ' 11' ' ' THR . 13.1 p30 -43.07 151.94 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.872 . . . . 0.0 110.227 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -103.15 -64.23 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 11.8 p-10 -164.31 51.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.367 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.682 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.5 mm? -71.73 165.76 46.43 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 15' ' ' LEU . 44.0 Cg_endo -70.6 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.094 1.576 . . . . 0.0 110.439 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.37 39.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.278 -0.889 . . . . 0.0 110.541 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.5 2.68 35.21 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.681 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 40.2 m95 -114.97 122.37 46.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.94 -1.33 . . . . 0.0 109.879 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 64.6 mmm -106.36 164.15 12.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -120.46 117.58 28.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.514 -0.741 . . . . 0.0 109.503 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.1 t -118.5 163.59 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.921 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.496 ' NE2' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.72 96.85 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.933 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.3 175.56 5.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.503 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.8 p -53.19 -57.16 11.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.361 -0.837 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.9 m -48.79 -43.04 37.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.9 -176.52 39.17 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.496 ' OG1' ' NE2' ' A' ' 23' ' ' GLN . 1.7 m -84.75 116.18 23.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -1.135 . . . . 0.0 110.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.11 -158.15 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 110.199 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 92.3 m-85 -132.01 130.31 41.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 110.031 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.473 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 8.2 t90 -98.95 110.72 23.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.681 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.5 t-160 -76.58 111.92 12.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.53 -0.731 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.613 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 9.8 mt -67.76 -40.17 22.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 112.117 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.4 Cg_endo -74.16 -55.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.243 1.128 . . . . 0.0 111.622 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.414 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 19.9 p -86.64 -8.61 57.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.943 -1.098 . . . . 0.0 110.476 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 60.96 12.92 31.49 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.407 ' HG1' ' CB ' ' A' ' 35' ' ' THR . 5.6 m -87.0 159.69 18.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -1.233 . . . . 0.0 110.078 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.48 156.43 31.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.996 . . . . 0.0 109.675 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 12.9 mt-30 -142.72 -141.43 0.13 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.158 -0.964 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CD1' ' C ' ' A' ' 39' ' ' GLN . 93.4 m95 -150.98 -38.04 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.287 -0.883 . . . . 0.0 110.178 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 32.2 mt-10 -100.31 163.89 17.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.9 Cg_endo -73.07 127.2 11.86 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.939 1.494 . . . . 0.0 110.399 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 15' ' ' LEU . 44.8 Cg_endo -72.67 79.66 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.043 1.549 . . . . 0.0 110.314 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.74 -176.63 18.37 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -73.4 144.21 46.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -1.129 . . . . 0.0 110.325 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' SER . . . 45.17 -98.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 0.0 110.331 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER 61.17 135.09 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.022 -1.049 . . . . 0.0 110.13 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.74 173.1 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.926 1.487 . . . . 0.0 110.487 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.63 144.21 22.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.286 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.245 0.545 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 1' ' ' ASP . 0.2 OUTLIER 43.55 79.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.201 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -107.4 53.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.89 . . . . 0.0 110.169 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 171.3 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 110.207 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -145.5 135.55 11.81 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 110.134 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.21 -92.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.934 1.491 . . . . 0.0 110.443 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -102.07 48.52 0.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 110.274 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.29 159.72 17.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.21 120.03 5.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 110.257 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.18 -175.93 3.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -72.16 -160.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.624 ' H ' HG22 ' A' ' 11' ' ' THR . 1.3 p30 -42.31 138.71 1.64 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -75.57 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 110.395 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' C ' HD22 ' A' ' 15' ' ' LEU . 47.0 m-20 -131.36 47.89 2.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.597 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.6 mm? -99.61 167.95 10.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.208 -0.932 . . . . 0.0 110.088 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.4 Cg_endo -69.8 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.98 1.516 . . . . 0.0 110.414 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 131.97 38.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.03 7.99 73.03 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.687 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 52.3 m95 -118.09 122.17 42.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.885 -1.362 . . . . 0.0 109.969 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.543 ' SD ' HD11 ' A' ' 33' ' ' ILE . 29.6 mmt -106.38 168.35 9.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.793 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -120.66 107.1 12.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.589 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 21.4 t -106.75 166.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.096 -1.003 . . . . 0.0 110.6 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 8.2 tt0 -120.39 87.84 2.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.5 -0.75 . . . . 0.0 109.847 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' CD1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -81.62 169.11 17.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 110.357 -179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 25' ' ' THR . 57.9 p -58.16 -27.83 64.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.347 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.76 -25.12 41.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 110.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.29 179.47 27.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 92.8 m -83.29 116.89 22.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 53.0 p90 -114.15 -154.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.487 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 77.4 m-85 -129.85 141.37 50.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 110.416 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 8.5 t90 -114.65 111.16 20.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.161 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.687 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 1.9 t-160 -76.74 107.18 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.484 -0.76 . . . . 0.0 110.304 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 7.6 mt -65.8 -40.33 38.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.575 -0.703 . . . . 0.0 111.954 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.45 -53.58 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.299 1.157 . . . . 0.0 111.874 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 20.4 p -86.46 -7.76 58.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.929 -1.107 . . . . 0.0 110.639 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.17 11.66 27.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -87.14 156.99 19.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 0.0 109.962 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.22 153.68 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.114 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' O ' ' CG ' ' A' ' 40' ' ' TRP . 35.3 mt-30 -146.84 -138.98 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 110.175 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 95.7 m95 -157.04 -37.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.945 . . . . 0.0 110.254 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.487 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 38.4 mt-10 -89.51 161.95 38.01 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 115.63 4.42 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.972 1.511 . . . . 0.0 110.304 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.522 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 45.0 Cg_endo -72.04 127.99 13.47 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.02 1.537 . . . . 0.0 110.469 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.66 -94.25 0.14 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -116.0 120.17 38.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -1.188 . . . . 0.0 110.204 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.62 72.9 1.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.193 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.549 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -54.17 -58.78 12.15 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.375 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' CD ' ' CB ' ' A' ' 47' ' ' SER . 46.5 Cg_endo -73.27 83.0 1.52 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.91 1.479 . . . . 0.0 110.531 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.69 -25.56 13.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -0.947 . . . . 0.0 110.18 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.25 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.186 0.517 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.7 p -59.16 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.275 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.55 -77.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -53.42 169.22 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.284 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.38 148.41 40.44 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.313 -0.867 . . . . 0.0 110.258 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.02 -31.6 7.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.975 1.513 . . . . 0.0 110.384 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.27 47.91 0.87 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.89 -90.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.366 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -173.44 86.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 110.27 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.88 -170.86 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 110.253 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -70.68 -173.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.047 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 11' ' ' THR . 38.9 p-10 -64.26 -173.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.931 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.48 ' OG ' HD21 ' A' ' 15' ' ' LEU . 2.2 p -86.57 49.63 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 13' ' ' SER . 66.7 m-20 56.36 50.25 13.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -0.889 . . . . 0.0 110.491 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 16' ' ' PRO . 4.2 mm? -68.74 171.43 6.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.011 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.5 Cg_endo -67.81 -160.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.374 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.74 128.33 36.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 111.068 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.92 75.07 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.685 ' CZ2' ' CE1' ' A' ' 32' ' ' HIS . 55.2 m95 -98.33 129.93 45.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.663 -1.493 . . . . 0.0 110.054 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 33' ' ' ILE . 57.0 mmm -114.72 165.27 12.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.396 -0.815 . . . . 0.0 110.816 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 12.7 ttt180 -120.7 106.49 11.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.565 -0.709 . . . . 0.0 109.64 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.588 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 6.6 t -106.4 164.31 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.087 -1.008 . . . . 0.0 110.845 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HG2' ' OG1' ' A' ' 28' ' ' THR . 0.3 OUTLIER -120.8 86.87 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.528 -0.732 . . . . 0.0 109.988 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.61 172.96 8.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.424 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.7 p -52.26 -50.46 62.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -52.96 -31.83 42.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.98 -179.59 22.9 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 58.3 m -79.01 114.67 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -1.114 . . . . 0.0 110.056 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.588 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.1 p90 -114.38 -159.51 0.7 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 110.535 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 20' ' ' MET . 50.8 m-85 -126.84 125.81 42.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.095 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 11.7 t90 -99.93 116.19 31.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.521 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.685 ' CE1' ' CZ2' ' A' ' 19' ' ' TRP . 2.3 t-160 -82.73 109.02 16.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 0.0 110.213 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 18.4 mt -68.22 -39.77 18.18 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.601 -0.687 . . . . 0.0 112.138 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 45.5 Cg_endo -74.58 -55.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.257 1.135 . . . . 0.0 111.602 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 p -86.64 -10.7 53.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.965 -1.085 . . . . 0.0 110.315 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 66.26 7.66 39.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.3 m -82.25 154.67 25.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.162 -1.199 . . . . 0.0 110.007 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -119.74 151.18 39.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.866 179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 13.3 mt-30 -141.91 -141.46 0.13 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.188 -0.945 . . . . 0.0 110.366 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 66.2 m95 -153.36 -40.17 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 110.11 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 1.7 mt-10 -93.63 169.19 10.51 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.198 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 45.4 Cg_endo -72.24 125.91 11.24 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.445 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 15' ' ' LEU . 45.8 Cg_endo -72.99 107.6 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.971 1.511 . . . . 0.0 110.596 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.06 153.89 5.73 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -113.43 142.4 45.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -1.115 . . . . 0.0 110.223 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 59.19 -170.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.19 107.43 53.9 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.188 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.88 -160.81 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.02 1.537 . . . . 0.0 110.408 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.6 m -139.55 178.02 7.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.167 -179.922 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 p -66.08 -22.73 66.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -0.96 . . . . 0.0 110.284 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.19 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.252 -0.905 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 8.8 m95 50.05 -162.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.207 -0.933 . . . . 0.0 110.397 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.63 118.7 62.76 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.237 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.3 -32.25 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.817 1.43 . . . . 0.0 110.406 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.679 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 1.5 t30 -74.13 -27.55 60.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.338 -0.852 . . . . 0.0 110.206 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 7' ' ' ASN . . . 66.09 -164.14 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.168 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -78.57 139.18 38.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.34 148.28 3.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.109 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -83.96 -161.52 0.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.636 ' HB2' HD23 ' A' ' 15' ' ' LEU . 4.7 p-10 -54.22 -167.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 110.376 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.41 -86.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.143 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -128.95 61.5 1.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.323 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 12' ' ' ASP . 4.1 mm? -85.9 168.24 20.4 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.073 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 44.3 Cg_endo -70.41 -162.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.969 1.51 . . . . 0.0 110.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.82 118.74 33.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -0.945 . . . . 0.0 110.368 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.18 5.35 37.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.535 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 53.4 m95 -119.88 140.5 50.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -1.232 . . . . 0.0 109.959 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.923 ' SD ' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -120.67 165.52 14.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 110.645 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 29.9 ttt180 -120.16 106.8 12.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.335 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 4.7 t -111.75 161.67 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.136 -0.978 . . . . 0.0 111.108 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -120.82 84.88 2.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.798 179.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.04 -175.39 4.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.189 -0.944 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.1 p -66.86 -28.91 68.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -27.56 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 110.206 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.45 -166.3 30.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 23.5 m -92.5 114.24 26.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 49.1 p90 -114.33 -157.74 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.028 . . . . 0.0 110.255 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.581 ' CE2' HD11 ' A' ' 15' ' ' LEU . 73.6 m-85 -135.85 130.23 33.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 110.362 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' MET . 6.8 t90 -98.04 130.36 44.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.177 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.55 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 5.4 t-160 -90.84 104.12 16.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.923 HD11 ' SD ' ' A' ' 20' ' ' MET . 14.5 mt -62.14 -41.35 74.9 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.684 -0.635 . . . . 0.0 112.637 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.2 Cg_endo -71.89 -56.18 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.278 1.146 . . . . 0.0 111.728 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.1 p -86.53 -44.37 11.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.94 -1.1 . . . . 0.0 110.409 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.88 -6.83 33.05 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 5.9 m -69.11 161.07 29.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -1.182 . . . . 0.0 110.375 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.437 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -120.38 165.89 14.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -0.945 . . . . 0.0 110.076 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' CD ' ' CH2' ' A' ' 19' ' ' TRP . 46.7 mt-30 -147.95 -141.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.146 -0.971 . . . . 0.0 110.35 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -146.63 -54.19 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' C ' ' CE1' ' A' ' 30' ' ' TYR . 35.5 mt-10 -90.73 163.11 31.44 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.431 -0.793 . . . . 0.0 110.308 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HB3' ' OH ' ' A' ' 30' ' ' TYR . 45.4 Cg_endo -73.51 116.64 4.76 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.039 1.547 . . . . 0.0 110.421 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.504 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.2 Cg_endo -73.29 130.83 15.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.91 1.479 . . . . 0.0 110.364 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.06 126.23 5.59 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -49.24 107.54 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -1.144 . . . . 0.0 110.243 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' PRO . . . -48.69 126.13 11.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 75.89 1.44 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' C ' ' A' ' 46' ' ' ALA . 46.6 Cg_endo -73.3 179.35 5.56 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.093 1.575 . . . . 0.0 110.524 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 p -170.39 126.27 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.177 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.236 179.982 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.263 0.554 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 p -139.4 73.6 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' HB2' ' A' ' 4' ' ' TRP . 72.6 t80 -130.43 133.58 46.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 110.16 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.51 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 60.47 63.39 1.37 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.59 149.21 4.39 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.134 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.33 -90.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.057 1.556 . . . . 0.0 110.456 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -147.0 68.42 1.16 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 110.508 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.86 160.29 19.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 110.043 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -160.13 88.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.001 . . . . 0.0 110.302 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER 41.97 -166.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 110.395 179.703 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.618 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -104.26 -162.8 0.92 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -0.955 . . . . 0.0 110.18 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.645 ' OD1' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -120.4 178.69 4.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -91.95 52.06 1.93 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 110.278 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.488 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.4 t0 67.52 51.22 0.86 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 110.283 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.742 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.7 mm? -94.79 165.82 16.38 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.195 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 45.5 Cg_endo -71.78 -161.29 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.033 1.543 . . . . 0.0 110.36 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.74 118.12 34.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -0.926 . . . . 0.0 110.411 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.12 7.08 23.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.566 ' CE2' ' CD2' ' A' ' 32' ' ' HIS . 45.2 m95 -120.29 133.4 55.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.108 -1.231 . . . . 0.0 109.56 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.696 ' SD ' HD11 ' A' ' 33' ' ' ILE . 9.5 mmm -114.72 167.55 10.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.159 -0.963 . . . . 0.0 110.916 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -120.9 108.93 14.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.499 -0.751 . . . . 0.0 109.47 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 10.9 t -109.0 165.22 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.923 . . . . 0.0 110.809 -179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.2 mt-30 -120.63 85.04 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.574 -0.704 . . . . 0.0 109.791 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.2 179.5 7.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.935 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -62.05 -34.44 76.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 110.042 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -25.32 63.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.126 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.53 -166.05 28.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 24.8 m -93.08 114.02 26.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.168 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 50.5 p90 -114.02 -156.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 110.292 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 20' ' ' MET . 43.5 m-85 -130.61 135.13 47.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.895 . . . . 0.0 110.337 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.504 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -104.98 115.55 30.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.567 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 2.8 t-160 -76.93 111.24 12.27 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.305 -0.872 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' SD ' ' A' ' 20' ' ' MET . 13.9 mt -68.79 -40.13 16.37 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.513 -0.742 . . . . 0.0 112.198 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.0 Cg_endo -73.25 -56.6 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.253 1.133 . . . . 0.0 111.785 -178.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.428 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 23.5 p -86.33 -22.86 26.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.96 -1.087 . . . . 0.0 110.423 -179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 83.82 -12.46 52.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -61.91 159.92 13.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -1.208 . . . . 0.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -121.17 163.0 19.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.386 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 38' ' ' THR . 36.6 mt-30 -147.32 -145.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.065 -1.022 . . . . 0.0 110.385 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 29' ' ' TYR . 33.7 m95 -145.95 -39.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 110.069 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 39.3 mt-10 -103.84 165.25 13.8 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.275 -0.89 . . . . 0.0 110.031 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.7 Cg_endo -71.96 123.85 9.63 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.885 1.466 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.709 ' HD2' HD12 ' A' ' 15' ' ' LEU . 45.7 Cg_endo -72.76 -19.27 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.887 1.467 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 45' ' ' ARG . . . 53.58 -174.07 0.44 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 1.1 mtm180 -44.26 -60.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -1.156 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 45' ' ' ARG . . . 61.66 114.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.213 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.42 126.91 29.29 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 110.205 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.67 83.88 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.879 1.463 . . . . 0.0 110.31 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.0 t -124.45 166.63 15.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.201 179.999 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.262 0.553 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 t -94.42 159.56 15.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.885 . . . . 0.0 110.202 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -78.35 104.21 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.292 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' O ' ' A' ' 5' ' ' ASN . 17.8 p-90 -57.01 -174.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 110.215 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 4' ' ' TRP . 3.7 m-20 -61.31 159.68 28.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.335 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.71 -90.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.039 1.547 . . . . 0.0 110.277 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.23 -64.56 1.16 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.126 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 5' ' ' ASN . . . 52.38 -170.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 110.2 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -78.45 126.23 30.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 110.17 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.07 162.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.218 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -108.93 -163.44 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.321 -179.893 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.607 ' H ' HG22 ' A' ' 11' ' ' THR . 2.2 p30 -57.19 -179.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.169 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.4 -54.2 2.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.317 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.56 ' C ' HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -150.96 46.99 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.42 -0.8 . . . . 0.0 110.177 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' HD22 ' A' ' 15' ' ' LEU . 4.2 mm? -99.36 168.6 9.36 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.932 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 42.0 Cg_endo -68.42 -160.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.875 1.46 . . . . 0.0 110.066 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 126.48 36.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.97 . . . . 0.0 110.643 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 33' ' ' ILE . . . 96.59 -20.19 51.53 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 45.8 m95 -89.98 129.07 36.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.909 -1.348 . . . . 0.0 109.957 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.471 ' HB2' ' HB3' ' A' ' 31' ' ' TRP . 23.2 mmt -106.56 166.47 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 110.704 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -120.18 110.83 17.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.567 -0.708 . . . . 0.0 109.489 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 29' ' ' TYR . 24.2 t -112.17 165.8 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 0.0 110.732 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' N ' HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.66 111.09 17.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.755 179.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.84 179.21 4.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.622 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.4 p -60.07 -45.62 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.357 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -27.95 69.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.324 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.42 177.56 22.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 22' ' ' VAL . 6.9 m -78.81 118.52 20.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -1.152 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 22' ' ' VAL . 51.5 p90 -114.28 -155.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.975 . . . . 0.0 110.283 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.456 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 36.4 m-85 -135.36 149.98 49.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.511 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 t90 -118.62 115.87 25.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.175 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CG ' ' HG1' ' A' ' 35' ' ' THR . 2.7 t-160 -76.84 111.47 12.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.155 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.4 mm -69.37 -40.74 15.49 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.507 -0.745 . . . . 0.0 112.324 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 43.9 Cg_endo -73.6 -50.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.293 1.154 . . . . 0.0 112.022 -178.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.566 ' HG1' ' CG ' ' A' ' 32' ' ' HIS . 38.1 p -86.27 -23.71 26.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 0.0 110.344 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.47 -12.42 51.56 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 38' ' ' THR . 58.3 m -71.88 166.74 21.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -1.209 . . . . 0.0 110.379 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.481 ' N ' HG22 ' A' ' 37' ' ' THR . 0.5 OUTLIER -121.49 158.35 28.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 110.045 179.494 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 64.6 mt-30 -150.22 -173.47 4.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.136 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -136.63 2.21 2.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.0 110.503 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 17.5 mt-10 -114.48 163.44 19.3 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.024 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 46.1 Cg_endo -73.12 111.66 3.33 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.036 1.545 . . . . 0.0 110.468 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 16' ' ' PRO . 46.2 Cg_endo -72.79 -160.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.488 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.08 65.88 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -97.54 -17.79 19.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.63 135.78 35.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.233 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 p 62.95 156.23 0.12 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 110.083 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.96 -89.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.087 1.572 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 t -105.31 155.91 18.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.888 . . . . 0.0 110.234 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.232 179.936 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.283 0.563 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -178.19 -164.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.235 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.13 -55.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.457 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -52.41 -19.84 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.144 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -99.4 104.21 25.59 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 4' ' ' TRP . 47.3 Cg_endo -73.18 -24.94 16.4 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.082 1.569 . . . . 0.0 110.525 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 9' ' ' PHE . 1.2 t-20 -128.52 20.32 6.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 110.289 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 9' ' ' PHE . . . 54.98 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 22.4 t80 57.84 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.276 -0.89 . . . . 0.0 110.219 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -74.36 153.15 39.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.276 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -108.58 -172.48 2.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.142 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' H ' HG22 ' A' ' 11' ' ' THR . 6.5 t70 -48.06 156.42 0.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.103 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.66 -92.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.181 -0.949 . . . . 0.0 110.228 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -125.59 60.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 110.199 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.781 HD11 ' CB ' ' A' ' 42' ' ' PRO . 3.9 mm? -92.19 168.41 12.92 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.0 Cg_endo -70.05 172.96 11.94 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.975 1.513 . . . . 0.0 110.088 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.32 22.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.637 -179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.17 1.11 22.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 57.6 m95 -120.48 142.42 49.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.278 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.702 ' SD ' HD11 ' A' ' 33' ' ' ILE . 1.4 mmt -120.64 167.49 12.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.873 . . . . 0.0 110.392 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -120.23 104.32 9.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.79 . . . . 0.0 109.607 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 28' ' ' THR . 11.9 t -108.34 164.43 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.443 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -120.66 96.64 5.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 110.09 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.17 170.92 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 110.198 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -49.61 -59.21 3.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.96 -31.83 5.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.115 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.41 -178.28 25.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.8 m -78.97 121.67 25.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.222 -1.163 . . . . 0.0 110.121 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 22' ' ' VAL . 49.4 p90 -114.63 -160.78 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.194 -0.941 . . . . 0.0 110.353 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' C ' ' A' ' 41' ' ' GLU . 61.2 m-85 -130.05 119.12 22.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.445 -0.784 . . . . 0.0 109.968 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.49 ' CD1' ' N ' ' A' ' 32' ' ' HIS . 8.7 t90 -88.7 141.2 28.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 110.055 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.603 ' CE1' ' HG2' ' A' ' 34' ' ' PRO . 1.9 t60 -100.42 105.43 16.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.954 -1.091 . . . . 0.0 109.976 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.702 HD11 ' SD ' ' A' ' 20' ' ' MET . 15.0 mt -60.05 -40.05 74.45 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.697 -0.627 . . . . 0.0 112.648 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 42.8 Cg_endo -71.88 -63.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.103 1.054 . . . . 0.0 111.66 -178.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.574 ' OG1' ' CD2' ' A' ' 32' ' ' HIS . 0.2 OUTLIER -86.1 -38.83 17.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.891 -1.131 . . . . 0.0 110.744 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 104.98 3.44 42.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.2 m -73.08 156.27 38.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.269 -1.136 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 1.8 p -120.59 160.15 23.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.178 -0.951 . . . . 0.0 109.766 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 27.7 mt-30 -145.16 -141.07 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 110.375 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 72.0 t-105 -140.09 -58.32 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 110.115 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' C ' ' CE2' ' A' ' 30' ' ' TYR . 17.8 mt-10 -89.62 165.24 26.16 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 110.079 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.781 ' CB ' HD11 ' A' ' 15' ' ' LEU . 43.8 Cg_endo -71.43 118.11 5.5 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.92 1.484 . . . . 0.0 110.36 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 15' ' ' LEU . 47.0 Cg_endo -73.12 137.36 26.17 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.972 1.512 . . . . 0.0 110.544 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.86 -131.78 3.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.36 -15.93 25.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -1.111 . . . . 0.0 110.219 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.77 100.6 0.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.169 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.2 p -57.46 144.76 70.89 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.345 -0.847 . . . . 0.0 110.315 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.62 152.69 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.081 1.569 . . . . 0.0 110.417 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.7 p -135.76 153.63 51.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.289 -0.882 . . . . 0.0 110.254 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.133 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.92 107.88 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 110.161 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -54.64 -29.23 51.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 5' ' ' ASN . 2.4 m95 -67.8 94.15 0.44 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.333 -0.854 . . . . 0.0 110.473 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 4' ' ' TRP . 2.9 t-20 177.2 98.46 0.12 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.0 110.126 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.75 -27.16 12.84 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.964 1.507 . . . . 0.0 110.597 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -120.15 65.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 10' ' ' GLU . . . -111.59 153.94 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 110.178 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -45.53 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 8' ' ' ALA . 15.7 pt-20 -68.2 -160.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 110.337 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -100.2 -161.95 0.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.438 -0.789 . . . . 0.0 110.305 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.593 ' HB2' HD23 ' A' ' 15' ' ' LEU . 3.0 p30 -61.21 -174.84 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 110.31 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -120.36 -44.38 2.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.346 -179.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -175.11 64.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 15' ' ' LEU . 3.9 mm? -93.32 167.89 13.17 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.237 -0.914 . . . . 0.0 109.833 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 41.3 Cg_endo -68.62 -161.12 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.97 1.511 . . . . 0.0 109.803 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.35 117.62 34.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 110.699 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.39 -12.13 28.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.6 ' CD2' ' HG3' ' A' ' 43' ' ' PRO . 43.2 m95 -98.68 139.93 33.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.956 -1.32 . . . . 0.0 109.928 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.991 ' SD ' HD11 ' A' ' 33' ' ' ILE . 47.2 mmm -116.65 165.7 12.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.211 -0.93 . . . . 0.0 110.884 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.517 ' NH1' ' OG ' ' A' ' 13' ' ' SER . 25.1 ttt180 -120.6 111.84 18.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 5.9 t -112.54 163.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 35.9 tt0 -120.47 89.57 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.05 179.13 6.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.67 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.1 p -63.1 -33.43 75.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.376 -0.827 . . . . 0.0 110.356 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' CH2' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -72.9 -21.84 60.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 110.211 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.45 -176.88 23.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 m -85.75 113.72 22.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.602 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 40.9 p90 -114.14 -154.9 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 110.082 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' N ' ' CD2' ' A' ' 29' ' ' TYR . 46.6 m-85 -133.99 145.78 49.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.943 . . . . 0.0 110.548 -179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.505 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 5.4 t90 -115.12 118.89 34.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.116 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.595 ' CD2' ' CE2' ' A' ' 19' ' ' TRP . 2.4 t-160 -79.85 110.12 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.321 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.991 HD11 ' SD ' ' A' ' 20' ' ' MET . 38.8 mt -69.41 -39.48 12.43 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.715 -0.616 . . . . 0.0 112.408 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.5 Cg_endo -73.59 -53.32 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.162 1.085 . . . . 0.0 111.92 -178.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 53.4 p -86.39 -21.39 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 110.322 -179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -8.83 57.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.4 m -70.56 163.28 27.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.187 -1.184 . . . . 0.0 110.162 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.27 148.15 44.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.845 . . . . 0.0 110.218 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 59.2 mt-30 -142.53 -170.97 3.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 29' ' ' TYR . 83.1 m95 -136.5 1.8 2.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.086 -1.009 . . . . 0.0 110.437 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.59 160.27 42.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.91 112.26 3.47 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.084 1.571 . . . . 0.0 110.477 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.6 ' HG3' ' CD2' ' A' ' 19' ' ' TRP . 46.0 Cg_endo -72.13 123.03 8.91 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.012 1.533 . . . . 0.0 110.436 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.56 36.68 0.29 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.51 85.83 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -1.127 . . . . 0.0 110.339 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.34 -179.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.295 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.51 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -75.97 -55.78 1.8 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 110.277 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 47' ' ' SER . 47.7 Cg_endo -74.21 122.6 7.68 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.868 1.457 . . . . 0.0 110.27 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 p -146.51 111.69 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.227 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.223 0.535 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -114.36 163.15 15.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 54.15 20.46 2.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -0.878 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -53.18 -30.88 39.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 110.372 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -44.5 125.52 4.8 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.75 -25.23 12.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.908 1.478 . . . . 0.0 110.391 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 7' ' ' ASN . 25.5 t-20 -103.21 44.11 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 110.24 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.42 68.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 110.256 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.69 121.92 16.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.25 -163.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.347 -0.845 . . . . 0.0 110.158 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -88.9 -168.52 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.245 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.609 ' H ' HG22 ' A' ' 11' ' ' THR . 0.5 OUTLIER -43.93 158.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.175 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 14' ' ' ASP . 9.6 p -77.56 -39.84 44.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 40.2 p-10 -178.94 53.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.338 -0.851 . . . . 0.0 110.246 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 30' ' ' TYR . 4.1 mm? -92.89 168.38 12.47 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 110.142 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 19' ' ' TRP . 43.6 Cg_endo -69.67 -160.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.905 1.476 . . . . 0.0 110.472 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.31 120.1 37.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 110.429 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.68 7.41 45.09 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.578 ' CD1' ' HG2' ' A' ' 16' ' ' PRO . 52.3 m95 -119.85 133.53 55.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.117 -1.226 . . . . 0.0 109.824 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.717 ' SD ' HD11 ' A' ' 33' ' ' ILE . 59.6 mmm -120.44 166.6 13.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HB2' ' OD1' ' A' ' 12' ' ' ASP . 6.0 ttt180 -121.08 111.34 17.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 29' ' ' TYR . 4.4 t -110.43 161.56 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 110.981 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.478 ' HG3' ' OG1' ' A' ' 28' ' ' THR . 0.1 OUTLIER -121.04 83.94 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.094 179.726 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.74 168.32 18.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -54.18 -35.5 62.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -32.61 73.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 110.23 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.85 -166.28 34.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 23' ' ' GLN . 24.0 m -101.44 113.4 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -1.122 . . . . 0.0 110.073 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 45.7 p90 -114.32 -157.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.604 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.591 ' HE2' HD11 ' A' ' 15' ' ' LEU . 27.6 m-85 -130.02 135.18 47.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.167 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.527 ' C ' ' CD1' ' A' ' 31' ' ' TRP . 7.3 t90 -105.4 121.84 44.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.43 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.562 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 3.2 t-160 -83.33 107.35 15.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.901 179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.717 HD11 ' SD ' ' A' ' 20' ' ' MET . 52.7 mt -67.42 -38.3 15.39 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.82 . . . . 0.0 112.372 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 33' ' ' ILE . 44.6 Cg_endo -73.5 -57.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.067 1.035 . . . . 0.0 111.529 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.406 ' OG1' ' ND1' ' A' ' 32' ' ' HIS . 13.9 p -86.89 -34.48 19.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.922 -1.111 . . . . 0.0 110.419 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 32' ' ' HIS . . . 98.68 -9.41 62.22 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 32' ' ' HIS . 1.6 m -62.89 156.68 23.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.397 -1.061 . . . . 0.0 110.348 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.477 HG22 ' CD2' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -120.29 159.57 24.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.167 -0.958 . . . . 0.0 109.554 179.331 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 37.5 mt-30 -144.33 -137.4 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 110.496 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -159.0 -48.37 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 42.1 mt-10 -92.45 165.54 19.22 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.647 -0.658 . . . . 0.0 110.002 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 44.4 Cg_endo -71.56 122.17 8.36 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.004 1.529 . . . . 0.0 110.292 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.57 92.71 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.913 1.48 . . . . 0.0 110.346 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.22 163.78 9.64 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -84.62 0.18 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -1.142 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.45 -55.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.147 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.38 152.12 7.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 49' ' ' SER . 46.6 Cg_endo -72.75 86.26 1.07 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.995 1.523 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 63.34 130.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 110.275 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.181 179.956 . . . . . . . . 1 1 . 1 stop_ save_